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ABSTRACT 
Investigation of Performance and Symptom Validity Testing in Children  
Utilizing Control, Simulation, and Clinical Groups 
 
 
Elisabeth M. Vogt 
 
Marquette University 2018 
 
 
 Integral to neuropsychology, assessment relies on valid self-report and credible 
performance on neuropsychological tests. Symptom exaggeration and misrepresentation 
of abilities confound interpretation of neuropsychological test data, subsequent diagnosis, 
and treatment. Measures evaluating performance and symptom validity have been 
extensively studied in adult populations; however, similar research in child and 
adolescent populations is limited. In accordance with recommended research 
methodology, this study utilized a simulation design with community recruited and 
medical center clinical criterion groups, which included 191 children and adolescents (7 
to 16 years old). Sensitivity, specificity, and proposed cut-off scores are described for the 
Victoria Symptom Validity Test, Digit Span Age Corrected Scaled Score, Reliable Digit 
Span, Reliable Digit Span-Revised, Rey Fifteen Item Test, and Automatized Sequences 
Task. Novel embedded performance validity indicators for WRAML-2 Verbal Learning 
were developed, and cut-off scores are proposed for recognition discriminability, d prime, 
and forced choice measures. Additionally, symptom validity scales from parent- and 
child-report questionnaires suggested that select parent-report BRIEF and BASC-2 and 
child-report BASC-2 validity scales distinguished simulators from control and clinical 
participants. This study meaningfully and substantially adds to the current understanding 
of objective validity measurement in youth neuropsychological assessment and provides 
a framework for future development and investigation of youth performance validity tests 
and youth and parent symptom validity tests.  
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Investigation of Performance and Symptom Validity Testing in Children Utilizing 
Control, Simulation, and Clinical Groups 
Neuropsychological assessment examines the brain-behavior relationship with 
specific focus on cognition, and emotional and behavioral functioning. 
Neuropsychological assessment has a rich history that evolved from the convergence of 
multiple fields, such as philosophy, science, and medicine, and continues to progress 
(Lezak, Howieson, Bigler, & Tranel, 2012). Today as an applied science, clinical 
neuropsychology focuses on the behavioral manifestation of cognitive impairment. 
Moreover, neuropsychological evaluation allows for the assessment of functioning across 
multiple cognitive domains that may be impaired due to neurological injury or disease 
(Bianchini, Mathias, & Greve, 2001). Neuropsychological evaluations inform clinicians 
and patients of a wide variety of important diagnostic and treatment-related issues that 
may include information about the presence or level of cognitive impairment, and the 
degree to which an individual is able to participate in treatment or other daily living 
activities (Schoenberg & Scott, 2011). This project specifically focused on 
neuropsychological assessment of children and issues that may affect the evaluation. 
Issues That may Affect Test Performance and Symptom Report 
There is an appreciation that misrepresentation of ability and symptom 
exaggeration are important issues to consider during test interpretation (Heilbronner et 
al., 2009). Misrepresentation of ability refers to the examinee’s inaccurate, diminished 
performance on neuropsychological tests. Symptom exaggeration refers to the act in 
which an examinee (or someone reporting on behalf of the examinee) over reports, or 
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fabricates, symptoms. Accurate reporting and credible performance are essential to 
accurately interpret neuropsychological assessment results. Non-credible performance or 
exaggeration of cognitive impairment results in an inaccurate quantitative representation 
of an individual’s actual abilities. Notably, performance and symptom invalidity are far 
more predictive of impairment on neuropsychological testing than severity of traumatic 
brain injury documented by neuroimaging and observed behavioral functioning (Lange, 
Pancholi, Bhagwat, Anderson-Barnes, & French, 2012). Thus, if not detected, 
performance and/or symptom invalidity confounds the diagnostic process and subsequent 
treatment for child, adolescent, and adult populations. In fact, inappropriate treatment 
may exacerbate an individual’s symptoms (Kirkwood, 2012) and result in inappropriate 
use of limited healthcare, educational, and other societal resources (Horner, VanKirk, 
Dismuke, Turner, & Muzzy, 2014).  
Neuropsychological evaluations are especially vulnerable to response distortion 
because the process requires cooperation and accurate reporting from the patient 
(Bianchini et al., 2001). To highlight the need for evaluation of validity in 
neuropsychological assessments, consensus statements by prominent neuropsychological 
organizations were developed to summarize empirical literature and to provide 
assessment, diagnostic, and general practice guidelines for validity assessment (American 
Academy of Clinical Neuropsychologists (AACN) Board of Directors, 2007; Bush et al., 
2005; Heilbronner et al., 2009). Further, recent case series have encouraged the 
incorporation of performance and symptom validity testing into child and adolescent 
assessments (McCaffrey & Lynch, 2017). Given that appropriately validated tools and 
tests must exist to provide quantifiable evidence of valid performance and symptom 
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report, clinical research related to validity assessment has drastically increased in recent 
years in adult populations (Berry & Nelson, 2010) and in child and adolescent 
populations (DeRight & Carone, 2015; Kirkwood, 2015).  
Development of Deception Abilities 
The development of the ability to misrepresent oneself or engage in deception is 
fundamentally relevant to research in child and adolescent performance and symptom 
validity testing. Development of deceptive abilities occurs throughout childhood. Some 
have erroneously concluded that children are not able to alter their performance or 
symptom report in a manner that would be considered valid (DeRight & Carone, 2015). 
In contrast to this opinion, developmental research suggests that abilities related to 
deception begin to develop in toddlerhood, and the ability to deceive significantly 
improves through early childhood. By around age eight, children can deny transgressions 
and consciously create false beliefs in others (Talwar & Lee, 2002). They are also able to 
sustain a lie by inhibiting verbal or non-verbal disclosure of deception and evade 
entrapment questions (Talwar, Gordon, & Lee, 2007). After age eight up to adolescence, 
deception becomes more sophisticated related to the development of executive 
functioning abilities (Anderson, 2002; Walczyk, Roper, Seemann, & Humphrey, 2003). 
By adolescence, deception skills are hypothesized to be similar to adults (Salekin, Kubak, 
& Lee, 2008). Thus, literature on the development of deception would suggest that by 
around age eight; children may be able to engage in response distortion. 
Further, experimental research documents the ability of children and adolescents 
to alter their symptom report and performance under the direction of researchers on 
  4 
 
neuropsychological testing in a manner that is believable (Baer, Kroll, Rinaldo, & 
Ballenger, 1999; Blaskewitz, Merten, & Kathmann, 2008; Faust, Hart, & Guilmette, 
1988; Gunn, Batchelor, & Jones, 2010; McKinzey, Prieler, & Raven, 2003; Nagle, 
Everhart, Durham, McCammon, & Walker, 2006; Rambo, Callahan, Hogan, Hullman, & 
Wrape, 2015; Rogers, Hinds, & Sewell, 1996; Stein, Graham, & Williams, 1995). In a 
seminal study, Faust and colleagues (1988) documented the ability of children to simulate 
believable impairment on neuropsychological testing. The simulated profiles and actual 
clinical profiles obtained from patients were then sent to numerous neuropsychologists 
for evaluation of response distortion. None of the neuropsychologists judged the profiles 
to be abnormal due to response distortion. Or said another way, no neuropsychologist 
viewed the results as invalid. Thus, given that children in research settings can produce 
believable, feigned profiles, it is imperative that clinicians consider non-credible report or 
performance, and research be conducted to identify it. 
Contexts in Which Children and Their Parents Misrepresent Themselves 
Multiple clinical cases of misrepresentation involving children also provide 
evidence that invalid symptom report or test performance occurs for numerous reasons 
(e.g. maintaining a sick role, avoiding legal consequences, securing monetary 
settlements). Those reasons may or may not be readily apparent to the clinician 
(Kirkwood, Yeates, Randolph, & Kirk, 2012). Invalid presentations are often identified in 
clinical contexts and research through diagnostic categories, namely conversion disorder, 
factitious disorder, and malingering (American Psychological Association; APA, 2013). 
For example, Libow (2000) identified 42 cases in which children and adolescents aged 8 
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to 18 years intentionally feigned (e.g., malingered) medical symptoms in order to assume 
sick roles for attention or to avoid other responsibilities (e.g. school attendance). Cases of 
malingering and malingering by proxy (or falsification of symptoms under the direction 
of someone else) also document the ability of children and adolescents to feign or 
exaggerate cognitive symptoms in neuropsychological evaluations in cases where 
external incentives are readily apparent. These clinical cases are documented in 
evaluations for various clinical conditions (e.g., Attention-Deficit/Hyperactivity Disorder; 
ADHD and mild Traumatic Brain Injury; mTBI; see Conti, 2004; Flaro, Green, & 
Blaskewitz, 2007; Kirkwood, Kirk, Blaha, & Wilson, 2010; Lu & Boone, 2002; Stutts, 
Hickey, & Kasdan, 2003), in disability evaluations (see Chafetz & Dufrene, 2014; 
Chafetz, & Prentkowski, 2011), and in forensic evaluations (see Flaro & Boone, 2009; 
Flaro et al., 2007).   
Invalid performance or symptom report is not invariably associated with 
conversion disorder, factious disorder, or malingering categories. For example, Flaro and 
colleagues (2007) reported that a nine-year-old boy had much larger than expected 
performance discrepancies between two cognitive evaluations. The initial evaluation 
documented low average intelligence and the presence of a reading disability, whereas 
evaluation a year later documented superior intelligence and reading abilities. As an 
explanation for these discrepant findings, the boy reported that the previous examiner 
was “mean,” so he was mad and did not do his best on testing. In this case, objective 
measurements of performance validity may have prevented misdiagnosis, utilization of 
unneeded special education services, setbacks to the child’s education, and the child’s 
frustrated response to being pulled out of class for services. Knowledge of child and 
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adolescent performance and symptom validity as well as parental symptom validity could 
provide objective evidence of credibility in evaluations like those clinical examples just 
presented. Ultimately, this would improve clinical practice because more accurate 
diagnoses and treatment recommendations would be provided by clinicians. 
Evidence related to base rates of invalid performance or symptom report in 
clinical, forensic or psychoeducational contexts has started to emerge. Notably, children 
and adolescents undergoing Social Security Administration disability evaluations for 
benefits display the highest rates invalidity; estimated at 26 to 60% of cases (Chafetz, 
2008; Chafetz, Abrahams, & Kohlmaier, 2007). It appears that parents may meaningfully 
influence the invalid presentation in those social security evaluations. In studies with 
children and adolescents who sustained a mild Traumatic Brain Injury (mTBI), base rates 
of invalid performance range from 12 to 20% (see Araujo et al., 2014; Baker, Connery, 
Kirk, & Kirkwood, 2014; Green, Kirk, Connery, Baker, & Kirkwood, 2014; Kirk, Hutaff-
Lee, Connery, Baker, & Kirkwood, 2014; Kirkwood, Connery, Kirk, & Baker, 2014; 
Kirkwood, Hargrave, & Kirk, 2011; Kirkwood & Kirk, 2010; Kirkwood, Peterson, 
Connery, Baker, & Grubenhoff, 2014; Kirkwood, et al., 2012). In mixed clinical 
populations, comprised of a variety of developmental, medical, and neurological 
conditions, base rates of invalid performance are typically estimated between 2 to 5% 
(see Donders, 2005; Green, Flaro, Brockhaus, & Montijo, 2012; Kirk, Harris, Hutaff-Lee, 
Koelemay, Dinkins, & Kirkwood, 2011; Ploetz, Mazur-Mosiewicz, Kirkwood, Sherman, 
& Brooks, 2014). Within college-aged samples undergoing psychoeducation evaluations, 
base rates of invalidity in ADHD evaluations are estimated at 15 to 47% (see Harrison & 
Edwards, 2010; Suhr, Hammers, Dobbins-Buckland, Zimak, & Hughes, 2008; Sullivan, 
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May, & Galbally, 2007), whereas in learning disability evaluations, performance 
invalidity base rates are approximately 15% (see Harrison, Edwards, & Parker, 2008; 
Sullivan et al., 2007). Unfortunately, literature related to base rates of child and 
adolescent invalid performance in psychoeducational evaluations is not available, though 
multiple papers documenting case studies of non-credible presentations exist (see 
Harrison, Green, & Flaro, 2012; Kirkwood et al., 2010; Lu & Boone, 2002). Thus, across 
settings in which psychological evaluations occur, documentation of non-credible 
presentations occurs.  
Performance and Symptom Validity Paradigms 
Larrabee (2012) proposed and defined the terms performance and symptom 
validity to provide clarity in validity research. These terms distinguish between self-
report and performance test methods. Performance validity is the credibility of 
performance on a measure assessing cognitive ability. Symptom validity refers to the 
accuracy or truthfulness of symptom reporting on self-report measures. Actual 
corresponding tests are therefore performance validity tests (PVTs) and symptom validity 
tests (SVTs; Larrabee, 2012).  
The overall goal of a PVT is to provide detection strategies for invalid cognitive 
performance. This detection involves non-credible, excessive impairment or an unlikely 
presentation that would be inconsistent with neuropsychological sequelae (Berry & 
Schipper, 2008). PVTs include stand-alone or embedded validity tests. A stand-alone 
PVT is a separate test specifically designed to assess credibility of performance, whereas, 
an embedded PVT reflects a psychometrically defined extreme cut score (e.g. a 
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benchmark that denotes passing or failure of a SVT or PVT) within a traditional 
neuropsychological test (Strauss, Sherman, & Spreen, 2006). Stand-alone PVTs are 
specifically developed to assess only the credibility of performance and designed to be 
exceptionally easy so that invalid performance is detected if test results are below a 
specific score or score range. As a result, diagnostic classifications may be optimized 
when using stand-alone measures (Bianchini et al., 2001), though the stand-alone 
measure must exhibit face validity consistent with actual measures of cognitive ability. 
The challenge in developing and utilizing embedded validity measures is that individuals 
with bona-fide impairment, or children and adolescents with developing cognitive 
abilities, may perform poorly on these measures due to actual relatively limited 
capabilities (Strauss et al., 2006). Subsequently, the floor must be low enough to avoid 
misidentifying an individual as providing invalid performance when his/her performance 
was credible (i.e., false positive classification). Thus, sensitivity of embedded PVTs may 
be moderate at best.  
SVTs are frequently scales developed within measures of psychological 
symptoms and assess the validity of responses (e.g. inconsistent responding to similar 
items or endorsement of highly atypical symptoms; Strauss et al., 2006). However, some 
SVTs were developed as stand-alone measures to only quantify validity of self-report 
(e.g., Structured Interview of Reported Symptoms (SIRS), Second Edition for adults; 
Rogers, Sewell, & Gillard, 2010). Typical categories of test taking attitudes are identified 
using the following methods: a) consistency in responding to similar items, b) attempts to 
appear desirable by responding in a positive light to infrequently endorsed items, c) 
  9 
 
efforts to create an overly negative, faked, or implausibly severe profile, and d) general 
engagement in responding (Hoelzle, Nelson, & Arbisi, 2012; Meehl & Hathaway, 1946).  
Research Methods Relevant to Performance and Symptom Validity Testing 
Investigation of performance and symptom validity testing poses unique 
challenges. A key challenge is that it is impossible to recruit participants that are 
genuinely and unmistakably providing an invalid profile in clinical contexts (Bigler, 
2012; Rogers, Harrell, & Liff, 1993). Individuals engaging in response distortion during 
clinical evaluations rarely, if ever, acknowledge doing so. As a result, PVT and SVT 
standardization studies must rely on simulation volunteers or other known clinical or 
forensic groups that exhibit a high likelihood of demonstrating invalid performance or 
symptom report to evaluate the clinical utility of measures (Brennan & Gouvier, 2006; 
Rogers, 2008).  
Performance and symptom validity research has primarily focused on adult 
populations. Only in very recent years have studies included child and adolescent 
samples (DeRight & Carone, 2015). The two most prominent performance and symptom 
validity design methods in adult research are known-groups comparison and simulation 
studies (Berry & Schipper, 2008; Rogers, 2008). However, in child and adolescent PVT 
and SVT research, descriptive studies are relatively common. The descriptive method 
involves administering a PVT to a clinical group of children and adolescents and then 
reporting the percentage of patients that “pass” (i.e., score above a previously determined 
cut score). The cut-off scores employed are frequently drawn from adult research. If a 
child or adolescent achieves a “passing” score based upon the adult cut-off score, it is 
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then suggested that the patient demonstrates valid performance or symptom report (e.g., 
Brooks, 2012). However, in these PVT and SVT descriptive studies, the researcher is 
unable to classify groups as providing valid or invalid performance based upon an 
established child and adolescent criterion. Thus, it is unknown if validity test failures are 
due to invalid performance or to other developmental factors.  
Conversely, the known-groups comparison design is a recommended method that 
includes individuals in real-world conditions that are classified by independent 
researchers according to their specific response style. This design may be utilized to 
determine cut-off scores and utility estimates of new PVTs and SVTs and to determine 
how performance and symptom invalidity are related to other factors (e.g. general 
neuropsychological test performance or daily functioning). For example, individuals in a 
clinical context with below-chance performance on two PVTs may be assigned to an 
invalid group, whereas individuals passing all PVTs would be assigned to the clinical 
control group (Slick, Sherman, & Iverson, 1999). A known-groups comparison approach 
includes two phases. First, groups are independently established based on whether the 
patient has provided a valid or invalid report or performance by, ideally, a well-
established criterion. Then the research team, blind to group assignment, investigates 
similarities or dissimilarities in order to determine how well a new validity measure may 
function, or to determine the effect of performance or symptom validity on other factors 
(e.g. performance on cognitive tests; Rogers, 2008). External or ecological validity is 
strong because participants have tangible incentives and consequences associated with 
the outcome of the assessment (Berry & Schipper, 2008). However, the initial 
classification of participants is challenging because researchers must utilize multiple, 
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empirically supported measures of validity classification (e.g., evidence from multiple 
PVTs, SVTs, and record review), and consensus is determined about cut-scores or other 
indicators for accurate classification. Thus, well-established criterion for validity is 
necessary in order to determine the initial group assignment. This requirement poses a 
particular challenge within child and adolescent populations due to the limited amount of 
information currently available for diagnostic classification statistics for the majority of 
PVTs and SVTs (DeRight & Carone, 2015; Kirkwood, 2012; 2015). Thus far, published 
PVT cut-scores from adult samples or youth mTBI samples have been primarily utilized 
to differentiate groups in multiple child and adolescent samples (see Appendix A).  
In response to limitations of descriptive and known-groups methods, simulation 
designs are recommended to initially investigate PVT and SVT diagnostic classifications 
prior to their use in known-groups comparisons (Rogers, 2008). The simulation design is 
an experimental method in which non-clinical participants are randomly assigned to a 
group a-priori, and those groups differ through instructions about how to complete study 
measures. The control group is asked to perform all tasks under standard procedures (e.g., 
to the best of one’s ability), while the simulation group is given instructions to produce a 
specific response style consistent with a specific disorder or cognitive impairment 
(Rogers et al., 1993).  
At the most basic level, simulation design includes only those two groups, 
simulators and controls. Thus, a common criticism of simulation research involves the 
assertion that simulators may not perform similarly to genuine patients who are feigning 
in clinical or forensic contexts since research participants do not encounter the same 
consequences associated with succeeding or failing PVTs and SVTs (Larrabee, 2012). 
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Consequently, external validity is weak, and it is unclear whether results of simulation 
research using only control and simulator groups can be generalized to clinical or 
forensic populations. On the other hand, the methodology of simulation designs is more 
complex than the designs previously described (e.g. descriptive studies and known-
groups comparison). Given the need for a standardized protocol, numerous decisions for 
experimental procedures must be made in simulation research in regards to instructions, 
incentives, and manipulation checks, which can all directly affect validity, but provide 
opportunity for strong internal validity (Brennan & Gouvier, 2006; Rogers, 2008). In 
addition, causal inferences can be made when differences arise between experimental 
groups since results are effectively testable (Berry & Schipper, 2008).  
Simulation research with only control and simulation groups has been effectively 
applied a number of times in child and adolescent assessment research. Utilizing non-
clinical samples, five PVT and two SVT studies sought to validate measures with 
variations on the specific simulation design that included: (a) community recruited 
control and simulation groups (Blaskewitz et al., 2008; Gunn et al., 2010; Rambo et al., 
2015) or (b) one non-clinical group of individuals that participated in both the control and 
simulation conditions (McKinzey et al., 2003; Nagle et al.,  2006; Rogers et al., 1996; 
Stein et al., 1995). Developmental literature suggests that children are capable of 
distortion or feigning, though documentation of ability to feign cognitive impairment or 
exaggerate symptoms in a research context is critical to simulation methodology. In most 
studies, children and adolescents in the simulation condition were able to feign cognitive 
impairment (see Blaskewitz et al., 2008; Gunn et al., 2010; Lucio, Durán, Graham, & 
Ben-Porath, 2002; McKinzey et al., 2003; Rambo et al., 2015) or exaggerate symptoms 
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(see Baer et al., 1999). However, in one study in which 6- to 12-year-olds completed both 
the simulation and control conditions, children were not able to suppress performance on 
a PVT (Nagle et al., 2006). It appears that requesting children to engage in two conditions 
in one session may negatively affect the experimental manipulation. Thus, internal 
validity may be optimized when children and adolescents participate in either control or 
simulation conditions. 
While the fore-mentioned studies documented child and adolescent ability to 
understand and comply with simulation conditions, it is unknown how children with 
clinical conditions (e.g. intellectual impairment) would perform on these same PVT or 
SVT measures. Documentation of PVT or SVT performance in children with clinical 
conditions is critical since performance should not be correlated with actual abilities 
(Strauss et al., 2006). Thus, exclusion of a clinical criterion group for comparison 
confounds results because it is unknown if individuals with bona-fide impairment would 
perform at a level consistent with simulators. In addition, it is unknown if the simulator 
group performance would be overly discrepant from a group with secondary gain 
incentives (e.g., forensic, compensation, or academic accommodations). Thus, while 
simulation design provides valuable information about non-clinical child and adolescent 
performance on PVTs and offers documentation of child and adolescent ability to feign, 
questions remain as to generalizability for clinical samples in which children and 
adolescents possess actual cognitive impairment or psychological disorders. 
The optimal and most rigorous simulation design for investigating PVTs and 
SVTs includes control, simulation, and criterion groups. To date, two symptom validity 
studies investigating the Minnesota Multiphasic Personality Inventory – Adolescent 
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(MMPI-A; Butcher et al., 1992) utilized this method without engaging participants in 
more than one condition (Baer, et al., 1999; Lucio et al., 2002). No PVT simulation 
studies, to date, have included a criterion group. In Baer et al. (1999) and Lucio et al. 
(2002), validity scales effectively discriminated between adolescents in clinical, non-
clinical control, and simulator groups providing confidence that the symptom validity 
scales could distinguish bona-fide patients from those providing invalid profiles. In 
addition, diagnostic classification statistics were derived for each validity scale at various 
cut-off scores, which made it possible to determine which scales and cut-off scores 
optimally differentiated between feigning and clinical groups. Simulation designs without 
criterion groups cannot effectively address how simulation results might compare to 
results from individuals in clinical settings who are engaging in some type of response 
distortion and who possess actual incentives or consequences; however, the fore-
mentioned studies (Baer et al., 1999; Lucio et al., 2002) could determine generalization 
of cut-off scores. While challenges would exist for recruitment of a criterion sample, data 
from these forensic or clinical populations is critical for application of simulation study 
results. 
In summary, multiple research designs are possible within PVT and SVT research 
(e.g. descriptive, known-groups comparison, and simulation). A primary research 
challenge is the inability to recruit individuals engaging in feigning due to real-world 
experiences and consequences (Bigler, 2012). Researchers are also faced with the 
challenge of balancing clinical relevance and experimental control, which can be 
inversely related (Rogers et al., 1993). Known criterion groups demonstrate better clinical 
relevance due to real-world situations that affect performance and symptom validity (e.g., 
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external validity), whereas, simulation and control groups allow the researcher to 
maximize internal validity, but participants do not experience the meaningful 
consequences or benefits associated with a clinical or forensic evaluation. Thus, the gold-
standard approach to evaluate PVTs and SVTs involves use of a control, simulation, and 
a criterion group (e.g. either forensic or clinical) to address internal and external validity 
concerns (Heilbronner et al., 2009; Rogers, 2008). Then, once criterion for valid report or 
test performance is reliably established, known-groups comparison designs are 
recommended (Larrabee, 2012). A very limited number of child and adolescent PVT and 
SVT studies are available that reflect recommended methodological approaches, thus, 
additional research is greatly needed. This study aims to fill that methodological gap in 
child and adolescent PVT and SVT literature. 
Aims 
To date, limited literature is available describing empirically derived cut-off 
scores for PVTs and SVTs in child and adolescent samples, despite documentation that 
children can engage in feigning in research settings and case studies demonstrating 
suppression of test performance or misrepresentation of symptoms to attain external 
rewards in clinical settings. Multiple PVT research studies are descriptive studies in 
which cut-off scores established with adults are applied to child and adolescent 
populations. For multiple measures, children can perform at a level consistent with valid 
performance in adults; however, given the methodological design of these studies, it is 
unclear if failures are due to invalid performance or related to other developmental 
factors. Further, children under 10 years are more likely to be identified as providing non-
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credible performance on some PVTs, so it seems that cut-off scores or measures may not 
be appropriate for all age groups (Constantinou & McCaffrey, 2003; Courtney, Dinkins, 
Allen, & Kuroski, 2003;  Donders, 2005; Perna and Loughan, 2013; Ploetz et al., 2014).  
Therefore, Aim 1 of the present study is to report PVT and SVT performance of 
children from clinical and non-clinical groups (e.g. control, simulation, community-
clinical, and medical center-clinical). Specifically, descriptive statistics, associations with 
age and intellectual functioning, and the percentage of children that were able to “pass” 
PVTs at adult or available child/adolescent cut-off scores is reported. It was hypothesized 
that the majority of children in the control and clinical groups would “pass” probabilistic 
measures of performance validity, whereas, younger children (e.g. under 10 years old) 
and children with greater degrees of cognitive impairment would demonstrate greater 
rates of PVT failure on embedded measures when using adult cut-off scores.  
Average performance of children in the simulation group was compared to the 
control, community-clinical, and medical center-clinical groups to determine if those 
children in the simulation group were able to suppress their performance on 
neuropsychological tasks and alter their responses on questionnaires to present with 
impairments (i.e., perform at a level suggesting “clinical” impairment). Based upon 
previous literature, it was hypothesized that children in the simulation group would be 
able to engage in response distortion and their PVT and SVT performance could be 
differentiated from control and clinical participants. 
Utility estimates (e.g. sensitivity and specificity) are exceptionally limited for the 
majority of PVTs and SVTs investigated, to date, in children. The strength of the 
simulation study approach is that it provides the opportunity for specific benchmarks of 
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validity to be established and their effectiveness for differentiation of key groups to be 
known. Subsequently, Aim 2 involved identification optimal cut scores for each included 
PVT and SVT utilizing the control, simulation, community-clinical, and medical center-
clinical groups. Based upon previously described literature, it was expected that stand-
alone PVTs would demonstrate better sensitivity and specificity than embedded 
measures. 
Additionally within Aim 2, multiple PVT measures were compared to determine 
which measures demonstrated optimal diagnostic classification cut-off scores. Previous 
literature suggested that the stand-alone measure the Victoria Symptom Validity Test 
(VSVT; Slick, Hopp, Strauss, & Thompson, 1997) would demonstrate better utility 
estimates than embedded measures; thus it was hypothesized that the VSVT would 
exhibit the strongest sensitivity and specificity when comparing stand-alone and 
embedded PVTs. 
To date, no PVT and SVT study with children has included parental report, nor 
has pediatric symptom validity been investigated in conjunction with performance 
validity in simulation research. VanDyke and colleagues (2013) reported that invalidity 
on a PVT does not necessarily equate with invalidity on symptom validity scales. While 
PVTs and SVTs are complimentary and help clinicians make decisions regarding the 
validity of a patient’s presentation, they are believed to assess different constructs. Thus, 
Aim 3 was to investigate the relationship between PVT and SVT validity in children in 
order to evaluate which measures converge and if certain tests possess greater utility. It 
was hypothesized that PVTs, relative to SVTs, would more effectively differentiate the 
control, simulation, community-clinical, and medical center-clinical groups. Further, it 
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was hypothesized that the parent/guardian would be able to simulate, or alter their report 
of child/adolescent emotional and behavioral functioning according to research 
instructions, since deception skills should be developed by adulthood. However, since no 
previous literature has investigated simulated parental report, it is unknown if SVT scales 
on parent-report measures will be useful for differentiation of control, clinical, and 
simulation parent groups.  
Method 
Participants 
 Four groups were included in this study. Three groups were recruited from the 
community. Children without a previously identified psychological diagnosis (e.g., 
ADHD, autism spectrum disorder, or intellectual disability) were assigned to the control 
or simulation groups. Whereas, children recruited from the community that had a 
previous diagnosis were within the community-clinical group. Inclusion criteria for the 
community-clinical group involved a previous DSM-5 diagnosis or a neurological 
condition (e.g., epilepsy) in the absence of a DSM-5 diagnosis. The fourth group included 
children seen for a clinical evaluation due to concerns for cognition in the context of 
neurological, medical, or developmental conditions. In order to identify participants for 
the fourth group, a retrospective chart review was completed to identify children 
evaluated in an academic medical center pediatric neuropsychology department that 
completed the VSVT as a part of their standard evaluation. The primary goal of the 
inclusion of two clinical groups (e.g. community-clinical and medical center-clinical) was 
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to ensure that criterion groups with varying levels of likely cognitive impairment were 
available for comparison and that one criterion group (e.g. community-clinical) did not 
possess any identifiable benefits from an evaluation. 
 Community Recruitment. 
For community recruitment, 8 to 16-year-old children and adolescents and their 
parent/legal guardian were recruited from community schools and through general 
advertisements. Institutional review board approval was obtained from Marquette 
University and the Medical College of Wisconsin. The principal investigator screened 
participants prior to scheduling a testing session. Importantly, parents and guardians were 
informed that participation in the research session would not constitute a diagnostic or 
academic accommodation evaluation and that cognitive test scores would not be provided 
in a report. This criterion, that the research session would not also constitute a clinical 
evaluation, decreased or eliminated the possibility of secondary gain issues impacting test 
performance or questionnaire responses. Children that had a prior psychological or 
neurological diagnosis (e.g. mood, behavior, or neurodevelopmental disorders) were 
assigned to the community-clinical group. Inclusion of this community-clinical criterion 
group ensured that the internal validity of measures administered was controlled so that 
direct comparisons could be made with the control and simulation groups. Children 
recruited from the community without a previous diagnosis were assigned to either the 
control or simulation group stratified by sex and age.  
Test sessions for community-recruited participants were completed at the 
Marquette University Center for Psychological Services. Since emotional and behavioral 
questionnaires were completed by the parent/guardian and the child or adolescent, critical 
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items from the Behavior Assessment System for Children-Second Edition (BASC-2; 
Reynolds & Kamphaus, 2004) were reviewed. When critical items were endorsed, the 
graduate student investigator conducted a risk assessment, discussed the item response 
with the parent/guardian, and followed Marquette University Center for Psychological 
Services procedures for self and/or other harm. During the course of the study, four 
children endorsed critical items. On two occasions, the child did not understand that the 
question referred to self-harm. On the other two occasions, the parent and child both 
reported awareness of self-harm desire during anger or frustration, and no evidence of 
suicidal intent were identified. Community referrals for therapy were provided to the 
parent/legal guardian in those cases and upon request from other families. After the test 
session was completed, the child selected a prize and received a Junior Researcher 
Certificate and a gift certificate to a restaurant. The parent/legal guardian received $20 
cash.  
Standard instructions. 
Parents and children in the community-clinical and control groups completed test 
measures and questionnaires according to standard testing procedures. After consent and 
assent were attained, parents were instructed to complete their questionnaires according 
to the standard manual instructions. Children received the following instructions prior to 
the start of their test session, “You’ll be doing a lot of things today, like looking at 
pictures, answering questions, and completing a task on the computer. Some things may 
be easy for you, but some may be hard. Just try your best.” After the test session, dyads in 
the clinical and control groups were thanked for their participation. 
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Simulation instructions. 
Following consent and assent procedures, children and adolescents in the 
simulation group completed three measures under standard conditions utilizing the same 
instructions that were given to the control and community-clinical groups. These 
measures were administered under standard conditions to ensure ability to identify 
numbers (e.g. the Bracken School Readiness Assessment; Bracken, 2007) and to obtain 
an estimate of intellectual functioning (e.g. Wechsler Intelligence Scale for Children – 
Fifth Edition (WISC-V) Vocabulary and Matrix Reasoning subtests; Wechsler, 2014). 
Meanwhile, the parent/guardian completed a demographics form in the lobby.  
Following those three tasks, the parent/guardian was asked to return to the testing 
room. The child or adolescent and their parent/guardian were informed that they were 
selected to be in the experimental group with special instructions (see Appendix B for 
child/adolescent and Appendix C for parent/guardian verbatim instructions). Consistent 
with simulation methodology recommendations, instructions were created and tested for 
clarity, ease of understanding, and a relatable scenario that provided context (Bianchini et 
al., 2001; Rogers, 2008). The child or adolescent was read a scenario in which they were 
asked to feign cognitive impairment as a means to reduce their workload at school. 
Comprehension was evaluated with a practice trial. Children and adolescents were also 
asked to describe instructions to the examiner to ensure instructions were understood. 
The parent/guardian received a similar scenario and was asked to respond to 
questionnaires in a manner that would assist their child in receiving academic 
accommodations.  
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In accordance with simulation methodology suggestions, debriefing and a 
manipulation check were utilized to, respectively, provide context and limit non-credible 
performance to the study and evaluate the participants’ recall, comprehension, and 
reported compliance with instructions (Bianchini et al., 2001). Following the test session, 
both the parent/guardian and child in the simulation group were informed of the study 
purpose and rationale for simulation (see Appendix D for verbatim debrief). Additional 
questions were addressed, as needed, regarding the experimental condition and aims of 
the research study. The child/adolescent and parent/guardian also completed a brief 
manipulation check, in which they rated their understanding of instructions and how 
accurately they followed the simulation instructions (see Appendix E). 
Academic Medical Center Recruitment. 
Recruitment of the medical center-clinical group entailed a retrospective chart 
review of patients that were seen for a clinical neuropsychological evaluation between 
January 1, 2016 through March 31, 2017 in the Medical College of Wisconsin (MCW) 
Pediatric Neuropsychology Department. These patients were referred for varied 
neurological concerns (e.g., seizure disorders), as a part of developmental follow-up 
clinics (e.g., cardiac conditions), or for general cognitive and behavioral concerns (e.g., 
attention problems). The purpose of the evaluations was to determine if the patient met 
criteria for a diagnosis and to provide treatment recommendations. The VSVT had been 
obtained for the department and providers could include the measure in the evaluation. 
Patients eligible for inclusion involved all children and adolescents, 7 to 16 years of age, 
that were administered the VSVT during their evaluation. Specific measures (Rey FIT, 
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AST, WRAML-2 Forced Choice Measure) included in the community-recruited sample 
were not administered to patients in the medical-center sample given that it would 
lengthen the evaluation. Further, parent questionnaires included in the community-
recruited sample were not routinely utilized in the medical-center group. The primary 
measure of interest was the VSVT. The Children’s Hospital of Wisconsin Institutional 
Review Board approved the retrospective chart review. 
Sample. 
 Child and adolescent participants [N = 191, Mage = 12.19 (2.80), age range 7.10 
to 16.11 years] in this study included community-recruited child/adolescent and 
parent/guardian dyads (n = 66) and medical center patients seen for a neuropsychological 
evaluation (n = 125). Previous research indicates that very large effect sizes (e.g., 
Cohen’s d > 1.00) are consistently observed in adult simulation research (Rogers, 2008) 
to validate PVTs and SVTs with control, clinical, and simulation groups. A-priori power 
analysis utilizing G*Power (Faul, Erdfelder, Buchner, & Lang, 2009) and the smallest 
observed effect size (Cohen’s d = 1.23, see Blaskewitz et al., 2008; Gunn et al., 2010; 
Nagle et al., 2006; Rambo et al., 2015) in child and adolescent simulation research 
indicated a sample size of 12 was needed to detect group differences in PVT and SVT 
performance for a two-tailed t-test with power set at 0.80, though a more conservative 
effect size (Cohen’s d = 1.00) indicated a sample of 17 participants was needed in each 
group. Post-hoc power analysis varied across analyses, however, for multiple PVTs (e.g., 
VSVT, Reliable Digit Span) observed power in the present study was generally > .92 to 
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detect a large effect size (Cohen’s d = 1.00), which indicated the present sample size was 
sufficient for research aims. 
Community-recruited children and adolescents [n = 66, Mage = 10.55 (2.50); age 
range 8.00 to 16.30; 54.5% male] all spoke English as their first language. 
Parents/guardians predominantly spoke English as their first language (98.5%, n = 65). 
Children/adolescents (Caucasian 69.7%, African American 18.2%, Bi/Multiracial 7.6%, 
Asian 1.5%, Native Hawaiian/Pacific Islander 1.5%, and Other 1.5%) and 
parent/guardians (Caucasian 71.2%, African American 18.2%, Bi/Multiracial 4.5%, 
Hispanic/Latino 1.5%, Asian 1.5%, and Other 3%) from the community primarily 
identified as Caucasian. They were subdivided into control [n = 23, Mage = 9.82 (2.10); 
52.2% male], simulation [n = 20, Mage = 11.72 (2.62); 50% male], and clinical [n = 23, 
Mage = 10.25 (2.52); 60.9% male] groups. Per study procedures, parent/guardians were 
assigned to the same group as their child in order to receive standard (control n = 23 and 
clinical n = 23) or simulation (n = 20) instructions. Children and adolescents were 
assigned to the community-clinical group if they had a pre-morbid diagnosis (see Table 
1). Of note, over half of the community-recruited clinical group had more than one 
psychological diagnosis [one diagnosis n = 10 (43.5%); two diagnoses n = 6 (26.1%); 
three diagnoses n = 3 (13%); four diagnoses n = 3 (13%); and six diagnoses n = 1 
(4.3%)]. The majority of participants in the community-clinical group had an 
Individualized Education Plan (IEP) or 504 Plan (56.5%, n = 13) and some participants 
(39.1%, n = 9) had taken a prescribed psychotropic medication prior to the research 
session. 
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Table 1 
DSM-5 Diagnoses of Clinical Participants 
 Community-Clinical  
(n = 23) 
Medical Center -Clinical  
(n = 125) 
ADHD 52.2% (12) 38.4% (48) 
Autism 21.7% (5) 4% (5) 
Intellectual Disability 17.4% (4)  6.4% (8) 
Learning Disorder 21.7% (5) 12% (15) 
Speech/Language 39.1% (9) 6.4% (8) 
Depressive Disorder 9.7% (2) 20.8% (26) 
Anxiety Disorder 52.2% (12) 19.2% (24) 
Trauma/Stress Disorder 0% 8% (10) 
Oppositional Defiant 4.3% (1) 0.8% (1) 
Note: DSM-5 = Diagnostic and Statistical Manual of Mental Disorders – Fifth Edition, ADHD 
= Attention-Deficit/Hyperactivity Disorder 
 
Retrospective chart review was conducted for children and adolescents [N = 125, 
Mage = 13.06 (2.55), age range 7.10 to 16.11 years, 48.8% male] that completed a 
neuropsychological evaluation at MCW and had a complete VSVT. Children/adolescents 
within the medical center-clinical group were predominantly Caucasian (52%; African 
American 15.2%, Hispanic/Latino 8%, Bi/Multi-racial 8%, Asian 1.6%, Other 0.8%, and 
Race/ethnicity not available 14.4%). Nearly half (48.8%, n = 60) of participants from the 
medical center-clinical group had an IEP or 504 Plan prior to their neuropsychological 
evaluation, and a quarter (24.8%, n = 31) had a prescribed psychotropic medication. 
Psychological disorder diagnoses from DSM-5 are described in Table 1. Of note, a 
quarter of the medical-center clinical group had more than one psychological diagnosis 
[No diagnosis n = 25 (20%); one diagnosis n = 67 (53.6%); two diagnoses n = 21 
(16.8%); three diagnoses n = 10 (8%); and four diagnoses n = 2 (1.6%)]. The majority of 
children and adolescents (n = 100) in the medical center-clinical group also had a medical 
or neurological diagnosis (Epilepsy 24%, n = 30; mild Traumatic Brain Injury 20.8%, n = 
26; moderate Traumatic Brain Injury 2.4%, n = 3; Brain tumor or lesion 10.4%, n = 13; 
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Congenital Heart Defect 3.2%, n = 4; Genetic Disorder 3.2%, n = 4; Encephalitis 3.2%, n 
= 4; other neurological condition 12.8%, n = 16). Of note, neurological diagnoses that 
represented less than 2% of the medical center-clinical sample were combined into the 
‘other neurological’ category and included, but were not limited to, multiple sclerosis, 
spina bifida, cerebral palsy, and hydrocephalus. 
Measures 
 Community-recruited children and adolescents completed the Bracken Number 
Identification task, subtests to estimate intellectual ability (WISC-V Vocabulary and 
Matrix Reasoning), embedded and stand-alone PVTs [WISC-V Digit Span Reliable Digit 
Span (RDS); Greiffenstein, Baker, & Gola, 1994; Reliable Digit Span-Revised (RDS-R); 
Spencer, Tree, Drag, Pangilinan, & Bieliauskas, 2010; Automatized Sequences Task 
(AST); Kirkwood et al., 2014; Rey Fifteen-Item Test (Rey FIT); Rey, 1964; Wide Range 
Assessment of Memory and Learning-Second Edition (WRAML-2) Verbal Learning 
subtest; Sheslow & Adams, 2003; VSVT)] and a mood and behavior questionnaire that 
includes symptom validity scales (BASC-2). To avoid test order effects, four different 
test orders were created and assigned randomly, though the WISC-V Vocabulary and 
Matrix Reasoning subtests and the Bracken Number Identification subtest were always 
administered first due to the simulation condition (see Appendix F for test orders). The 
parent/guardian completed two parent-observation mood and behavior questionnaires that 
contain symptom validity scales [BASC-2; Behavior Rating Inventory of Executive 
Function (BRIEF); Gioia, Isquith, Guy, & Kenworthy, 2000]. 
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 Children and adolescents from the medical center-clinical group completed the 
VSVT, and the majority completed the WISC-V Vocabulary (n = 120, 96%), Matrix 
Reasoning (n = 117, 94%), and Digit Span (n = 122, 97%) subtests. The majority of 
participants were administered the complete WISC-V, though some had completed an 
abbreviated WISC-V or another intelligence measure. A portion of the medical center-
clinical group (n =54, 43%) also completed the WRAML-2 Verbal Learning subtest. 
Bracken School Readiness Assessment. The Bracken School Readiness 
Assessment – Third Edition (Bracken, 2007) is utilized to determine a child’s 
understanding of early academic concepts related to color, letter, shape, and number 
identification. While the normative data is not relevant to the age group included in the 
proposed study (8 to 16 years of age), the Number Identification subtest was utilized to 
ensure that children included in the study possessed basic number knowledge since this 
skill is needed to complete PVT tasks. 
Wechsler Intelligence Scale for Children – Fifth Edition. Two subtests from the 
Wechsler Intelligence Scale for Children-Fifth Edition (WISC-V; Wechsler, 2014) were 
included to estimate verbal and non-verbal abilities. In the Vocabulary subtest, the child 
or adolescent was read a word and was asked to describe the meaning of the word. The 
vocabulary subtest assesses ability to access and express word knowledge. In the Matrix 
Reasoning task, the child was shown a pattern with a missing piece and selected a 
response from five options. Matrix Reasoning assesses non-verbal conceptual 
relationships utilizing inductive reasoning. 
Reliable Digit Span. Digit Span is a frequently administered WISC-V subtest that 
assesses verbal attention and working memory. Reliable Digit Span (RDS; Greiffenstein 
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et al., 1994) is an embedded effort measure in which a floor effect cut-off score was 
developed for evaluation of adult performance validity. RDS is calculated by summing 
the longest string of digits forward and backward in which there were no errors across 
two trials. Many individuals with well-documented cognitive impairment can repeat 
strings of digits consisting of 3, 4, or 5 digits reliably, thus failure to do so might suggest 
insufficient engagement. In adults, an RDS ≤ 7 indicates invalid performance. An 
additional cut score utilizing the achieved age-corrected scaled score (Digit Span Age-
Corrected Scaled Score; DS ACSS ≤ 5) from Digit Span has also been developed in adult 
samples to provide an alternative validity measure (Axelrod, Fitchenberg, Millis, & 
Wertheimer, 2006). In a sample of children and adolescents with mTBI, Kirkwood and 
colleagues (2011) established new cut-off scores (RDS ≤ 6 and ACSS ≤ 5) that resulted 
in moderate sensitivity and strong specificity. In contrast, in a more heterogeneous 
clinical sample of children and adolescents (Perna, Loughan, Hertza, & Segraves, 2014) 
and in a sample with children and adolescents with dual diagnoses (Loughan, Perna & 
Hertza, 2012), an optimal RDS cut-off score was ≤ 4. However, the higher pediatric RDS 
cut-off is more commonly referenced (see Araujo et al., 2014; Welsh, Bender, Whitman, 
Vasserman, & MacAllister, 2012). 
Reliable Digit Span-Revised. The WISC-V added a sequencing trial to Digit 
Span, in contrast previous versions of the WISC that only included forward and backward 
trials. Reliable Digit Span-Revised (RDS-R; Spencer et al., 2010) adds the reliable span 
(the longest string of numbers correct across two trials in the same set) from sequencing 
to reliable spans from forward and backward trials. Investigations with adult samples 
have suggested a RDS-R cut-off score of ≤ 11 was optimal for differentiating 
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undergraduates in control and simulation conditions (Reese, Suhr, & Riddle, 2012), 
Veterans that sustained a mTBI with valid or invalid test performance (Spencer, Axelrod, 
Drag, Waldron-Perrine, Pangilinan, & Bieliauskas, 2013), and Veterans with mixed 
clinical conditions with valid or invalid test performance (Young, Sawyer, Roper, & 
Baughman, 2012).  
Automatized Sequences Task. The Automatized Sequences Task (AST) was 
derived from the Sequences Task in the Children’s Memory Scale (CMS; Cohen, 1997), 
which assesses processing speed and the ability to mentally manipulate and sequence rote 
verbal information. The AST involves completing four basic tasks as quickly as possible 
(e.g., reciting the alphabet, days of the week, months of the year and counting to 20). 
Kirkwood and colleagues (2014) identified that saying the alphabet (≥ 8 seconds), 
counting to 20 (≥ 6 seconds), days of the week (≥ 4 seconds), months of the year (≥ 10 
seconds), and total test time (≥ 27 seconds), generally exhibited moderate sensitivity to 
invalid performance in a mTBI sample of 8- to 17-year-olds. 
Rey Fifteen-Item Test. The Rey FIT (Rey, 1964) is a stand-alone validity test that 
requires reproduction of familiar and repetitive stimuli (e.g. A, B, C), and thus, it is 
designed to be very simplistic so that even individuals with cognitive impairment can 
reproduce nearly all of the stimuli on the recall task. The number of items correctly 
recalled from the stimulus card is interpreted for validity, which in adult normative 
studies has resulted in divergent recommendations (Rey FIT total score ≤ 7, ≤ 8, ≤ 9, ≤ 
11) with higher benchmarks resulting in better sensitivity but lower specificity (Strauss et 
al., 2006). Child and adolescent literature suggested cut-off scores of ≤ 7 for non-clinical 
6- to 11-year-olds and < 9 for 8-to 17-year-olds with mTBI (Green et al., 2014). 
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However, younger children (< 10 years) exhibit generally poorer performance 
(Constantinou & McCaffrey, 2003) 
Boone and colleagues (2002) developed a novel FIT recognition task in which 
examinees are shown 30 items on a sheet, which include the 15 actual items and 15 foils. 
Due to documentation in adult PVT literature of varied sensitivity and specificity from 
the various recommended cut scores for the FIT recall task (Strauss et al., 2006), the FIT 
recognition task was designed to improve classification accuracy. Green and colleagues 
(2014) found that utilization of a FIT recall cut-score (< 9) yielded very poor sensitivity 
(.12), but excellent specificity (.98) in a child and adolescent mTBI sample. Whereas, the 
combination cut-score (< 26) had the best combined score (sensitivity = .55, specificity = 
.91).  
Wide Range Assessment of Memory and Learning – Second Edition. Multiple 
tasks assessing immediate and delayed memory and learning in visual and verbal formats 
are included in the WRAML-2. The verbal learning task assesses a child’s ability to 
learn, retain, and recall words from a list. A word list is presented multiple times, and the 
child or adolescent is asked to freely recall words from the list and then recognize the 
target words when verbally presented a list that includes target words and foils. To date, 
no studies have investigated possible WRAML-2 embedded validity measures.  
Embedded measures investigated using other verbal learning tasks include a 
recognition discriminability (RD) index, d prime (d’), and forced choice recognition. 
Investigation of the California Verbal Learning Test –Children’s Version (CVLT-C; 
Delis, Kramer, Kaplan, & Ober, 1994) RD index (assesses ability to distinguish target 
words from distracter words) indicated variability in recommended cut-off scores that 
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range from an age-corrected z-score of -0.5 in a mTBI sample (Baker et al., 2014) to age-
corrected z-score of -3.0 in a mixed clinical group (Brooks & Ploetz, 2015).  In adult 
PVT literature, d prime, has served as an embedded PVT in the California Verbal 
Learning Test-Second Edition (CVLT-II; Delis, Kramer, Kaplan, & Ober, 2000) 
recognition subtest (e.g., Curtis, Greve, Bianchini, & Brennan, 2006; Wolfe et al., 2010), 
but it has not yet been investigated in youth samples.  
For the purposes of this study, RD (i.e., ability to discriminate target words from 
distractors) and response bias (or tendency to acquiesce or nay-say) were calculated 
based upon descriptions provided in the CVLT-C manual (Delis et al., 2000).  A 
parametric signal detection statistic, d prime (z score that reflects the absolute difference 
between hit rate and false positive rate) was also calculated (Macmillan & Creelman, 
1991). Utilizing the recognition trial from the WRAML-2 Verbal Learning Task the raw 
number of hits, false alarms, misses, and correct rejections were identified for each 
participant. Then the hit rate ‘H’ (i.e., the proportion of YES trials to which a participant 
responded yes) and false alarm rate “F” (i.e., the proportion of NO trials to which a 
participant responded YES) were also calculated. Lastly, an excel calculator was used to 
determine the d prime statistic [d’ = z(H) – z(F)] which is the difference between the z-
transformations of the hit rate ‘H’ and false alarm rate ‘F’. 
Recently, an experimental forced-choice recognition task (FCR-C; Lichtenstein, 
Erdodi, & Linnea, 2017) was developed for the CVLT-C. Recommended cut-off scores 
varied in sensitivity (sn) and specificity (sp) (≤ 12, sn = .14, sp = .97; ≤ 13, sn = .15, sp = 
.94; ≤ 14/15 sn = .31, sp = .87) in this intial CVLT-C FCR-C study with children and 
adolescents (6 to 15 years of age) with mixed clinical conditions. A novel WRAML-2 
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Verbal Learning Forced Choice task was created for the purposes of this study (see 
Appendix G). Item content for foil type was based upon CVLT-II example. Children 8 
years and younger learn a 13-item word list, while children 9 years and older learn a 16 
item word list, thus forced choice length is 13 or 16 items dependent on age. 
Victoria Symptom Validity Test. The Victoria Symptom Validity Test (VSVT; 
Slick, et al., 1997) is stand-alone computer-administered, forced-choice PVT that 
includes 48 items. A 5-digit number is presented, must be retained briefly and then the 
examinee selects the correct answer from two 5 digit numbers. Items are “easy” (the 
study number and foil do not share common digits) or “difficult” (foils are identical to the 
study number except for transposition of two digits). Manual published VSVT cut scores 
include ranges for likely valid scores (≥ 16 total easy or difficult items correct and ≥ 30 
total items correct), questionably valid scores (8 to 15 total easy or difficult items correct 
and 18 to 29 total items correct), and invalid scores (≤ 7 total easy or difficult items 
correct and ≤ 17 total items correct). Cut scores are also available for examinee response 
latency on easy or difficult items (e.g.≤ 1.67 seconds average easy item response latency, 
≤ 2.68 difficult item response latency). In a mixed clinical sample study with 6- to 19-
year-olds, the majority of children could achieve VSVT scores in the manual-
recommended valid range for the total score (95%), easy items (97%), and difficult items 
(84%; Brooks, 2012). 
 Additional empirically derived VSVT cut-off scores have been proposed in adult 
samples. For example, in studies with adults who have intractable epilepsy (≤ 20 total 
difficult items correct; Grote et al., 2000; Loring, Lee, & Meador, 2005), adults who 
sustained a mTBI (≤ 22 easy items correct, ≤ 17 difficult items correct, and ≤ 40 total 
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items correct; Silk-Eglit, Lynch, & McCaffrey, 2016 and ≤ 18 easy items correct, ≤ 16 
difficult items correct, ≤ 39 total items correct; Jones, 2013) and undergraduate ADHD 
simulation samples (≤ 18 total difficult items correct; Frazier, Frazier, Busch, Kerwood, 
& Demaree, 2008) all suggested cut-off scores that are higher than manual 
recommendations and demonstrate better classification statistics.  
Behavior Assessment System for Children-Second Edition. The Behavior 
Assessment System for Children-Second Edition (BASC-2; Reynolds & Kamphaus, 
2004) is a system of questionnaires that assess emotional and behavioral difficulties in 
children, adolescents, and young adults. Child and adolescent versions were completed 
by youth, and the parent/guardian completed a parent-report version. Three validity 
scales are included that are sensitive to various aspects of response distortion (e.g., 
intentional dissimulation, lack of motivation to respond truthfully, or poor 
comprehension). The F index, also known as the ‘fake bad’ scale assesses excessive 
negativity. The L index, or ‘faking good’ scale, assesses for a response pattern in which 
the respondent tries to portray themselves in an overly positive or defensive manner. 
Finally, the V index, or validity index serves as a basic check for random and/or careless 
responding, poor reading comprehension, or uncooperative responding. For example, the 
child is asked to respond to nonsensical statements such as, “I drink 50 glasses of milk 
per day.” 
Alpha coefficients were derived for all BASC-2 scales (see Appendix H). 
Methodological limitations and measurement-based issues should be considered when 
interpreting reported alpha coefficients. Alpha coefficients reported are likely to be 
biased based on limited sample sizes (n ranged from 14 to 32) and the dimensionality of 
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scales. Simulation research suggest a sample size approaching 100 would be necessary to 
obtain unbiased alpha coefficients for these scales (Yurdugul, 2008). The BASC-2 
Technical Manual (Reynolds & Kamphaus, 2004) reports generally acceptable alpha 
coefficients for substantive scales (Parent-report questionnaires: α ≥ .72; Child and 
adolescent self-report α ≥ .67). The Technical Manual does not report validity scale 
internal consistency. While alpha coefficients for validity scales are technically below an 
acceptable range (see Appendix H; e.g., Child Self-Report: F Index α = .48; L Index α = 
.46; V Index α = .05), these values are not unexpected given the previously noted issues 
and the fact that validity scales are composed of indications of error variance rather than 
a substantive theoretical construct. Notably, the internal consistency of BASC-2 validity 
scales are similar to Personality Assessment Inventory (Morey, 2007) and Minnesota 
Multiphasic Personality Inventory-2-Restructured Form (Ben-Porath, Graham, & 
Tellegen, 2009) validity scales.  
Behavior Rating Inventory of Executive Function. The Behavior Rating 
Inventory of Executive Function (BRIEF; Gioia et al., 2000) is a frequently utilized 
parent-report measure to assess working memory, planning, organization, emotional 
control, and other executive function related behaviors. It includes two validity scales: 
Negativity and Inconsistency. The Negativity scale sums specific items endorsed as 
“almost always” to determine if the respondent provided an excessively negative or 
infrequent profile. The Inconsistency scale is used to identify random or careless 
responding or poor reading accuracy. These scales were validated in the normative group 
and selected clinical groups; however, no other external SVT studies investigating these 
validity scales have been conducted.  
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The BRIEF Technical Manual (Gioia et al., 2000) does not report internal 
consistency of the Negativity and Inconsistency scales. The internal consistency of 
BRIEF validity scales was acceptable (See Appendix I; Negativity α = .82; Inconsistency 
α = .89). Internal reliability for index (α ≥ .93) and sub-scales (α ≥ .78) was also 
acceptable, though slightly below reported alpha levels in the Technical Manual (α ≥ 
.81).  
Data Analysis 
This study was comprised of four groups (control, simulation, community-
clinical, and medical center-clinical), thus group similarities in age and estimated 
intellectual functioning were evaluated through multivariate analysis of variance. 
Additionally, it was important to determine if the stratification procedure for control and 
simulation group assignment was successful. Thus multivariate results and demographic 
characteristics were evaluated for similarity. Also in regard to sample characteristics, the 
ability of simulation participants to suppress performance on neuropsychological tasks 
and alter their responses on questionnaires in order to present with impairments was 
assessed through multivariate analyses. Simulation participants also completed 
manipulation check questionnaires, thus descriptive statistics were generated to evaluate 
instruction comprehension and adherence with children and parents. 
For the control and clinical groups, correlations of age, estimated intellectual 
functioning, and memory with PVTs are presented. Proposed PVT cut-off scores are 
available for VSVT, DS ACSS, RDS, RDS-R, Rey FIT, and AST from either adult or 
pediatric samples. The percentage of children and adolescents from the control and 
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clinical groups that can “pass” these PVT cut-offs are presented. Additionally, PVT 
“passing” rates for younger children and those with more significant cognitive 
impairment are displayed (i.e., FSIQ < 70). 
Receiver Operating Curve (ROC) analyses were conducted and classification 
statistics (e.g., sensitivity, specificity, predictive power) were generated for PVTs and 
SVTs that differentiated simulation participants from control and clinical participants in 
multivariate analysis and display acceptable AUC values.  Subsequently, optimal PVT 
and SVT cut-off scores were identified. Lastly, correlations between PVTs and SVTs 
were generated to evaluate the degree to which measures converge. 
Results 
Multivariate Analysis of Demographics 
Consistent with Aim 1, multivariate analyses were conducted to evaluate 
differences between the control, simulation, community-clinical, and medical center-
clinical groups in demographic characteristics and performance and symptom validity test 
results. Given multiple comparisons, Bonferroni correction was applied in each model. 
Levene’s test of homogeneity of variance was frequently violated, thus a more 
conservative alpha level (p < .01) was frequently utilized (Tabachnick & Fidell, 2013). 
In regard to demographic characteristics (see Table 2), multivariate analysis 
indicated that groups differed in age and years of education [Wilk’s ʌ = .779, F(6, 370) = 
8.21, p < .001, partial  The medical center-clinical group was significantly older 
[F(3, 186) = 16.62, p < .001, partial  and in a higher grade [F(3, 186) = 14.17, p 
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< .001, partial than the community-recruited control and clinical groups but was 
not significantly older than the simulation group. The community-recruited control and 
simulation groups did not significantly differ in age or years of education; thus, 
stratification on age was successful.  Additionally, the community-recruited simulation 
and control groups and the medical-center clinical group included an approximately equal 
number of males and females. 
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WISC-V Vocabulary and Matrix Reasoning subtests were utilized to estimate 
cognitive ability. Of note, participants assigned to the simulation condition completed 
Vocabulary, Matrix Reasoning, and Bracken number identification subtests prior to 
receiving simulation instructions. Community recruited and medical center groups 
differed in performance on the WISC-V Vocabulary and Matrix Reasoning subtests 
[Wilk’s ʌ = .791, F(6, 354) = 7.36, p < .001, partial  The medical center-clinical 
participants had significantly lower WISC-V Vocabulary subtests scores than the 
community recruited groups [F(3, 178) = 14.40, p < .001, partial  though, 
notably, group means were within the average range. The medical center-clinical 
Table 2 
Participant Demographics and MANOVA Results 
 Community MCW   
 Controla 
n = 23 
Simulationb 
n = 20 
Clinicalc 
n = 23 
Clinicald 
n = 125 
F Post hoc 
Age 
(years.months) 
9.82 (2.10) 11.72 
(2.62) 
10.25 (2.52) 13.06 
(2.55) 
16.62*** (a=b=c); (b = d) 
(a=c) < d 
Age range 8.02 - 15.04 8.01 - 
16.30 
8.00 - 16.11 7.10 - 
16.11 
  
Grade in school 4.39 (2.29) 6.35 (2.60) 4.78 (2.78) 7.47 
(2.58) 
14.17*** (a=b=c); 
(a=c) < d 
% female 47.8% (11) 50% (10) 39.1% (9) 51.2% 
(64) 
  
% Caucasian 56.5% (13) 85% (17) 69.6% (16) 52% 
(65) 
  
WISC-V 
Vocabulary (ss) 
11.57 (3.04) 12.60 
(3.07) 
10.74 (4.01) 8.58 
(2.94) 
14.40*** d < (a=b=c) 
WISC-V Matrix 
Reasoning (ss) 
10.78 (3.18) 11.00 
(3.34) 
9.00 (3.29) 8.73 
(3.10) 
4.98** d < (a = b);  
(c= d); (a=b=c) 
WISC-V Digit 
Span (ss) 
10.91 (2.07) 5.85 (4.72) 9.17 (3.23) 8.30 
(2.85) 
9.90*** b < (c = d) < a 
Bracken (Raw) 18 (0) 18 (0) 18 (0) -   
WRAML-2       
     Immediate 
     Recall (ss) 
10.18 (3.26) 6.60 (3.12) 10.52 (3.41) 9.07 
(2.52) 
7.56*** b < (a=c=d) 
     Delayed  
     Recall (ss) 
9.77 (3.88) 7.00 (3.69) 10.74 (2.83) 9.30 
(2.25) 
5.95** b < (a =c) 
Note: * = p < .05; ** = p < .01; *** = p < .001; WISC-V = Wechsler Intelligence Scale for Children – 
Fifth Edition; ss = scaled score; WRAML-2 = Wide Range Assessment of Memory and Learning – 2nd 
Edition. 
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participants also had significantly lower Matrix Reasoning subtest scores [F(3, 178) = 
4.98, p < .01, partial  than the community recruited control and simulation 
groups; however they had similar performance to the community recruited-clinical 
participants. Mean performance on Matrix Reasoning was also in the average range for 
all groups. Importantly, on estimates of intellectual functioning (see Table 2), simulation 
participants did not differ from control participants in word knowledge [t(41) = -1.11, p 
=.27] or nonverbal reasoning [t(41) = -0.22, p =.83], given that the Vocabulary and 
Matrix Reasoning subtests were administered prior to simulation instructions.  
Analysis of Simulation Adherence 
Also within Aim 1, assessment of simulation adherence was completed. 
Performance of children and adolescents assigned to simulate was evaluated to determine 
if they could intentionally suppress performance or alter responses. Following simulation 
instructions, participants performed more poorly than clinical and control participants on 
the WISC-V Digit Span [F(3, 183) = 9.90, p < .001task Simulators also suppressed 
memory performance (see Table 2) to be lower than control and clinical participants 
[Wilk’s ʌ = .82, F(6, 228) = 3.97, p < .001The simulation group also had poorer 
immediate recall of words from the WRAML-2 Verbal Learning task than the control and 
clinical groups [F(3, 115) = 7.56, p < .001, partial . Simulation participants also 
had poorer delayed recall of words than the control and community recruited-clinical 
groups but not the medical center-clinical group [F(3, 115) = 5.95, p < .01, partial 
after correcting for multiple comparisons.  
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In regard to symptom validity scales, child and adolescent simulators altered their 
response pattern on the BASC-2 which elevated the V Index [F(2, 62) = 5.71, p < .01, 
partial but not the other validity scales. Evaluation of non-symptom validity 
scales on the BASC-2 indicated that simulators did not differ from control or clinical 
participants on BASC-2 clinical scales [Wilk’s ʌ = .38, F(38, 88) = 1.44, p = 
.09Therefore, the request that simulators exaggerate cognitive symptoms associated 
with a brain injury did not cause them to exaggerate self-reported psychological 
difficulties.  
Parents/guardians assigned to the simulation condition also altered their response 
pattern on parent questionnaires which elevated the BASC-2 F Index [F(2, 63) = 8.64, p 
< .01, partial  and BRIEF Negativity scale [F(2, 63) = 14.56, p < .01, partial 
Of note, parents/guardians also altered responses in a manner that resulted in 
scale elevation on all BASC-2 clinical [Wilk’s ʌ = .25, F(36, 92) = 2.58, p < .001, partial 
50and BRIEF clinical [Wilk’s ʌ = .35, F(22, 106) = 3.31, p < .001, partial 
scales. Clinical scales from the simulation group were significantly different 
from control and clinical participants in nearly every scale (see Table 3). 
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Table 3 
Parent-report BASC-2 and BRIEF Clinical Scale Manova Results (T Scores) 
 Controla 
n = 23 
Simulationb 
n = 20 
Clinicalc 
n = 23 
F Post hoc 
BASC-2      
Composite Scores      
     Externalizing Problems 48.48 (9.61) 67.90 (19.68) 54.35 (12.41) 10.32*** (a = c) < b 
     Internalizing Problems 48.35 (10.85) 76.75 (17.62) 56.96 (13.42) 22.64*** (a = c) < b 
     Behavioral Symptoms 47.43 (8.36) 77.65 (22.24) 59.09 (10.55) 23.19*** a < c < b 
     Adaptive Skills 52.52 (8.96) 28.35 (16.08) 42.00 (9.70) 22.53*** a < c < b 
Scale Scores      
     Hyperactivity 49.96 (9.42) 69.55 (18.01) 57.43 (14.21) 13.70*** a < c < b 
     Aggression 50.61 (10.35) 62.20 (17.59) 51.57 (10.55) 5.11** (a = c) < b 
     Conduct Problems 48.35 (9.23) 66.45 (19.09) 52.83 (11.27) 10.16*** (a = c) < b 
     Anxiety 48.48 (12.34) 64.90 (8.60) 55.91 (13.67) 10.26*** (a = c) < b 
     Depression 49.74 (9.08) 74.55 (21.00) 55.96 (9.17) 18.34*** (a = c) < b 
     Somatization 47.74 (11.25) 75.70 (18.89) 55.13 (15.51) 18.73*** (a = c) < b 
     Atypicality 45.57 (3.87) 80.05 (23.84) 59.65 (12.57) 27.57*** a < c < b 
     Withdrawal 47.52 (9.64) 72.15 (18.40) 58.26 (13.33) 16.52*** a < c < b 
     Attention 47.78 (9.58) 69.40 (13.19) 59.70 (8.67) 22.80*** a < c < b 
     Adaptability 51.65 (9.38) 31.65 (14.27) 40.78 (10.17) 16.87*** b < c < a 
     Social Skills 49.91 (10.36) 35.25 (15.13) 46.26 (11.40) 8.07*** b < (a = c) 
     Leadership 54.65 (9.96) 35.15 (13.17 45.78 (10.53) 16.19*** b < c < a 
     Daily Living 50.91 (9.36) 29.25 (13.27) 41.57 (9.71) 21.56*** b < c < a 
     Communication 53.70 (7.31) 25.65 (15.85) 41.70 (10.80) 31.19*** b < c < a 
BRIEF      
     Inhibit 46.78 (8.71) 65.95 (16.31) 56.78 (11.58) 12.85*** a < c < b 
     Shift 47.65 (7.11) 72.85 (18.96) 63.13 (14.37) 17.67*** a < c < b 
     Emotional Control 48.39 (9.02) 64.90 (16.85) 57.13 (9.56) 10.05*** (a = c) < b 
     BRI 47.39 (7.97) 69.70 (18.39) 60.09 (10.53) 16.59*** a < c < b 
     Initiate 48.13 (7.52) 68.70 (15.65) 59.13 (11.06) 16.72*** a < c < b 
     Working Memory 50.09 (9.16) 74.15 (15.16) 63.22 (10.54) 22.74*** a < c < b 
     Planning 46.35 (8.15) 70.95 (14.11) 57.87 (9.12) 28.84*** a < c < b 
     Organization of Materials 51.96 (8.76) 60.30 (11.06) 53.52 (8.67) 4.59* (a = c) < b 
     Monitor 45.26 (8.32) 65.55 (14.08) 57.35 (11.59) 17.22*** a < (b = c) 
     MI 48.04 (7.79) 70.90 (15.41) 59.78 (9.24) 22.87*** a < c < b 
    GEC 47.78 (6.74) 72.10 (16.59) 60.74 (10.04) 23.74*** a < c < b 
Note: * = p < .05; ** = p < .01; *** = p < .001; BASC-2 = Behavior Assessment System for Children – Second 
Edition; BRIEF = Behavior Rating Inventory of Executive Function; Scores are displayed in T-scores. Bolded 
scores are considered clinically significant; Italicized scores are at risk, but sub-clinical. 
 
Finally, a manipulation check was conducted using a 5-pointlikert scale (see 
Appendix E) that was administered at the end of the testing session. Children and 
adolescents in the simulation group reported strong comprehension (M = 4.05, SD = 
1.03) of simulation instructions and moderate ability to follow the instructions (M = 3.47, 
SD = 1.02). Similarly, parents assigned to simulate indicated nearly complete 
understanding of instructions (M = 4.60, SD = 0.68) and moderate to strong ability to 
follow instructions (M = 3.90, SD = 1.52) while completing questionnaires. 
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Correlations of Age, IQ, and Memory with PVTs & SVTs 
In accordance with Aim 1, relationships between performance and symptom 
validity test results and age, estimates of intellectual functioning, and memory were 
evaluated for children and adolescents in the control and clinical groups (n = 171; see 
Table 4). Correlations for the control and clinical were first investigated separately and 
then, due to similarity, were combined in Table 4. Additionally, given the small control 
group sample size (n = 23) it was determined that correlations would be more stable if the 
medical center- and community-clinical groups were combined with the control group. 
VSVT scores were generally associated with age and estimates of intellectual functioning 
but generally not related to memory. Performance on the VSVT was weakly to 
moderately, positively associated with age and WISC-V Vocabulary. VSVT performance 
was also moderately, positively related to WISC-V Matrix Reasoning performance. 
VSVT total easy, difficult, and correct items were moderately, positively associated with 
WISC-V Digit Span. The easy latency time displayed a small, negative association with 
Digit Span. Additionally, immediate recall performance on the WRAML-2 word list was 
weakly, positively associated with the number of VSVT Difficult Items correct score. 
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Table 4 
Correlations of PVTs and SVTs with Age, Intellectual Estimates, and Memory for Control and Clinical 
Participants   
  Age 
WISC-V 
Vocab 
WISC-V 
Matrix 
Reasoning 
WISC-
V Digit 
Span 
WRAML-2 
Immediate 
Recall 
WRAML
-2 
Delayed 
Recall 
VSVT (n = 171) 
   
 
  
     Easy Correct .25*** .31*** .40*** .40*** .15 .12 
     Difficult Correct .30*** .29*** .45*** .38*** .20* .18 
     Total Correct .30*** .32*** .47*** .42*** .19 .17 
     Easy Latency1 -.46*** -.08 -.18* -.16* -.12 .03 
     Difficult Latency1 -.29*** .01 -.04 -.10 .02 .15 
Digit Span (n = 167) 
   
 
  
     ACSS -.03 .53*** .50*** -- .40*** .26* 
     RDS .23** .40*** .42*** -- .36*** .21* 
     RDS-R .29*** .44*** .43*** -- .39*** .23* 
WRAML-2 (n = 100) 
   
 
  
  Signal Detection        
     Discriminability .12 .26* .11 .28** .49*** .33** 
     Response Bias -.23* .01 -.02 .01 -.05 -.10 
     d Prime .22* .24* .15 .29** .50*** .35*** 
  Forced Choice       
     Raw Correct .75*** .18 -.01 .07 .11 .13 
     Percent Correct .01 -.12 -.05 -.05 .11 .10 
Rey FIT (n = 45) 
   
 
  
     Recall Correct .33* .39** .43** .17 .28 .26 
     Recognition .31* .33* .30* .12 .30* .25 
     False Positives .08 -.18 -.21 .01 -.16 .01 
     Combination Score .25 .35* .34* .11 .24 .22 
AST (n = 45) 
   
 
  
     Alphabet1 -.23 -.10 -.30* -.11 .03 -.13 
     Alphabet Errors -.08 -.01 -.27 -.12 -.27 -.05 
     Counting1 -.30* -.33* -.40** -.46** -.02 -.04 
     Counting Errors -.21 -.12 -.17 -.12 -.09 -.05 
     Days of Week1 -.31* -.35* -.32* -.41** -.10 -.27 
     Days of Week Errors -.15 -.36* -.22 -.36* -.23 -.27 
     Months1 -.35* -.25 -.30* -.09 -.06 -.14 
     Months Errors -.16 -.31* -.28 -.24 .02 -.02 
     Total1 -.36* -.25 -.37* -.19 -.04 -.16 
     Total Errors -.23 -.25 -.41** -.29 -.26 -.11 
BASC-2 (n = 45) 
   
 
  
     F Index -.12 -.32*  -.34* -.19 -.14 -.24 
     Consistency -.15 -.32* -.23 -.01 -.03 .01 
     L Index -.22 -.39* -.44** -.40** -.44** -.27 
     V Index -.26 -.10 -.17 -.14 -.09 -.07 
Note: * = p < .05; ** = p < .01; *** = p < .001; VSVT = Victoria Symptom Validity Test; Dif. = 
Difficult; 1 = time in seconds; DS ACSS = Digit Span Age Corrected Scaled Score; RDS = Reliable 
Digit Span; RDS-R = Reliable Digit Span Revised; WRAML-2 = Wide Range Assessment of Memory 
and Learning; Rey FIT = Rey 15-Item Test; AST = Automatized Sequences Task; BASC-2 = Behavior 
Assessment System for Children – Second Edition. 
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Embedded validity tests from the WISC-V Digit Span test were weakly, 
positively associated with age and delayed verbal memory, while moderately, positively 
associated with WISC-V Vocabulary and Matrix Reasoning and immediate verbal 
learning recall (see Table 4).  
Embedded validity scales on the WRAML-2 were somewhat associated with age 
and word knowledge and WRAML-2 recall conditions, though there was variability 
across measures. The Forced Choice task raw score was strongly, positively related to 
age, though notably, children and adolescents are administered a different number of 
items based on their age (i.e., 8 years and younger 13 items; 9 years and older 16 items). 
Percentage correct on the Forced Choice task was not associated with age. Recognition 
discriminability was weakly, positively associated with WISC-V Vocabulary and Digit 
Span, while moderately, positively related to WRAML-2 immediate and delayed recall 
conditions. Response bias was weakly, negatively associated with age. D prime was 
weakly, positively correlated with age and WISC-V Vocabulary, while moderately, 
positively correlated with WISC-V Digit Span and WRAML-2 immediate and delayed 
recall conditions. 
The Rey FIT tasks were generally associated with age and intellectual estimates. 
Rey FIT immediate recall was moderately, positively associated with age and WISC-V 
Vocabulary and Matrix Reasoning tasks. The Rey FIT recognition condition was 
moderately, positively associated with age, WISC-V Vocabulary and Matrix Reasoning, 
and WRAML-2 Immediate Recall. The Rey FIT combination score, which accounts for 
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recall and errors, was moderately, positively associated with WISC-V Vocabulary and 
Matrix Reasoning. 
In regard to the Automatized Sequences Task, completion time was generally 
associated with age and estimates of intellectual functioning, though there were variations 
across conditions. Time to say the alphabet was moderately, negatively associated with 
WISC-V Matrix Reasoning. Time to count to 20 and state the days of the week were 
moderately, negatively associated with age, and WISC-V Vocabulary, Matrix Reasoning, 
and Digit Span. Time to say the months of the year and total completion time were 
moderately, negatively associated with age and WISC-V Matrix Reasoning. The amount 
of errors on counting and months of the year were moderately, negatively associated with 
WISC-V Vocabulary; while the total number of errors across conditions was moderately, 
negatively correlated with WISC-V Matrix Reasoning. 
BASC-2 validity scales were generally negatively associated with word 
knowledge performance, though there was variability. The F Index was moderately, 
negatively associated with WISC-V Vocabulary and Matrix Reasoning. Consistency in 
responding was moderately, negatively related to WISC-V Vocabulary. The L Index was 
negatively, moderately correlated with WISC-V Vocabulary, Matrix Reasoning, and 
Digit Span, and WRAML-2 Immediate Recall. The V Index was not associated with age, 
intellectual estimates, working memory, or verbal memory tasks. 
Frequency of Invalidity 
For children and adolescents in the control and clinical groups, PVT and SVT 
results were investigated to determine what percentage of participants performed below 
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previously established cut-off scores to identify invalidity, which were derived from adult 
or pediatric mTBI samples. Additionally, the frequency of performance below established 
cut-off scores was evaluated in two clinical sub-samples a) children 10 years or younger 
(n = 58) and b) children with possible Intellectual Disability (ID; n = 14; see Table 5). 
Individuals assigned to the ID group either received a formal diagnosis of ID, had a Full 
Scale IQ of less 70, or obtained scaled scores of < 5 on both WISC-V Vocabulary and 
Matrix Reasoning subtests. Due to relatively restricted sample sizes, the two clinical sub-
samples include individuals from both the community and MCW clinical groups. 
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Table 5 
Percentage of Control and Clinical Participants at Previously Identified Cut-off Scores  
  Cut-off Control 
Community 
Clinical 
MCW 
Clinical 
≤ 10 years 
old 
Intellectual 
Disability 
(ID)g 
  n = 23 n = 23 n = 125 n = 58 n = 14 
VSVTa       
  Invalid       
     Easy Correct ≤ 7 0% (0) 0% (0) 0% (0) 0% (0) 0% (0) 
     Difficult Correct ≤ 7 0% (0) 0% (0) 0% (0) 0% (0) 0% (0) 
     Total Correct ≤ 17 0% (0) 0% (0) 0% (0) 0% (0) 0% (0) 
 Questionable        
     Easy Correct 8 - 15 0% (0) 4% (1) 5% (6) 9% (5) 29% (4) 
     Difficult Correct 8 - 15  5% (1) 22% (5) 18% (23) 26% (15) 57% (8) 
     Total Correct 18 - 29 0% (0) 9% (2) 6% (7) 11% (6) 36% (5) 
 Valid       
     Easy Correct ≥ 16 100% (22) 96% (22) 95% (119) 91% (52) 71% (10) 
     Difficult Correct ≥ 16 95% (21) 78% (18) 81% (102) 76% (42) 43% (6) 
     Total Correct ≥ 30 100% (22) 91% (21) 94% (118) 89% (51) 64% (9) 
Digit Span       
     ACSSb ≤ 5 0% (0) 26% (6) 13% (16) 15% (8) 64% (9) 
     RDSb ≤ 6 5% (1) 17% (4) 20% (24) 24% (13) 50% (7) 
     RDS-Rc ≤ 11 14% (3) 39% (9) 39% (39) 32% (10) 57% (8) 
Rey FITd       
     Recall Correctd ≤ 7 5% (1) 13% (3) -- 13% (4) 0% (0) 
     Combinatione < 26 41% (9) 35% (8) -- 52% (16) 50% (1) 
ASTf       
     Alphabet1 ≥ 8 18% (4)  26% (6) -- 28% (9) 0% (0) 
     Counting1 ≥ 6 23% (5)  35% (8) -- 38% (12) 0% (0) 
     Days of Week1 ≥ 4 14% (3) 22% (5) -- 22% (7) 0% (0) 
     Months1 ≥ 10 18% (4) 48% (11) -- 41% (13) 0% (0) 
     Total1 ≥ 27 18% (4) 39% (9) -- 38% (12) 0% (0) 
Note: Samples size varied for some measures since some tasks were only administered to community 
participants or due to missing data so both percentage and frequencies are reported. Cut-off scores were 
identified from the following publications; VSVTa = Slick et al., 1997 VSVT manual with adult 
normative data; ACSSb and RDSb = Kirkwood et al., 2011 child and adolescent mTBI sample; RDS-Rc = 
Spencer et al. 2013 and Young et al., 2012 adult veterans; Rey FIT  Recall Correctd = Blaskewitz et al., 
2008 child simulation study; Rey FIT Recognitione = Green et al., 2014 child and adolescent mTBI 
sample; ASTf = Kirkwood et al., 2014 child and adolescent mTBI sample; 1 = time in seconds 
 
No children or adolescents in the control and clinical groups exhibited invalid 
performance on the VSVT according to manual published cut-off scores. However, 
children and adolescents did exhibit VSVT performance in the “questionable” range. 
Additionally, children and adolescents were more likely to be in the “questionable” range 
if they were in one of the clinical groups, were younger or had an intellectual disability.  
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Using cut-off scores derived from pediatric mTBI samples, children and 
adolescents in the community and medical-center clinical groups were more likely to be 
classified as providing invalid performance on the Digit ACSS and RDS than controls. 
Additionally, younger children and individuals with intellectual disability were more 
likely to have invalid Digit ACSS and RDS scores. Cut-off scores for the RDS-R have 
not yet been established for a child and adolescent sample. When using the adult veteran 
derived RDS-R cut-off score, a third of children and adolescents would be within an 
invalid group and, notably, half of children with an intellectual disability would be within 
an invalid group. 
The Rey FIT and Automatized Sequences Task were only completed by the 
community recruited control and clinical participants (n = 46). A child and adolescent 
cut-off score for the Rey FIT Recall Correct Score had been previously established in a 
simulation study with only control and simulation participants. The majority of children 
in the present study could pass the previously established cut-off score, though the only 
children within the invalid range were 10 years or younger. A child and adolescent cut-
off score for the Rey FIT Combination Score was established using patients with mTBI. 
When applying that cut-off score to the current mixed clinical and control samples, over a 
third of children and adolescents would be classified as providing invalid performance, 
while half of children 10 and younger and individuals with intellectual disability would 
be within the invalid range. 
Cut-off scores for the AST were established from a child and adolescent mTBI 
sample. Approximately 15-20% of control participants would be identified as providing 
invalid performance if the previously established cut-off scores were utilized. Further, 20 
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to 50% of clinical participants would be identified as providing invalid performance. 
Additionally, younger children were more likely to exhibit performance in the invalid 
range. However, the two children with intellectual disabilities that completed the AST 
were able to perform within the previously established valid range. 
In summary, these results supported the hypothesis that a majority of children in 
the control and clinical groups would “pass” probabilistic measures of performance 
validity evidenced by the VSVT results. Additionally, the hypothesis that younger 
children (e.g., ≤ 10 years) and children with greater degrees of cognitive impairment 
(e.g., intellectual disability) would demonstrate greater rates of PVT failure on embedded 
PVTs was supported. 
Performance Validity Multivariate Analyses 
PVT performance differences were evaluated for simulator, control, and clinical 
groups in accordance with Aim 1 (see Table 6). Multivariate analysis indicated that 
groups differed in performance on the VSVT measures [Wilk’s ʌ = .84, F(15, 500) = 
2.17, p < .01, partial  The simulation group had significantly fewer VSVT easy 
items correct than the control or clinical groups [F(3, 185) = 6.77, p < .001, partial 
The simulation group also had significantly fewer VSVT difficult items correct 
than the control and medical center-clinical groups but not the community-clinical group 
[F(3, 185) = 4.84, p < .01, partial . Similarly, the simulation group had fewer 
VSVT total items correct than the control and medical center-clinical groups but not the 
community-clinical group [F(3, 185) = 6.25, p < .001, partial While VSVT 
easy item latency appears significantly different across groups, the more conservative 
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alpha level requirement was not met [F(3, 185) = 2.66, p < .05, partial Groups 
did not differ in VSVT difficult item latency [F(3, 185) = 1.08, p = .36, partial 
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Table 6 
Performance Validity Test Descriptive Statistics and MANOVA Results 
 Community MCW   
 Controla 
n = 23 
Simulationb 
n = 20 
Clinicalc 
n = 23 
Clinicald 
n = 125 
F Post hoc 
VSVT       
Easy Correct 23.50 (1.06) 19.53 (5.23) 22.83 (2.21) 22.45 (2.95) 6.77*** b < 
(a=c=d) 
Dif. Correct 21.64 (2.54) 16.95 (5.40) 19.04 (4.85) 19.95 (3.95) 4.84** b < (a = d) 
b = c 
Total Correct 45.14 (3.41) 36.47 (9.92) 41.87 (6.62) 42.38 (6.38) 6.25*** b < (a = d) 
b = c 
Easy Latency1 2.65 (1.24) 3.12 (2.61) 2.93 (1.30) 2.36 (1.05) 2.66*  
Dif. Latency1 4.13 (1.45) 4.28 (2.53) 4.26 (1.91) 3.76 (1.52) 1.08  
Digit Span       
DS ACSS 10.91 (2.07) 5.85 (4.72) 9.17 (3.23) 8.30 (2.75) 10.16*** b < d < 
(a=c) 
RDS 8.23 (1.07) 5.90 (2.51) 7.96 (1.94) 7.87 (1.73) 7.74*** b < 
(a=c=d) 
RDS-R 12.91 (1.48) 9.30 (3.81) 11.91 (3.15) 12.03 (2.79) 6.46*** b < 
(a=c=d) 
WRAML-2 Verbal Learning      
Signal Detection Measures      
Response Bias .05 (.24) -.04 (.32) .12 (.30) .07 (.30) 1.17  
   
Discriminability  
95.31 (3.46) 75.52 
(22.33) 
94.32 (5.72) 91.99 
(11.42) 
11.80*** b < 
(a=c=d) 
d Prime 3.66 (.61) 2.04 (2.06) 3.63 (.84) 3.46 (1.17) 8.24*** b < 
(a=c=d) 
Forced Choice      
Raw Score 14.73 (1.49) 11.60 (4.62) 14.70 (1.52 -- 8.28** b < (a=c) 
Percent Correct 99.68 (1.49) 74.36 (30) 100 (0.0) -- 16.25*** b < (a=c) 
Rey FIT       
Recall Correct 13.36 (2.50) 11.25 (4.67) 12.04 (3.88) -- 1.71  
Recognition  12.82 (2.26) 10.00 (4.86) 12.30 (4.08) -- 3.14* b < (a = c) 
False Positives 0.32 (0.89) 1.70 (2.81) 0.35 (0.71) -- 4.50* (a = c) < b 
Combination 
     Score 
25.86 (4.45) 20.05 (9.97) 23.39 (8.61) -- 2.80  
AST      
Alphabet1 6.32 (3.46) 15.80 
(10.83) 
8.17 (8.33) -- 8.10*** (a = c) < b 
Alphabet2  0.05 (0.21) 1.20 (1.82) 1.09 (3.37) -- 1.73  
Counting1 4.68 (1.13) 12.65 
(11.58) 
5.70 (2.67) -- 8.85*** (a = c) < b 
Counting2  0.05 (0.21) 0.65 (1.50) 0.26 (0.92) -- 1.96  
Days of Week1 2.45 (0.80) 5.70 (3.96) 3.00 (1.48) -- 10.79*** (a = c) < b 
Days of Week2  0.14 (0.35) 0.55 (1.15) 0.39 (0.58) -- 1.63  
Months1 8.00 (8.47) 11.80 (7.10) 11.48 (9.40) -- 1.35  
Months2 0.73 (2.33) 1.20 (1.74) 1.17 (1.47) -- 0.44  
Total1 21.45 
(12.02) 
46.30 
(30.37) 
28.35 
(18.21) 
-- 7.60*** (a = c) < b 
Total (Err.) 1.09 (2.43) 3.60 (5.39) 2.91 (3.55) -- 2.33  
Note: *p < .05; **p < .01; ***p < .001; VSVT = Victoria Symptom Validity Test; Dif. = Difficult; 1 = 
time in seconds; 2  = Errors; DS ACSS = Digit Span Age Corrected Scaled Score; RDS = Reliable Digit 
Span; RDS-R = Reliable Digit Span Revised; WRAML-2 = Wide Range Assessment of Memory and 
Learning; Rey FIT = Rey 15-Item Test; AST = Automatized Sequences Task 
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 Groups also differed in performance on embedded Digit Span validity measures 
[Wilk’s ʌ = .706, F(9, 387) = 6.62, p < .001, partial  The simulation group had a 
significantly lower Digit Span Age Corrected Scaled Score (DS ACSS) than all other 
groups, though the medical center-clinical group had a significantly lower score than 
community-clinical and control groups [F(3, 161) = 10.16, p < .001, partial The 
simulation group had a significantly lower RDS score than clinical and control groups 
[F(3, 161) = 7.74, p < .001, partial Similarly, the simulation group had a 
significantly lower RDS-R score than clinical and control groups [F(3, 161) = 6.46, p < 
.001, partial 
 Some of the medical center-clinical group (n = 54) completed the WRAML-2 
Verbal Learning task; whereas all of the community-recruited control, simulation, and 
clinical groups completed the verbal memory task and an experimental Forced Choice 
recall task. Response bias, recognition discriminability, and d prime indices were 
generated (Macmillan & Creelman, 1991). Two multivariate analyses were conducted for 
the WRAML-2 since the medical center-clinical group did not complete the experimental 
Forced Choice measure. Groups differed in measures of response bias, discriminability, 
and d prime [Wilk’s ʌ = .64, F(9, 250.83) = 5.64, p < .001, partial  Groups did 
not significantly differ on the response bias measure [F(3, 105) = 1.17, p = .33, partial 
 The simulation group performed more poorly than control or clinical groups on 
recognition discriminability [F(3, 105) = 11.80, p < .001, partial  and d prime 
[F(3, 105) = 8.24, p < .001, partial  
In the second multivariate analysis that included only the community-recruited 
control, simulation, and clinical groups, groups differed on WRAML-2 Verbal Learning 
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Forced Choice performance [Wilk’s ʌ = .63, F(4, 120) = 8.82, p < .001, partial  
The simulation group had fewer items correct on the Forced Choice task [Forced Choice 
total correct F(2, 62) = 8.28, p < .01, partial Forced Choice percent correct F(2, 
62) = 16.25, p < .001, partial 
The medical center-clinical group did not complete the remaining two PVTs; the 
Rey FIT and AST so multivariate analyses were conducted with only the community-
recruited groups. Community recruited groups differed on Rey FIT measures [Wilk’s ʌ = 
.74, F(8, 118) = 2.45, p < .05, partial  Groups did not differ in the total number 
of Rey FIT test stimuli remembered during an immediate recall condition [F(2, 62) = 
1.71, p = .19On a delayed recognition task, simulators performed more poorly than 
clinical or control participants [F(2, 62) = 3.14, p = .05, partial however, the 
alpha was larger than recommended value (p < .01) due to Levene’s test violationAlso 
on the delayed recognition task, simulators had more false positive errors than control or 
clinical participants [F(2, 62) = 4.50, p = .02, partial however, the alpha was 
also larger than the more conservative recommended value given homogeneity of 
variance violation Groups did not differ on the Rey FIT test combination score, which 
accounts for the number of correctly recalled items and recognition errors [F(2, 62) = 
2.80, p = .07
Completion time for the four AST conditions (e.g., saying the alphabet, counting 
to 20, saying the days of the week, and saying the months of the year), the total 
completion time, and error rate across the conditions and total error rate were evaluated 
and multivariate analysis suggested that groups differed [Wilk’s ʌ = .50, F(20, 106) = 
2.17, p < .01, partial  The simulators took longer to say the alphabet [F(2, 62) = 
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8.10, p < .001, partial count to 20  [F(2, 62) = 8.85, p < .001, partial  
and say the days of the week [F(2, 62) = 10.79, p < .001, partial than control or 
clinical participants. However, groups did not differ in the amount of time it took to say 
the months of the year [F(2, 62) = 1.35, p = .27]. When the amount of time was added 
together for all conditions, simulation participants were slower than control and clinical 
participants [F(2, 62) = 7.60, p < .001, partial Groups did not differ in the 
number of errors made in any condition [alphabet errors F(2, 62) = 1.73, p = .19; 
counting errors F(2, 62) = 1.96, p = .15; days of the week errors F(2, 62) = 1.63, p = .20; 
months of year errors F(2, 62) = 0.44, p = .65; total errors F(2, 62) = 2.33, p = .11 
 Similarly, symptom validity scales were investigated for group differences for 
both child and parent report in the community recruited groups (see Table 7). With 
respect to child and adolescent self-report, multivariate analysis of BASC-2 validity 
scales indicated that the overall model was not significant [Wilk’s ʌ = .78, F(8, 118) = 
1.94, p = .06 However, examination of the individual validity scales indicated that 
simulators had higher scores on the V scale than control or clinical participants [F(2, 62) 
= 5.71, p < .01, partial  Children and adolescents did not differ on the responses 
that comprise the BASC-2 F Index [F(2, 62) = 1.89, p = .16], Consistency scale [F(2, 62) 
= 0.87, p = .43], or the L Index [F(2, 62) = 1.03, p = .36]. 
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Table 7 
Community Recruited Child and Parent Symptom Validity Test MANOVA Results 
 Controla 
n = 23 
Simulationb 
n = 20 
Clinicalc 
n = 23 
F Post hoc 
BASC-2 Child      
     F Index .41 (.73) 1.20 (2.07) .65 (.94) 1.89  
     Consistency 7.50 (4.35) 8.85 (5.90) 9.30 (3.93) 0.87  
     L Index 3.18 (2.79) 4.10 (3.09) 4.52 (3.59) 1.03  
     V Index .14 (.47) 1.70 (2.92) .22 (.60) 5.71** (a = c) < b 
      
BASC-2 Parent      
     F Index .13 (.34) 2.60 (3.27) .74 (1.48) 8.64*** (a = c) < b 
     Consistency 7.22 (3.53) 8.15 (2.94) 8.65 (4.14) 0.94  
      
BRIEF Parent      
     Negativity .09 (.29) 3.20 (2.88) 1.61 (1.73) 14.56*** a < c < b 
     Inconsistency 2.30 (1.64) 2.60 (1.39) 3.30 (1.49) 2.63  
Note: *p < .05; **p < .01; ***p < .001; BASC-2 = Behavior Assessment System for Children – Second 
Edition; BRIEF = Behavior Rating Inventory of Executive Function 
 
 Multivariate analysis of parent report BASC-2 validity scales indicated that 
groups differed [Wilk’s ʌ = .76, F(4, 124) = 4.46, p < .01 Parents assigned to the 
simulation condition had higher scores on the F Index than parents in the clinical or 
control conditions [F(2, 63) = 8.64, p < .001, partial . This was still significant 
after utilization of a conservative alpha level due to violation of homogeneity of variance. 
Parents from control, clinical, and simulation groups exhibited consistency in their 
responses on the BASC-2 [F(2, 63) = 0.94, p =.40].  
Parents also completed the BRIEF and the overall model indicated that groups 
differed [Wilk’s ʌ = .64, F(4, 124) = 7.91, p < .001 Parents in the simulation condition 
had higher negativity scale scores than parents in control or clinical conditions  [F(2, 63) 
= 14.56, p < .001, partial  even with accounting for a more conservative alpha 
level given violation of Levene’s test. Parents in all groups provided consistent BRIEF 
responses [F(2, 63) = 2.63, p = .08]. 
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Receiver Operating Curve Analyses 
 
In accordance with Aim 2, analyses were conducted to identify optimal cut-off 
scores for PVTs and SVTs. Initially, Receiver Operating Characteristic (ROC) curves 
were constructed by comparing the simulation group sequentially to the control and two 
clinical groups. Area Under the Curve (AUC) values were evaluated for acceptability for 
each PVT (see Table 8) and SVT (see Table 9). General guidelines for interpretation of 
the magnitude of discrimination of the AUC involve the following a) ≥ .90 outstanding, 
b) .80 to .90 excellent, c) .70 to .80 acceptable d) .60 to .70 fair, and e) .50 no 
discrimination (Hosmer & Lemeshow, 2000). Not surprisingly, discrimination of PVTs 
between the control and simulation groups was generally better than discrimination 
between simulation and clinical groups, as evidenced by higher ROC AUCs.  
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Table 8 
PVT Area Under the Curve (AUC) Control and Clinical Groups Compared to the Simulation Group 
 Control Community 
Clinical 
MCW Clinical 
 n = 23 n = 23 n = 125 
VSVT    
     Total Easy Correct .76 .70 .67 
     Total Difficult Correct .75 .61 .66 
     Total Items Correct .75 .65 .66 
     Easy Latency1 .51 .56 .44 
     Difficult Latency1  .59 .55 .51 
    
Digit Span    
     DS ACSS .81 .73 .65 
     RDS .76 .71 .71 
     RDS-R .79 .69 .70 
    
WRAML-2     
     Response Bias .51 .60 .53 
     Discriminability % .69 .69 .68 
     d Prime .68 .70 .69 
     Forced Choice % Correct .74 .74 -- 
    
Rey FIT     
     Recall Correct .61 .50 -- 
     Recognition Correct .65 .64 -- 
     False Positives .66 .63 -- 
     Combination Score .64 .57 -- 
    
AST     
     Alphabet Time1 .79 .75 -- 
     Alphabet Errors .69 .60 -- 
     Counting Time1 .85 .78 -- 
     Counting Errors .61 .58 -- 
     Days of Week Time1 .82 .76 -- 
     Days of Week Errors .57 .47 -- 
     Months Time1 .76 .56 -- 
     Months Errors .62 .45 -- 
     Total Time1 .81 .68 -- 
     Total Errors .63 .41 -- 
Note: AUC = area under the curve; AUC values with at least acceptable discrimination are bolded (≥ 
.70); VSVT = Victoria Symptom Validity Test; Dif. = Difficult; 1 = time in seconds; DS ACSS = Digit 
Span Age Corrected Scaled Score; RDS = Reliable Digit Span; RDS-R = Reliable Digit Span Revised; 
WRAML-2 = Wide Range Assessment of Memory and Learning; Rey FIT = Rey 15-Item Test; AST = 
Automatized Sequences Task 
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Table 9 
Symptom Validity AUC for the Control and Community-Clinical Groups  
 Control Community Clinical 
BASC-2 Child   
     F Index .58 .52 
     Consistency .56 .44 
     L Index .59 .48 
     V Index .64 .63 
   
BASC-2 Parent   
     F Index .81 .72 
     Consistency .56 .49 
   
BRIEF Parent   
     Negativity .86 .66 
     Inconsistency .56 .37 
Note: AUC = area under the curve; AUC values with at least acceptable discrimination are bolded (≥ 
.70); BASC-2 = Behavior Assessment System for Children – Second Edition; BRIEF = Behavior Rating 
Inventory of Executive Function 
 
While it may be defensible to only examine classification statistics for PVTs and 
SVTs with at least acceptable AUC values, other literature highlights a drawback to this 
approach. For example, the AUC value summarizes test performance over the entire 
region of the ROC including areas in which attention would not be given (Lobo, Jiménez-
Valverde, & Real, 2007). Thus, further investigation of classification statistics was 
conducted if multivariate analyses indicated statistically significant group differences and 
AUCs were at least fair. Given these requirements, VSVT latency scores, WRAML-2 
response bias, Rey FIT recall and combination scores, and AST error scores were not 
investigated further. 
Classification Statistics and Cut-off Scores 
Given, the similarities between the community- and medical center-clinical 
groups in demographics (see Table 1), memory (see Table 2), performance validity (see 
Table 6), and particularly in AUC values (see Table 7), those two groups were combined 
  59 
 
for determination of diagnostic classification and optimal cut-off scores. While the 
medical-center clinical group and community-recruited clinical group differed in 
estimates of intellectual functioning and working memory (see Table 2), both groups 
were still within the average range. Further, the combined clinical group is primarily 
comprised of medical-center clinical participants who generally exhibit a higher degree 
of cognitive impairment than the community clinical groups. Thus, combining the groups 
leads to establishing more conservative PVT and SVT cut-off scores, which decreases the 
probability of incorrectly identifying a child or adolescent as putting forth insufficient 
effort when they are in fact trying to perform to the best of their ability.  
For clarification, diagnostic classifications refer to sensitivity, specificity, positive 
predictive power, and negative predictive power. Sensitivity (Sn) reflects the proportion 
of individuals with the condition of interest (COI) that are correctly classified by the test 
(Berry & Schipper, 2008; Bianchini et al., 2001; Slick, 2006). Specificity (Sp) is the 
proportion of individuals without the COI that are correctly classified. Sensitivity and 
specificity can be combined into an index of test accuracy that specifies the odds or 
likelihood of positive or negative test results. Thus, a positive likelihood ratio (LR+) 
indicates the odds of a positive test result coming from a COI+ individual, whereas, a 
negative likelihood ratio (LR-) indicates the odds that a negative result came from a COI- 
individual. Positive predictive power (PPP) provides the probability that an individual 
with a positive test result has the COI, whereas, negative predictive power (NPP) is the 
probability that individuals with a negative test result do not possess the COI. These 
diagnostic classification statistics are also referred to as utility estimates and are utilized 
to develop the cut-off scores, or benchmarks, to denote passing or failure of a SVT or 
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PVT (Strauss et al., 2006). Cut-off scores are considered optimal when specificity is at 
least 90% and sensitivity is maximized. 
Complete classification statistics (e.g., Sn, Sp, LR+, LR-, PPP, NPP) for every 
possible cut-off score for each PVT and SVT are presented in Appendices J through U. 
Only the optimal cut-off scores for PVTs and SVTs are presented in the following tables 
and text. Selection of optimal cut-off scores involved specificity of at least .90 while 
maximizing sensitivity.   
In general, PVT cut-off scores (see Table 10) were more conservative for clinical 
participants than control participants. While it was hypothesized that stand-alone 
measures of performance (see VSVT, Rey FIT, AST) would display better classification 
statistics than embedded measures (see embedded Digit Span, WRAML-2), that was not 
always the case. Optimal cut-off scores for most PVTs displayed moderate sensitivity 
when specificity was maximized. However, the Rey FIT and the AST Months of the Year 
condition displayed weak sensitivity. WRAML-2 discriminability, d prime, and the 
forced choice task show promise as novel embedded PVTs given that they display 
classification statistics that are consistent with, or better than, previously identified PVTs. 
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Table 10 
Optimal PVT Cut-off Scores and Classification Statistics  
 Cumulative %  
of sample at cut-score 
PVT Cut-
Score 
Sn Sp LR+ LR- PPP NPP Control/ 
Clinical 
Simulation 
VSVT          
     Easy Correct          
Control ≤ 21 .47 .95 10.42 .55 .90 .68 4.55% 47.37% 
Clinical ≤ 17 .37 .93 5.45 .68 .41 .92 6.76% 36.84% 
     Dif. Correct          
Control ≤ 18 .53 .95 11.58 .50 .91 .70 4.54% 52.63% 
Clinical ≤ 12 .32 .91 3.60 .75 .32 .91 8.78% 31.58% 
     Total Correct          
Control ≤ 34 .47 .95 10.42 .55 .90 .68 4.55% 47.37% 
Clinical ≤ 31 .42 .90 4.15 .64 .35 .92 10.14% 42.11% 
Digit Span          
     DS ACSS          
Control ≤ 7 .55 .95 12.10 .47 .92 .70 4.55% 55.00% 
Clinical ≤ 4 .50 .92 6.59 .54 .48 .93 7.59% 50.00% 
     RDS          
Control ≤ 6 .50 .96 11.50 .52 .91 .69 4.35% 50.00% 
Clinical ≤ 5 .45 .92 5.81 .60 .45 .92 7.75% 45.00% 
     RDS-R          
Control ≤ 10 .50 .91 5.50 .55 .83 .67 9.09% 50.00% 
Clinical ≤ 8 .50 .92 6.15 .54 .50 .92 8.13% 50.00% 
WRAML-2           
     
Discriminability  
         
Control ≤ 87.50 .60 .91 6.60 .44 .86 .71 9.09% 60.00% 
Clinical ≤ 75.00 .55 .95 11.14 .47 .73 .90 6.00% 55.00% 
    d Prime          
Control ≤ 3.0 .60 .91 6.60 .44 .86 .71 4.50% 60.00% 
Clinical ≤ 1.5 .55 .93 7.37 .49 .69 .87 7.50% 55.00% 
    Forced Choice 
% 
         
Control ≤ 92 .50 .95 11.00 .52 .91 .68 4.55% 50.00% 
Clinical ≤ 92 .50 1.00 0.00 .50 1.00 .70 0.00% 50.00% 
Rey FIT           
     Recognition           
Control ≤ 6 .35 1.00 0 .65 1.00 .63 0.00% 35.00% 
Clinical ≤ 3 .20 .91 2.30 .88 .67 .57 8.70% 20.00% 
False Positives          
Control ≥ 2 .30 .91 3.30 .77 .75 .59 4.55% 30.00% 
Clinical ≥ 2 .30 .96 6.90 .73 .86 .61 4.35% 30.00% 
AST          
     Alphabet          
Control ≥ 14 .55 .91 6.05 .50 .85 .69 9.09% 55.00% 
Clinical ≥ 19 .40 .91 4.60 .66 .80 .64 8.70% 40.00% 
     Count to 20          
Control ≥ 7 .65 .95 14.3 .37 .93 .75 4.55% 65.00% 
Clinical ≥ 8 .55 .91 6.33 .49 .85 .70 8.70% 55.00% 
     Days of Week          
Control ≥ 5 .50 1.00 0 .50 1.00 .69 0.00% 50.00% 
Clinical ≥ 6 .45 .96 10.35 .58 .90 .67 4.35% 45.00% 
Table 10 continued on next page 
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Table 10 
Optimal PVT Cut-off Scores and Classification Statistics 
        Cumulative %  
of sample at cut-score 
PVT Cut-
Score 
Sn Sp LR+ LR- PPP NPP Control/ 
Clinical 
Simulation 
AST          
     Months of 
Year 
         
Control ≥ 23 .10 .91 1.1 .99 .50 .53 9.09% 10.00% 
Clinical ≥ 22 .15 .91 1.73 .93 .60 .55 8.70% 15.00% 
     Total Time          
Control ≥ 45 .50 .91 5.50 .55 .83 .67 9.09% 50.00% 
Clinical ≥ 52 .40 .91 4.60 .66 .80 .64 8.70% 40.00% 
Note: Sn = sensitivity, Sp = specificity, LR+ = positive likelihood ratio; LR- = negative likelihood ratio; 
PPP = positive predictive power; NPP = negative predictive power; VSVT = Victoria Symptom Validity 
Test; Dif. = Difficult; DS ACSS = Digit Span Age Corrected Scaled Score; RDS = Reliable Digit Span; 
RDS-R = Reliable Digit Span Revised; WRAML-2 = Wide Range Assessment of Memory and Learning; 
Rey FIT = Rey 15-Item Test; AST = Automatized Sequences Task 
 
 With respect to SVT cut-off scores, one scale from each questionnaire (e.g., 
BASC-2 child report V Index, BASC-2 parent report F Index, and BRIEF parent report 
Negativity scale) was identified as distinguishing simulation participants from control or 
clinical participants (see Table 11). SVT sensitivity was slightly weaker than PVTs when 
specificity was maximized.  
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Table 11 
Community Recruited Control and Clinical SVT Classification Statistics 
 Cumulative %  
of sample at cut-
score 
SVT Cut-Score Sn Sp LR+ LR- PPP NPP Control Simulation 
BASC-2 Child          
     V Index          
Control ≥ 2 .35 .95 7.70 .68 .88 .62 4.55% 35.00% 
Clinical ≥ 2 .35 .91 4.03 .71 .78 .62 8.70% 35.00% 
BASC-2 
Parent 
         
     F Index          
Control ≥ 3 .40 1.00 0 .60 1.00 .66 0.00% 40.00% 
Clinical ≥ 4 .35 .96 8.05 .68 .88 .63 4.35% 35.00% 
BRIEF – 
Parent 
         
     Negativity          
Control ≥ 1 .75 .91 8.63 .27 .88 .81 8.70% 75.00% 
Clinical ≥ 5 .35 .96 8.05 .68 .88 .63 4.35% 35.00% 
Note: Sn = sensitivity, Sp = specificity, LR+ = positive likelihood ratio; LR- = negative likelihood ratio; 
PPP = positive predictive power; NPP = negative predictive power; BASC-2 = Behavior Assessment 
System for Children – Second Edition; BRIEF = Behavior Rating Inventory of Executive Function 
 
Correlations between PVTs and SVTs 
 Consistent with Aim 3, associations between PVTs and SVTs for the measures 
that effectively distinguished simulation participants from clinical and control 
participants were explored. Associations varied across measures (see Table 12). The 
BASC-2 parent report F Index was moderately, negatively associated with child 
performance on the VSVT difficult items (r(43) = -.30, p < .05), embedded Digit Span 
measures (DS ACSS r(43) = -.32, p < .05; RDS r(43) = -.32, p < .05; RDS-R r(43) = -
.46, p < .01), and Rey FIT recognition (r(43) = -.34, p < .05). The BASC-2 parent report 
F Index was moderately, positively associated with their child’s Rey FIT false positive 
score (r(43) = .39, p < .01). The BASC-2 self-report V Index was negatively, moderately 
correlated with WRAML-2 d prime (r(43) = -.34, p < .05) and Rey FIT recognition 
performance (r(43) = -.32, p < .05), while the BASC-2 self-report V Index was positively 
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associated with AST Counting (r(43) = .45, p < .01) and Total Time (r(43) = .52, p < 
.01). 
Table 12 
Correlations between PVTs and SVTs for Community Recruited Control and Clinical Participants 
 Brief  
Negativity 
BASC-2  
Parent F Index 
BASC-2  
Child V Index 
VSVT    
     Easy Correct .03 -.16 -.22 
     Difficult Correct -.18 -.30* -.27 
     Total Correct -.13 -.28 -.27 
Digit Span    
     DS ACSS -.10 -.32* -.14 
     RDS -.01 -.32* -.16 
     RDS-R -.07 -.46** -.24 
WRAML 2    
     Discriminability % .06 -.03 -.25 
     d Prime .14 -.05 -.34* 
     Forced Choice %  .09 .06 .05 
Rey FIT    
     Recognition  -.08 -.34* -.32* 
     False Positives .20 .39** .02 
AST    
     Alphabet  -.01 -.09 .16 
     Counting  -.09 .23 .45** 
     Days of Week  -.16 -.05 .32* 
     Months  .13 .20 .28 
     Total .03 .13 .52** 
Note: *p < .05; **p < .01; BASC-2 = Behavior Assessment System for Children – Second Edition; 
BRIEF = Behavior Rating Inventory of Executive Function; VSVT = Victoria Symptom Validity Test; 
Dif. = Difficult; DS ACSS = Digit Span Age Corrected Scaled Score; RDS = Reliable Digit Span; RDS-
R = Reliable Digit Span Revised; WRAML-2 = Wide Range Assessment of Memory and Learning; Rey 
FIT = Rey 15-Item Test; AST = Automatized Sequences Task 
 
Associations between PVTs and SVTs for simulation participants were conducted 
separately from the control and clinical participants, given inherent differences in 
instructions (see Table 13). Parent-report SVTs, BRIEF Negativity and BASC-2 F 
Indices, were not meaningfully associated with any youth PVT performances. However, 
the child and adolescent BASC-2 V Index was significantly, moderately associated with 
nearly all PVT measures, except the Rey FIT false positives and AST counting and 
alphabet completion time. 
  65 
 
Table 13 
Correlations between PVTs and SVTs for Community Recruited Simulation Participants 
 Brief  
Negativity 
BASC-2  
Parent F Index 
BASC-2  
Child V Index 
VSVT    
     Easy Correct .12 .09 -.46* 
     Difficult Correct .20 .15 -.49* 
     Total Correct .17 .13 -.51* 
Digit Span    
     DS ACSS .12 -.07 -.50* 
     RDS .28 -.02 -.48* 
     RDS-R .16 -.11 -.51* 
WRAML 2    
     Discriminability % .13 .01 -.50* 
     d Prime .12 -.01 -.49* 
     Forced Choice %  .27 -.06 -.59** 
Rey FIT    
     Recognition  .02 -.14 -.71** 
     False Positives .01 .08 .21 
AST    
     Alphabet  -.20 -.04 .44 
     Counting  -.31 -.03 .40 
     Days of Week  -.09 -.02 .46* 
     Months  -.12 -.16 .60* 
     Total -.24 -.05 .50* 
Note: *p < .05; **p < .01; BASC-2 = Behavior Assessment System for Children – Second Edition; 
BRIEF = Behavior Rating Inventory of Executive Function; VSVT = Victoria Symptom Validity Test; 
Dif. = Difficult; DS ACSS = Digit Span Age Corrected Scaled Score; RDS = Reliable Digit Span; RDS-
R = Reliable Digit Span Revised; WRAML-2 = Wide Range Assessment of Memory and Learning; Rey 
FIT = Rey 15-Item Test; AST = Automatized Sequences Task 
 
Discussion 
 Neuropsychological assessment relies on valid self-report and credible 
performance. Symptom exaggeration and misrepresentation of abilities may confound 
interpretation of neuropsychological test data, subsequent diagnosis, and treatment. The 
development of PVTs and SVTs has provided psychometric tools to evaluate the validity 
of test performance and self- and parent-report of symptoms. While PVTs and SVTs have 
been extensively studied in adult populations, literature regarding measures validated in 
child and adolescent samples is still emerging (DeRight & Carone, 2015; Kirkwood, 
2015).  
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Developmental research suggests that children are capable of deception (Talwar 
& Lee, 2002; Talwar et al., 2007) and that sophistication of deception improves with 
development of executive functioning (see Anderson, 2002; Walczyk et al., 2003) 
through adolescence (Salekin et al., 2008). While deception can be volitional, children 
and adolescents may also exhibit invalid profiles due to presence of a conversion or 
factitious disorder, or due to more nuanced or unknown reasons (see Flaro et al., 2007). 
Thus, it is not surprising that invalid performance and symptom report occur in child and 
adolescent clinical, forensic, and educational evaluations. Estimated base rates of invalid 
performance in clinical contexts range from 2 to 20% (see Kirkwood, 2015) and are 
much higher in disability contexts (26 to 60%; Chafetz, 2008; Chafetz et al., 2007). Rates 
of invalid performance and symptom report in child and adolescent psychoeducational 
evaluations are currently unknown; however, case studies document response distortion 
(Harrison et al., 2012; Lu & Boone, 2002). Clearly, there is a need to systematically 
examine how children and adolescents engage in response distortion during 
psychoeducational evaluations. 
While evidence of invalid performance and symptom report in child and 
adolescent evaluation is available in the literature and highlights the need for PVT and 
SVT use, consensus statements by prominent neuropsychological organizations also 
encourage pediatric validity assessment research (AACN Board of Directors, 2007; Bush 
et al., 2005; Heilbronner et al., 2009). Further, discussion of ethical considerations in 
child and adolescent assessment highlights the need for systematic evaluation of 
performance and symptom validity to prevent erroneous conclusions regarding 
functioning and subsequent treatment (MacAllister & Vasserman, 2015). Notably, a 
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recent survey documents a majority of pediatric neuropsychologists incorporate at least 
one PVT (92%) or at least one SVT (88%) within assessments (Brooks, Ploetz, & 
Kirkwood, 2016). Thus, it appears that routine PVT and SVT use is becoming an 
accepted practice. 
A primary challenge within child and adolescent PVT and SVT literature relates 
to available cut-off scores and the respective samples that scores and classification 
statistics are derived from. For example, survey results indicate that pediatric 
neuropsychologists most commonly utilize embedded PVTs, specifically; RDS, CVLT-C 
discriminability index, and CVLT-II forced choice (Brooks et al., 2016). However, 
recommended cut-off scores for RDS and the CVLT-C discriminability index vary 
depending on sample (e.g., mTBI see Baker et al., 2014; Kirkwood et al., 2011; or 
neurological conditions see Brooks & Ploetz, 2015; Perna et al., 2014). Further, the 
CVLT-II Forced Choice cut-off score has not been validated with adolescents (Schwartz 
et al., 2016). Frequently in child and adolescent PVT literature, studies have described 
rates at which youth can pass PVTs at adult derived cut-off scores (e.g., Brooks, 2012), 
have utilized youth control and simulation groups without corresponding clinical groups 
(e.g., Blaskewitz et al., 2008), or commonly utilized cut-off scores are derived from 
mTBI samples which are inherently less cognitively impaired than other medical, 
neurological, or developmental populations (e.g., Kirkwood et al., 2014). Thus, 
interpretation of some available PVT cut-off scores can be challenging. Further, a paucity 
of research related to parent and child SVTs outside of standardization samples exists, 
even though neuropsychologists report they commonly utilize the BRIEF and BASC-2 
SVTs (Brooks et al., 2016).  
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Further, some clinicians have expressed concerns regarding the use of PVTs and 
SVTs with young children or individuals with cognitive impairment (Brooks et al., 2016). 
These concerns are consistent with some literature that has highlighted limitations of 
PVTs with young children (e.g., Rey FIT see Constantinou & McCaffrey, 2003, or 
Lichtenstein et al., 2017; Computerized Assessment of Response Bias (CARB); Allen, 
Conder, Green, & Cox, 1997, see Courtney et al., 2003; Word Memory Test WMT; 
Green, 2003 see Courtney et al., 2003). Research that documents PVT performance from 
children and adolescents with cognitive disabilities (Carone, 2014; Gidley-Larson et al., 
2015; Green & Flaro, 2014) is still emerging. Thus, concerns related to the use of PVTs 
and SVTs appear to have merit, given the current body of literature. Thus, the present 
study sought to evaluate those concerns in cut-off score validation. 
The primary goal of the present study was to identify youth appropriate validity 
cut-off scores for children and adolescents with various neurological, medical, and 
developmental conditions. Therefore, through a recommended validation approach 
utilizing control, simulation, and two clinical groups, the present study sought to 
investigate numerous PVTs and parent- and child-report SVTs.  Non-clinical participants 
were assigned to control or simulation conditions using a stratified method based upon on 
age and sex. The two clinical groups in the present study were intentionally selected; the 
medical-center pediatric neuropsychological practice represents standard clinical practice, 
and a community-recruited clinical group eliminates potential secondary gain issues 
associated with securing a diagnosis.  
An important component of this project was to evaluate whether children, 
adolescents, and parents can simulate. In response to a brain injury scenario, children and 
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adolescents did simulate cognitive impairment on performance tasks (WRAML-2 Verbal 
Learning, WISC-V Digit Span) by performing at a level below clinical participants. This 
finding is consistent with previous literature that has documented that children and 
adolescents can feign cognitive impairment (see Blaskewitz et al., 2008; Gunn et al., 
2010; Lucio et al.,, 2002; McKinzey et al., 2003; Rambo et al., 2015). With respect to 
SVT completion, while youth altered response patterns on a self-report questionnaire 
(BASC-2) to elevate one validity scale, clinical scales reflecting psychological issues 
were not elevated. In a novel aspect of this research, parents altered their response 
patterns on two observer-report questionnaires (BRIEF and BASC-2) to a degree that 
generally reflected clinical impairment in emotional and behavioral domains. Therefore, 
our hypothesis was partially supported. It appears that youth could suppress cognitive 
performance, but they may not have possessed insight into how feigned cognitive 
symptoms might affect their emotional or behavioral functioning or the ability to 
complete daily activities. Whereas, parents could exaggerate symptoms indicating that 
they may have been able to consider how cognitive symptoms might affect emotional, 
behavioral, and adaptive functioning.  
With respect to PVT performance in the current study, cut-off scores from 
previous studies were considered to determine false positive rates. Additionally, PVTs 
were evaluated for relationships with age and cognitive tasks. Finally, cut-off scores 
derived from the present study are presented and discussed. These considerations are 
presented for all PVTs in the study in the following order: VSVT, embedded Digit Span 
measures, embedded WRAML-2 measures, Rey FIT, and AST. 
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Victoria Symptom Validity Test 
Investigation of currently available VSVT cut-off scores derived from adult 
standardization samples in the manual revealed that the majority of control, community-
clinical, and medical center-clinical participants could ‘pass’ VSVT easy items (≥ 16 
easy items correct, ≥ 95% passed) and total items (≥ 30 total items correct ; ≥ 91% 
passed). However, only 78% of the community-clinical and 81% of the medical-center 
clinical participants could achieve a score in the valid range for VSVT difficult items 
correct. The only other study to investigate the VSVT in youth sample described similar 
pass rates (Brooks, 2012). Further, only 76% of children younger than 10 years of age 
and only 43% of individuals with an intellectual disability could achieve a VSVT 
difficult items score in the manual recommended valid range. It is clear that it would be 
inappropriate to apply adult-derived cut-off scores to a youth clinical sample. 
Thus, empirically derived VSVT cut-off scores are necessary for youth with 
clinical conditions. Optimal cut-off scores were proposed based upon achievement of at 
least 90% specificity while maximizing sensitivity.  Based upon clinical participant 
performance, optimal cut-off scores to indicate invalid performance are: VSVT easy 
items ≤ 17 (Sn = .37, Sp = .93), difficult items ≤ 12/13 (Sn = .32, Sp = .91), and total 
items ≤ 31 (Sn = .42, Sp = .90); however, a clinician may wish to further maximize 
specificity to avoid false positives by utilizing other scores proposed in Appendix J (e.g., 
VSVT easy items ≤ 7 Sn = 0.00, Sp = 1.00), though sensitivity is sacrificed. Other scores 
investigated such as VSVT item response latencies were not useful for discrimination of 
simulation participants from control or clinical participants. 
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Notably, VSVT performance was significantly associated with age, estimates of 
intellectual ability, and working memory, but not verbal memory. Similarly, Brooks 
(2012) found VSVT performance was related to age, intelligence, processing speed, but 
not sustained attention or memory. Therefore, clinicians may wish to consider this 
information when selecting a PVT to utilize if there are known cognitive deficits. 
Nonetheless, VSVT cut-off scores presented above are considered appropriate for a youth 
clinical sample. 
Embedded Digit Span Performance Validity Measures 
Regarding embedded digit span measures, RDS (≤ 6) and ACSS (≤ 5) cut off 
scores have been previously established in an mTBI sample (Kirkwood et al., 2011), and 
are higher than those derived utilizing more heterogeneous clinical samples (≤ 4; 
Loughan et al., 2012; Perna et al., 2014). The cut-off score established with a mTBI 
sample resulted in a high degree of false positives (35-39%) in samples of children and 
adolescents with epilepsy (Welsh et al., 2012) and a non-clinical community sample 
(Blaskewitz et al., 2008). Similarly, the present study documents that if cut-off scores 
derived from an mTBI sample are applied, there is an unacceptable number of false 
positives within this mixed clinical sample (RDS ≤ 6 =17-20%; DS ACSS ≤ 5 = 13 – 
26%). Understandably, false positive risk was even higher with children younger than 10 
(15-24%) and youth with intellectual disability (50-64%). Proposed cut-off scores in this 
mixed clinical sample displayed moderate sensitivity when specificity was optimized (DS 
ACSS ≤ 4 Sn = .50, Sp = .92; RDS ≤ 5 Sn = .45, Sp = .92). Though an RDS ≤ 4 (Sn = 
.40, Sp = .99) cut-off score in this mixed clinical sample was consistent with 
  72 
 
classification statistics presented elsewhere (Loughan et al., 2012; Perna et al., 2014), 
there is a decrease in sensitivity.   
While RDS has been investigated with children and adolescents (e.g. Araujo et 
al., 2014; Blaskewitz et al., 2008; Kirkwood, et al., 2011; Welsh et al., 2012), the utility 
of incorporating reliably accurate performance on the sequencing trial had not yet been 
considered as an indicator of task engagement. RDS-R has exhibited more optimal 
classification statistics than RDS in preliminary adult studies (e.g. Reese et al., 2012; 
Spencer et al., 2013; Young et al., 2012). The proposed adult RDS-R cut-off score (≤ 11) 
was clearly not appropriate for a youth sample due to high false positive rates in clinical 
participants (39%), children younger than 10 (32%), and youth with intellectual disability 
(57%). A novel RDS-R proposed cut-off score (≤ 8, Sn = .50, Sp = .92) displayed similar 
sensitivity and specificity to other embedded digit span measures (i.e., RDS; DS ACSS). 
Nevertheless, clinicians and researchers may wish to utilize this embedded measure 
because it incorporates the entire WISC-V digit span task for a slightly larger and more 
continuous evaluation of task engagement.  
It is important to keep in mind that RDS and RDS-R are derived from a task that 
assesses simple verbal attention and working memory (Wechsler, 2014), which can be 
affected by multiple neurological conditions. Supporting the notion that Digit Span 
performance is associated with cognitive constructs, RDS and RDS-R were associated 
with estimates of intellectual functioning and verbal memory. It is reasonable that RDS 
and RDS-R are correlated with other areas of cognitive functioning given that these 
scores are raw scores (i.e., not age corrected) and cognitive functions are generally 
related. Importantly, a recent survey of pediatric neuropsychologists reported that RDS is 
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the most commonly utilized measure of child and adolescent performance validity 
(Brooks et al., 2016). While survey respondents did not indicate what cut-off score is 
most commonly applied, the current findings suggest that some published RDS cut-off 
scores are problematic. Consideration of the cut-off scores proposed in the present study 
is warranted and will likely decrease the probability of false positive errors in clinical 
decision making. 
Embedded WRAML-2 Performance Validity Measures 
In adult PVT literature, a parametric signal detection statistic, d prime, and non-
parametric signal detection statistics, recognition discriminability and response bias, have 
been effectively utilized as embedded PVTs on list learning tasks (Delis et al., 2000, see 
Curtis et al., 2006; Wolfe et al., 2010). These statistics were derived from WRAML-2 
Verbal Learning Recognition task performance. Response bias was not useful in 
discrimination of simulation participants from control or clinical participants. 
Discriminability (≤ 75.00 Sn = .55, Sp = .95) and d prime (≤ 1.5 Sn = .55, Sp = .93) cut-
off scores displayed moderate sensitivity with optimized specificity in this mixed clinical 
sample. Presently, discriminability and d prime WRAML-2 Verbal Learning statistics are 
not included in the WRAML-2 scoring program, so clinicians and researchers would 
need to generate them, but initial evidence suggests that they are a useful embedded tool. 
Related to the previously described embedded WRAML-2 PVTs, some 
researchers have investigated similar measures in the CVLT-C with youth. For example, 
in a mTBI sample, an age-corrected z-score of -0.5 from the CVLT-C Recognition 
Discriminability index optimally identified individuals with invalid performance (Baker 
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et al., 2014); whereas, in a mixed clinical group, a much more extreme age-corrected z-
score of -3.0 was optimal (Brooks & Ploetz, 2015).  These vastly different cut scores 
clearly reflect underlying sample characteristics, meaning that the mTBI sample is 
inherently less impaired, whereas, individuals with varied neurological conditions will 
demonstrate bona-fide memory impairments. This obviously presents a challenge for a 
clinician, given that testing determines the level of functioning so one cannot necessarily 
select a PVT cut-off score a-priori. Certainly the goal is to optimize specificity and 
sensitivity, though it is generally thought to be more important to limit false positives 
(i.e., maximize specificity). Similar to Brooks and Ploetz (2015), the present study 
included a mixed clinical sample with varied medical, neurological, and developmental 
conditions in which memory and learning may be affected. Thus, the cut-off scores 
derived for the WRAML-2 embedded measures are likely to exhibit poorer sensitivity in 
a less cognitively impaired sample.  
Additionally, a novel WRAML-2 Forced Choice recognition task was created as 
an embedded PVT, which displayed moderate sensitivity when specificity was optimized 
(Forced choice percent correct ≤ 92%, Sn = .50, Sp = 1.00). Dependent on age, children 
or adolescents are administered a different number of Forced Choice items due to the 
number of initial words on the learning trials, thus, children 8 years and younger must 
identify 12 out of 13 items correctly on the forced choice task. Whereas, children 9 years 
and older must identify 15 out of 16 items correctly. Encouragingly, the WRAML-2 
forced choice task was not associated with age, estimates of intellectual functioning, 
working memory, or verbal memory. Therefore, the forced choice task exhibits some 
benefit over the other WRAML-2 embedded measures. In a similar study, Lichtenstein 
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and colleagues (2017) developed a forced choice task for the CVLT-C (FCR-C raw score 
≤ 13, Sn = .15, Sp = .94), which displayed poor sensitivity when specificity was 
optimized. The WRAML-2 forced choice task performed slightly better in terms of 
sensitivity in our sample than the CVLT-C forced choice task. 
Rey Fifteen Item Test 
Previous Rey FIT research with non-clinical youth suggested that a Rey FIT recall 
cut-off score of ≤ 7 was optimal (Blaskewitz et al., 2008), whereas a slightly higher cut-
off score (< 9) was optimal in youth with a mTBI (Green et al., 2014). In the current 
community recruited sample, applying a Rey FIT recall cut-off score from a non-clinical 
sample (≤ 7) resulted in approximately 13% of the clinical group being identified as 
providing invalid performance, further all children scoring below that cut-off score were 
younger than 10 years of age. The latter finding is consistent with previous research 
indicating an association between Rey FIT performance and age, and children under 10 
years have displayed higher rates of failure (Constantinou &McCaffrey, 2003; 
Lichtenstein et al., 2017).   
The Rey FIT Combination Score (Boone, Salazar, Lu, Warner-Chacon, & Razani, 
2002) takes into account the total number of correctly recalled items, correctly 
recognized items, and recognition error rate.  A Rey FIT combination score derived from 
a youth mTBI sample (< 26; Green et al., 2014) would have identified large percentages 
of children and adolescents across control (41%), clinical (35%), children under 10 years 
old (52%), and youth with intellectual disability (50%) groups as providing invalid 
performance. Thus, the youth Rey FIT combination score cut-off score proposed by 
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Green and colleagues (2014) appears to be problematic, as well, and associated with 
unacceptable false positive rates.  
All possible Rey FIT scores were investigated and the recall and combination 
scores described above did not differentiate simulation participants from control or 
clinical participants. Whereas, the Rey FIT Recognition total correct score (≤ 3 Sn = .20, 
Sp = .91) and recognition False Positive score (≥ 2 Sn = .30. Sp = .96) differentiated 
simulators from other participants. However, sensitivity was the lowest for these 
measures compared to other PVTs investigated in the present study. While stand-alone 
PVTs often perform more optimally than embedded PVTs, this does not appear to be the 
case when comparing the Rey FIT to embedded Digit Span and WRAML-2 PVTs.  
Automatized Sequences Task 
The AST was first developed as a PVT for a youth mTBI clinical sample 
(Kirkwood et al., 2014a). Application of the cut-off scores derived from the mTBI sample 
would have indicated higher than acceptable rates of invalidity across select groups 
(control 14-23%, clinical 22-48%, and children under 10 years of age 22-41%). Though, 
notably, children with intellectual disability passed the AST conditions at the cut-off 
scores proposed by Kirkwood and colleagues (2014). Optimal cut-off scores for the 
mixed clinical group for each condition in seconds are as follows: alphabet ≥ 19 (Sn = 
.40, Sp = .91), counting to 20 ≥ 8 (Sn = .55, Sp = .91), days of the week ≥ 6 (Sn = .45, Sp 
= .96), months of the year ≥ 22 (Sn = .15, Sp = .91), and total time for the four conditions 
≥ 52 (Sn = .40, Sp = .91). Of note, the months of the year task did not actually 
differentiate simulators from control or clinical participants. In fact, many children had 
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difficulty reciting the months of the year. Therefore, for purposes of exploration, a 
revised total time score for the three conditions (≥ 38, Sn = .40, Sp = .91) was generated. 
When specificity was optimized, sensitivity was slightly lower than the original AST 
total time. Novel error rates for each AST condition were explored in the present study, 
but they were not useful for differentiating simulators from control or clinical 
participants. 
In summary, the hypothesis that stand-alone PVTs would exhibit better 
classification statistics than embedded measures (see Bianchini et al., 2001) was not 
supported in the current study. While the sensitivities for the stand-alone measures (e.g., 
VSVT, Rey FIT) were acceptable, multiple embedded measures were more optimal in 
differentiating simulators and a mixed clinical sample. The WRAML-2 signal detection 
measures (Discriminability, d Prime), WRAML-2 Verbal Learning Forced Choice, AST, 
and adjusted RDS, DS ACSS, and RDS-R show promise with sensitivities ranging from 
.40 to .55. Further, applying PVT cut-off scores derived from youth mTBI samples 
routinely resulted in high false positive rates in groups consisting of mixed clinical 
conditions, young children, and youth with intellectual disability. Clinicians should 
recognize an increased probability of incorrectly identifying invalid performance if mTBI 
derived cut-off scores are applied to other clinical populations.  
Symptom Validity Measures 
PVTs and SVTs are complimentary and may help clinicians make decisions 
regarding the validity of a patient’s overall presentation. As mentioned previously, while 
SVTs have been extensively investigated in adult samples, literature regarding their 
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utility in youth neuropsychological evaluations is limited. Thus, the present study sought 
to investigate SVT utility. Further, previous research indicates that invalidity on a PVT 
does not necessarily equate with invalidity on SVTs (Kirk et al., 2014; VanDyke et al., 
2013). PVTs and SVTs may assess different constructs, thus the present study sought to 
evaluate their convergence. 
Regarding SVTs in the present study, child and adolescent report on the BASC-2 
indicated that only the V Index, a scale designed to detect random responding, 
distinguished simulators from control or clinical participants, while other validity scales 
(e.g., F Index) were not beneficial. Classification statistics suggested that a V Index cut-
off score of ≥ 2 was optimal, which is classified by the BASC-2 manual as 
“questionable” for interpretation. Of note, the BASC-2 manual suggests caution when 
interpreting self-report measures with a V Index raw score of ≥ 4. None of the individuals 
in the community-clinical or control group exhibited invalid performance on V Index at 
the manual suggested cut-off scores. The majority of individuals in the simulation group 
(n = 15, 75%) also exhibited valid performance on the V Index. This finding is generally 
consistent with a broader literature.  
Somewhat similarly, Kirk and colleagues (2014) reported that children and 
adolescents who sustained a mTBI and failed a PVT did not provide invalid response 
patterns on the BASC-2. However, Kirkwood and colleagues (2014b) found that children 
and adolescents in a mTBI sample who failed PVTs reported significantly more post-
concussion symptoms on rating forms than youth who passed PVTs. Notably, none of the 
BASC-2 validity scales were designed to detect over-reporting of cognitive or somatic 
symptoms. Thus, it is logical that BASC-2 validity scales would be unlikely to detect 
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simulators feigning cognitive and physical symptoms associated with the 
neuropsychological scenario provided or similar real-world clinical contexts (e.g., 
medical/neurological contexts). Our hypothesis, that PVTs, relative to SVTs, would more 
effectively differentiate groups was supported in this context. While PVTs and SVTs can 
be complimentary, youth may pass an SVT and not exhibit valid neuropsychological 
performance. Conversely, youth that pass PVTs may provide invalid symptom report, 
since current SVTs and PVTs assess different constructs.  
Other SVT research is limited and directed towards identifying psychopathology, 
not cognitive or somatic complaints. Previous adolescent SVT research conducted with 
the MMPI-A utilized scenarios in which simulators were asked to feign psychological 
disorders indicated that MMPI-A F-family of validity scales discriminated simulators 
from clinical and control participants (F see Baer et al., 2010; Stein et al., 1995; F, F1, 
F2 see Lucio et al., 2002; F-K see Rogers et al., 1996). The MMPI-A VRIN scale also 
effectively discriminated random responding from clinical participants (Baer et al., 
2010). Of note, in the present study, BASC-2 clinical scales were not elevated by 
simulators, possibly, suggesting that the brain injury scenario provided may not prompt 
individuals to over-report psychological distress. Further, the MMPI-A studies only 
included adolescents, whereas, the present study included younger children. While 
children and adolescents were asked to respond in a manner that might assist them in 
receiving accommodations and provided with common brain injury symptoms, they may 
not have possessed the insight to consistently alter response patterns on items that were 
less obviously related to the scenario or relevant to populations with bona-fide 
impairments. 
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In contrast to youth samples, SVT scales relevant to over-reporting of cognitive 
and somatic symptoms have been extensively investigated in adult populations. For 
example the Minnesota Multiphasic Personality Inventory – Second Edition (MMPI-2; 
Butcher, Dahlstrom, Graham, Tellegen, & Kaemmer, 1989) and the Minnesota 
Multiphasic Personality Inventory-2 Restructured Form (MMPI-2-RF; Ben-Porath & 
Tellegen, 2008) possess validity scales designed to detect over-reporting of somatic and 
cognitive symptoms. For example, the MMPI-2 Response Bias Scale meaningfully 
predicts PVT failure (Whitney, Davis, Shepard, & Herman, 2008). Additionally, multiple 
MMPI-2-RF validity scales have demonstrated strong associations with invalid PVT 
performance (Gervais, Wygant, Roger, Sellbom, & Ben-Porath, 2011) and malingered 
neurocognitive dysfunction (Tarescavage, Wygant, Gervais, & Ben-Porath, 2012). While 
other researchers investigating validity within youth mTBI populations have suggested 
that further development and investigation of child and adolescent SVTs within contexts 
relevant to over-reporting of cognitive or somatic symptoms is necessary (Kirk et al., 
2014; Kirkwood et al., 2014b), this research has yet to be initiated.  
A particularly novel component of the present study, involved the inclusion of the 
BRIEF and BASC-2 parent-report measures with group assignment matched to their 
child or adolescent. While recent pediatric neuropsychologist survey data indicates that 
the BRIEF and BASC-2 questionnaires are the most common SVTs utilized in practice 
(Brooks et al., 2016), no youth PVT or SVT validation studies conducted to date include 
investigation of parent-report. Parents may consciously or unconsciously experience a 
desire to for the child to receive academic accommodations, various types of treatment, 
or disability benefits (Chafetz & Dufrene, 2014; Chafetz & Prentkowski, 2011). Thus, 
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our goal was to investigate the ability of parents to feign symptom report and compare 
response patterns to parents of youth with and without clinical conditions. 
The present study revealed that the BASC-2 F Index and the BRIEF Negativity 
scale effectively discriminated parents within the simulation condition from parents in the 
control or clinical conditions. Both scales are designed to detect overly negative 
appraisals of child or adolescent emotional and behavioral functioning. However, very 
few parent SVTs within the simulation group were elevated to the level of invalidity 
suggested by the administration manuals (e.g., BRIEF Negativity ≥ 9; n = 1, 5%; BASC-
2 F Index ≥ 6, n = 2, 10%). In this context, the majority of parents were essentially able 
to avoid invalidity detection, without specific instructions to do so. Thus, in actual 
clinical or research contexts, these parents while intentionally simulating, they would not 
be detected by validity scales and clinical scales would simply appear elevated. This may 
lead a clinician or researcher to interpret the questionnaire as valid and utilize their 
responses to support a diagnosis or research findings. 
Parents in the simulation condition also altered their responses to the degree that 
clinical scales were elevated.  Each BASC-2 and BRIEF clinical scales from simulation 
parents were meaningfully greater than parents in clinical and non-clinical groups asked 
to appraise their child’s typical emotional and behavioral functioning. Further, clinical 
scale averages for simulating parents were frequently elevated to the sub-clinical or 
clinical range. Thus, when parents were given a false brain injury scenario and asked to 
respond in a manner that would ensure academic accommodations or other supports, 
profiles were infrequently identified as invalid, and clinical scales were elevated to a 
degree that a clinician would likely interpret impairment. Similar to youth self-report, 
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current parent-report SVTs are not specifically designed to detect over-reporting of 
cognitive or somatic symptoms. Given frequent reliance on parent-report for diagnosis or 
treatment recommendation, findings from youth literature of over-reporting post-
concussive symptoms (Kirkwood et al., 2014b), and adult cognitive and somatic over-
reporting (Gervais et al., 2011; Tarescavage et al., 2012), additional investigation is 
certainly warranted. Further, development of a parent SVT scale more specific to 
cognitive and somatic over-reporting appears necessary. One method to develop BASC 
or BRIEF validity scales specific to feigned cognitive impairment might include 
investigating items responses from individuals who do and do not pass PVTs. Similar to 
the development of RBS, the scale could consist of items that differentiate the two 
groups.   
Investigation of relationships between SVT and PVT scales revealed some 
notable associations. For parents in the clinical and control groups as negative appraisals 
of child or adolescent emotional and behavioral functioning on the BASC-2 increased, 
performance on PVTs dependent (in part) on working memory abilities decreased. 
Abnormally high BASC-2 F Index scores are designed to detect respondents that may 
attempt to make a child ‘look bad’ on a questionnaire. However, some items within that 
scale are associated with difficulties that children with impairments in working memory 
or attention may exhibit (i.e., acts without thinking, forgets things; Reynolds & 
Kamphaus, 2004). Thus, these associations are expected given overlap of items designed 
to ask about real-world experiences. Importantly, the parent BASC-2 F Index in the 
clinical and control group was not elevated to the degree of invalidity. In contrast, the 
parent BRIEF Negativity scale was not associated with child or adolescent PVT 
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performance. Similarly, SVTs from parents in the simulation group were not associated 
with child or adolescent PVTs. As indicated in the paragraph above, these results may 
suggest that investigation of an additional validity scale more specific to 
neuropsychological contexts of misrepresentation may be warranted in order to more 
accurately detect over-reporting of cognitive and somatic symptoms typically seen those 
contexts rather than more general contexts.  
Additionally, there is a broad literature suggesting a low level of parent and 
child/adolescent agreement or association between the parent and self-report 
questionnaires (e.g., see Reynolds & Kamphaus, 2010). Correlational analyses were 
conducted for the clinical scales that overlapped in parent- and self-report questionnaires 
(see Appendix V). Observed associations were generally consistent with correlations 
published in the BASC-2 manual supplement (Reynolds & Kamphaus, 2010). Despite 
discrepant reports of emotional functioning, it may be valuable to consider and discuss 
the unique contribution or perspective of these two types of report in validity research. 
For example, when evaluating a younger child, it may be appropriate to place more 
weight on parent report and critically evaluate validity and clinical elevations due to 
developmental considerations associated with younger children and their emerging ability 
to fully report, recall, and describe experiences. Conversely, when evaluating an older 
adolescent, it may be more valuable to critically consider their self-report given emerging 
autonomy and ability to engage in research and clinical contexts. In summary, 
psychometric properties of the BASC-2 will be important to consider in future validity 
studies. 
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Limitations and Future Directions 
The present study was limited by several factors and there remains opportunity for 
future development in multiple areas. Notably, each PVT was not incorporated into 
batteries for the medical-center participants. Thus, further exploration of the AST with 
adjusted cut-off scores and WRAML-2 Verbal Learning Forced Choice task with 
children and adolescents with various neurological, medical, and developmental 
conditions is warranted. Given promising sensitivity and specificity of these two 
measures further investigation is needed to more comprehensively document clinical 
utility. Further, the AST cut-off scores proposed in the present study using a community-
recruited clinical group should be evaluated in samples where processing speed may be 
slowed (e.g., depression) to further evaluate the risk of false positives. While the 
proposed PVT and SVT cut-off scores have been systematically derived in the present 
study, they should be considered in other clinical contexts and populations, particularly 
within disability evaluations. The present study provides preliminary cut-off score 
recommendations for youth VSVT, RDS-R, and WRAML-2 embedded measures and 
suggests adjustments to youth DS ACSS, RDS, Rey FIT, and AST cut-offs. However, 
additional validation would increase confidence in utility of these PVTs across samples.  
The present study also highlighted an important finding, that some PVTs (e.g., 
VSVT difficult items, embedded Digit Span PVTs) are strongly associated with working 
memory abilities. Additionally, working memory is known to be affected by multiple 
neurological (e.g., TBI, epilepsy) and developmental conditions (e.g., ADHD). Related to 
the current finding, adult VSVT studies reported that patients with intractable epilepsy 
exhibited a high rate of false positives when utilizing VSVT difficult item cut-off scores 
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derived from adult mTBI or non-clinical simulation samples (Grote et al., 2000; Loring et 
al., 2005). Further, epilepsy patients with low intellectual functioning and poor working 
memory displayed a higher risk for VSVT difficult item failure at certain cut-offs (Keary 
et al., 2013). These examples further highlight the need for consideration of diverse 
clinical samples in PVT cut-off score validation, so that clinicians may make informed 
decisions regarding their application. The present study, which included a mixed clinical 
sample, consisted of a small number of individuals with intellectual disability and/or 
epilepsy thus, it would be valuable to explore the VSVT in those specific populations 
with a larger sample size.  
To further investigate the relationship between working memory and select PVT 
performances, exploratory analyses were conducted with a sub-sample of participants 
previously diagnosed with ADHD (n = 60). When considering previously proposed cut-
off scores from other samples (i.e., mTBI), children with ADHD exhibited a similar 
frequency of failure as the general clinical sample (see Appendix W), which was greater 
than the generally accepted false positive error rate of 10%, on measures such as the 
VSVT, embedded Digit Span measures, and AST tasks. When considering the newly 
proposed cut-off scores presented in the current study (see Table 10), participants with 
ADHD exhibited failure rates (see Appendix X) within a generally expected range. 
However, children with ADHD had unacceptable failure rates on the VSVT tasks (see 
Appendix X). While specificity was optimized in the larger clinical sample, this smaller 
subset of clinical patients, children and adolescents with ADHD, exhibited a higher rate 
of failure than ideal, thus further exploration of the VSVT and consideration of 
alternative cut-off scores is warranted (as suggested above). These exploratory analyses 
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suggest that while many of the proposed PVT cut-off scores are appropriate to apply 
when evaluating a child or adolescent with ADHD, the proposed VSVT cut-off scores 
should be conservatively considered. Further, while previous literature does not suggest 
that the VSVT performance is associated with sustained attention (see Brooks, 2012), 
there may be other cognitive factors such as impulsivity that negatively affect VSVT 
performance that warrant investigation.  
The present study also identified that a PVT that employs a response speed 
component (AST) demonstrated the some of the most optimal classification statistics in 
the present study. Memory-like paradigms [e.g., CARB, MSVT, MVP, Rey FIT, TOMM 
(Tombaugh, 1996); VSVT, and WMT], developed initially for adults, are popular and 
have varying degrees of empirical support with children and adolescents (Kirkwood, 
2015). However, it is possible that simple timed tasks may be more beneficial for 
detection of invalid performance in youth samples and warrant further exploration, given 
the promising results from the AST in the present study. Further, as presented above, 
when cut-off scores are identified for a broader clinical sample, or specifically children 
and adolescents with ADHD, for the AST there is increased confidence in limitation of 
false positive rates for speeded tasks.  
In addition to future exploration of simple timed tasks, PVT researchers may wish 
to consider investigation of adaptive platforms or flexible approaches for youth. For 
example, adult researchers have identified that an abbreviated TOMM administration 
(e.g., first 10 items) can exhibit better sensitivity than traditional TOMM administration 
(Denning, 2014), which could lead to improved efficiency and accuracy of validity 
assessment. Researchers may wish to explore similar options in youth. If an abbreviated 
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administration (e.g., first block of the VSVT) indicates valid performance, then perhaps 
validity testing may be discontinued. Conversely, if invalidity is indicated, additional 
measures may be warranted to increase confidence in validity determination.  
Consistent with the concept of increased confidence of validity determination, 
adult PVT and SVT literature highlights the importance of defining validity on the basis 
of multiple PVT and/or SVT failure. Slick and colleagues (1999) identified that two or 
more validity tests must be failed as a part of the criteria of Malingered Neurocognitive 
Dysfunction. Additionally within adult literature, methods for objectively identifying or 
interpreting failure of multiple validity indicators has emerged (see Odland, Lammy, 
Martin, Grote,& Mittenberg, 2015). Additional exploratory analyses were conducted 
using the community-recruited sample to evaluate multiple PVT failure rate for 14 
possible PVTs (see Appendix Y). Of note, for tasks that included multiple opportunities 
for failure (i.e., embedded Digit Span measures) only one possible failure was 
considered. Simulators were much more likely to exhibit multiple PVT failure (> 2), than 
control or clinical participants. However, there were still clinical participants (n = 5) that 
failed more than 2 PVTs. Though, all PVTs were included in that analysis and as the 
present study suggests, some PVTs may be more optimal than others for children and 
adolescents. In consideration of that point, statistical measures that take into account the 
sensitivity and specificity of each PVT or SVT failure in aggregation in order to improve 
detection of invalidity (versus false positive over-identification) have been proposed in 
adult literature (see Larrabee, 2008; Meyers et al., 2014). Thus, statistical evaluation of 
aggregated PVT failure is the logical next step in research for child and adolescent PVT 
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and SVT research in order to increase confidence in invalidity detection through 
utilization of measures with optimal classification statistics. 
An additional limitation of the present study was that the researchers were not 
blind to group assignment. A survey of pediatric neuropsychologists indicated that some 
clinicians believe PVTs are unnecessary because they can determine subjectively that 
children and adolescents displayed invalid performance (Brooks et al., 2016). Due to the 
necessary study design, we were unable to effectively test if researchers could 
discriminate simulators from control or clinical participants. This remains an important 
area of further exploration. If experienced clinicians can effectively distinguish valid 
versus invalid presentations through interaction then use of SVTs and PVTs may not be 
critical; however, it would be highly valuable to test these assumptions in research and 
clinical contexts. Developmental literature does suggest that children and adolescents are 
capable of conscious deception that evades detection. Further, unconscious invalid 
presentations can create unclear profiles. Regardless of subjective appraisal of validity, 
some assert that objective PVTs and SVTs can be critical for clinical decision making 
(e.g., pre-surgical evaluations; Connery & Suchy, 2015). Further, discussing PVT or SVT 
failure with a parent, and, at times, the child/adolescent could result in meaningful 
conversations regarding psychosocial stressors as opposed to inaccurately attributing 
neurocognitive symptoms to an erroneous diagnosis. The ultimate goal is to utilize PVTs 
and SVTs as tools to inform clinical decision-making and improve patient outcomes. 
In summary, this study identified that youth are capable of simulating cognitive 
difficulties and multiple PVTs could detect invalid performance. Parents are also able to 
exaggerate symptom report without detection from currently available SVTs. Application 
  89 
 
of previously identified adult or youth mTBI PVT cut-off scores results in high false 
positive rates for most measures, particularly in younger children and those with 
intellectual disability. Thus, PVT cut-off scores should be adjusted for mixed clinical 
samples in order to prevent over identification of invalidity while maintaining moderate 
sensitivity. This study also provides a framework for future investigation and 
development of youth PVTs and SVTs that may exhibit strong clinical utility, important 
considerations for specific clinical samples, and suggests opportunities for aggregated 
evaluation of validity failure. Finally, responsible utilization of PVTs and SVTs could 
improve clinical decision-making and outcomes by providing additional clarity of 
validity and platforms for discussion of invalid profiles.  
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Appendix A 
Child and adolescent performance and symptom validity test research studies 
Author(s) Test(s) Population N Age 
rang
e 
Cut 
Score(s)  
Results Research 
Method 
Araujo et 
al. (2014) 
CMS 
(RDS) 
mTBI  
  
38
2 
8 – 
16 
RDS ≤ 6 
and/or 
ACSS ≤ 5 
20% of sample classified 
as invalid performance 
and had higher rates of 
reported post-concussion 
symptoms and poorer 
performance on Trails A 
and B 
Known 
Groups 
Comparison 
Baker, 
Connery, 
Kirk, & 
Kirkwood 
(2014) 
CVLT-C 
MSVT 
mTBI  
 
41
1 
8 - 
16 
 Sn Sp Known 
Groups 
Comparison CVLT-C 
RD = -0.5 
.55 .91 
CVLT-C 
RD = -1.0 
.41 .97 
Blaskewitz, 
Merten, & 
Kathmann 
(2008) 
MSVT 
TOMM 
FIT 
RDS 
Non-
Clinical 
Communit
y 
Sample 
38 6 - 
11 
FIT ≤ 7 
 
None of the controls 
failed the MSVT, 
TOMM, & Rey FIT 
 
59% of  the controls 
failed RDS 
 
70 to 90% of simulators 
failed the MSVT, 
TOMM, & RDS 
 
10% of simulators failed 
the Rey FIT 
Simulation 
Study 
MSVT ≤ 
90% 
 
TOMM < 
45 
 
RDS ≤ 6 
Brooks 
(2012) 
VSVT Mixed 
Clinical 
10
0 
6 – 
19 
Total 
Items <  
30 
95% exhibited a valid 
performance on Total 
Items 
Descriptive 
Study 
Easy 
Items < 16 
97% exhibited a valid 
performance on Easy 
Items 
Hard 
Items 
< 16 
84% exhibited a valid 
performance on Hard 
Items 
Brooks & 
Ploetz 
(2015) 
CVLT-C 
TOMM 
Mixed 
Clinical 
29
4 
5 - 
16 
 Sn Sp PPP NP
P 
Known 
Groups 
Comparison CVLT-C 
RD z ≤ -
0.5 
.81 .67   
CVLT-C 
RD z ≤ -
3.0 
.44 .90 .16 .97 
Constantino
u & 
McCaffrey 
(2003) 
TOMM 
FIT 
Cross 
Cultural 
Nonclinica
l 
12
8 
5 - 
12 
TOMM 
Trial 2 < 
45 
98% of children achieved 
a valid TOMM score 
Descriptive 
Study 
FIT cut-
score not 
reported 
Age and education effects 
present in children until 
age 10 
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Appendix A (continued) 
Child and adolescent performance and symptom validity test research studies 
 
Author(s) Test(s) Population N Age 
range 
Cut Score(s)  Results Research 
Method 
Green, 
Kirk, 
Connery, 
Baker, & 
Kirkwood 
(2014) 
FIT mTBI 31
9 
8 - 17  Sn Sp Known 
Groups 
Comparison FIT Recall 
 < 9 
.12 .98 
Recognition 
< 26 
.55 .91 
Kirk et al. 
(2014) 
 
BASC-2 
Self-Report 
F Index 
mTBI 27
4 
8 - 17 __ Invalid performance 
group established with 
MSVT failure. No 
relationship between 
invalid MSVT and 
BASC-2 
Known 
Groups  
Kirkwood 
et al. (2014) 
Automatize
d Sequences 
mTBI 45
2 
8 - 17  Sn Sp AUC Known 
Groups 
Compariso
n 
Alphabet  
≥ 8 seconds 
.50 .91 .73 
Counting 
≥ 6 seconds 
.50 .92 .75 
Days of 
Week  
≥ 4 seconds 
.31 .96 .77 
Months of 
Year 
≥ 10 seconds 
.36 .90 .76 
Total Time 
≥ 27 seconds 
.55 .90 .80 
Kirkwood 
et al. (2011) 
RDS 
 
mTBI 27
4 
8 - 16  Sn Sp Known 
Groups 
Compariso
n 
ACSS ≤ 5 .51 .96 
RDS ≤ 6 .51 .92 
Loughan et 
al. (2012) 
RDS Mixed 
Clinical 
51 --  Sn Sp Known 
Groups 
Compariso
n 
RDS ≤ 4 .43 .91 
Lichtenstein 
et al. (2017) 
CVLT-C 
(FCR-C) 
Mixed 
Clinical 
72 6 - 15  Sn Sp Known 
Groups 
Compariso
n 
≤ 14/15 .31 .87 
≤ 13 .15 .94 
Lu & 
Boone 
(2002) 
FIT 
WRT 
Dot 
Counting 
b Test 
mTBI 1 9 FIT < 8 
WRT < 6 
Other cut-
offs not 
reported 
Exhibited invalid 
performance on all four 
PVTs 
Descriptiv
e 
Case Study 
Perna et al. 
(2014) 
RDS Mixed 
Clinical 
75 6 - 18 RDS ≤ 4 Sn Sp Known 
Groups 
Compariso
n 
.44 .94 
Welsh et al. 
(2012) 
RDS 
 
Epilepsy 54 6 – 
17 
 Sn Sp PPP NP
P 
Known 
Groups 
Compariso
n 
RDS ≤ 6 1.0
0 
.71 .26 1.0
0 
  105 
 
Appendix A (continued) 
Child and adolescent performance and symptom validity test research studies 
 
Note: Cut scores are reported as a value at or below the specified number indicates invalidity. Results were 
documented as reported in manuscripts. If sensitivity, specificity, positive predictive power, or negative 
predictive power were available these were reported. AUC = Area under the curve from receiver operating 
characteristic analysis; BASC-2 = Behavior Assessment System for Children – Second Edition Self Report; 
CMS = Children’s Memory Scale; CVLT-C = California Verbal Learning Test – Children’s Version; FIT = 
Fifteen Item Test; MSVT = Medical Symptom Validity Test; mTBI = mild Traumatic Brain Injury; RDS = 
Reliable Digit Span; TOMM = Test of Memory Malingering; VSVT = Victoria Symptom Validity Test; Sn = 
sensitivity; Sp = specificity; PPP = positive predictive power; NPP = negative predictive power 
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Appendix B 
Child or Adolescent Simulation Instructions 
“You did well on those last 3 tasks, and I can tell that you tried your best. Now, I will ask 
you to pretend that you recently had an accident playing sports or on the playground and 
that you hit your head. After you hit your head you weren’t feeling good and got to stay 
home from school for a couple days.  
When you get back to school, your friend tells you that if kids have trouble paying 
attention, remembering things, can’t think as quickly as they used to, have headaches, or 
feel more irritable than normal, then they can get out of doing some assignments and may 
only have to go to classes for half of the day. You decide that this would really help you 
in school, and it could be fun to get out of some classes you don’t like.  
On these next texts, I want you to pretend that you have trouble paying attention, 
can’t remember some things, and can’t complete things as fast as you normally would. 
 
So let’s practice, I am going to read a short list of words and I want you to pretend 
that you have trouble paying attention or remember things. Ready? 
Chicken,  Horse,   Pig,   Duck 
Now tell me as many words as you remember.” 
If the child completes the task slowly or “remembers” less than 4 words or 
incorrect words say, “Good job pretending!” 
If the child completes the task quickly and recalls all 4 words say, “Remember I 
want you to pretend that you have trouble paying attention or remembering things.” Then 
try practice again. 
Ask child to tell you in their own words what the instructions are and record 
response.  
Clarify instructions as necessary. 
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Appendix C 
Parent/guardian simulation instructions 
“You will be asked to complete two questionnaires. We want you to pretend that your 
child recently had a head injury playing sports or on the playground and has returned to 
school a couple days after their injury. You are concerned that your child might 
experience some difficulty with headaches or dizziness, paying attention, staying 
organized, remembering things, completing tasks quickly, and keeping his/her emotions 
under control when he/she returns to school. You believe that your child should get 
academic accommodations for assignments and testing in case he/she needs them. Please 
answer these questionnaires in a manner that would help your child get accommodations 
at school.” 
Ask parent to tell you in their own words what they should do. Clarify as needed. 
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Appendix D 
Debriefing instructions for simulation group 
“Thank you for participating in our study. The purpose of this study was to find out if 
certain tests can help us determine if children are not doing their best with paying 
attention or remembering, or if parents are not giving accurate reports. While we gave 
you a scenario in which someone might experience some trouble with thinking after a 
minor injury that may not actually occur in real life. We are working on developing tests 
that help us diagnose cognitive problems more accurately so that we can ensure children 
and teens receive the right kind of therapy or treatments for their difficulties. While we 
asked you to pretend in this research study, it is important that you always do your best 
on tests and provide honest answers on questionnaires. Do you have any questions?” 
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Appendix E 
Manipulation check for simulation instructions 
Briefly describe the directions you were given.  
What were you were supposed to pretend in this study? 
 
______________________________________________________________________ 
 
______________________________________________________________________ 
 
 
 
Please rate how successfully you were able to understand the directions for this study. 
 
  0  1  2  3  4  5 
    Not At All       Somewhat    Completely 
 
 
 
Please rate how successfully you were able to follow the directions for this study. 
 
  0  1  2  3  4  5 
    Not At All       Somewhat   
 Completely 
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Appendix F 
 
Test Order: A 
 
 Parents: BRIEF, BASC-2, Demographics Form 
 WISC-V Vocabulary 
 WISC-V Matrix Reasoning 
 Bracken Number Identification  
 Victoria Symptom Validity Test 
 WRAML-2 Verbal Learning Immediate Recall 
 WISC-V Digit Span 
 WRAML-2 Verbal Learning Delayed Recall 
 Rey 15-Item Test 
 Automatized Sequences 
 WRAML-2 Verbal Learning Recognition 
 BASC-2 Self Report 
 WRAML-2 Verbal Learning Forced Choice 
 
Test Order: B 
 
 Parents: BRIEF, BASC-2, Demographics Form 
 WISC-V Vocabulary 
 WISC-V Matrix Reasoning 
 Bracken Number Identification  
 Victoria Symptom Validity Test 
 WRAML-2 Verbal Learning Immediate Recall 
 Rey 15-Item Test 
 Automatized Sequences 
 WRAML-2 Verbal Learning Delayed Recall 
 WISC-V Digit Span 
 WRAML-2 Verbal Learning Recognition 
 BASC-2 Self Report 
 WRAML-2 Verbal Learning Forced Choice 
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Appendix F continued 
 
Test Order: C 
 
 Parents: BRIEF, BASC-2, Demographics Form 
 WISC-V Vocabulary 
 WISC-V Matrix Reasoning 
 Bracken Number Identification  
 BASC-2 Self Report 
 WRAML-2 Verbal Learning Immediate Recall 
 WISC-V Digit Span 
 WRAML-2 Verbal Learning Delayed Recall 
 Rey 15-Item Test 
 Automatized Sequences 
 WRAML-2 Verbal Learning Recognition 
 Victoria Symptom Validity Test 
 WRAML-2 Verbal Learning Forced Choice 
 
Test Order: D 
 
 Give to parents: BRIEF, BASC-2, Demographics Form 
 WISC-V Vocabulary 
 WISC-V Matrix Reasoning 
 Bracken Number Identification  
 BASC-2 Self Report 
 WRAML-2 Verbal Learning Immediate Recall 
 Rey 15-Item Test 
 Automatized Sequences 
 WRAML-2 Verbal Learning Delayed Recall 
 WISC-V Digit Span 
 WRAML-2 Verbal Learning Recognition 
 Victoria Symptom Validity Test 
 WRAML-2 Verbal Learning Forced Choice 
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Appendix G 
WRAML-2 Verbal Learning Forced Choice Recognition 
 
(Administer 10 minutes after recognition) 
 
Remember that long list of words I had you learn? I want to see which words from the list 
you remember now. Was boat or cake on the list? Was _______ or _______ on the list? 
 
(Continue with the rest of the list for the appropriate age below. You may prompt/encourage the 
examinee to take a guess if they are unsure of the answer. Instructions may be abbreviated when 
the examinee understands the task.)  
 
Was _______ or _______ on the list? Score Distractor 
Type 
Boat or Cake 0     1 C 
Hat or Stove 0     1 C 
Quiet or Door 0     1 A 
Flag or Lamp 0     1 C 
Dream or Wood 0     1 A 
Apple or Sand 0     1 C 
Nail or Brave 0     1 A 
Cow or Ear 0     1 C 
Game or Soft 0     1 A 
Ice or Love 0     1 A 
Ball or Map 0     1 C 
Comb or Luck 0     1 A 
Banana or Tree 0     1 C 
                  Ages 9 to adult continue with words below 
Sleep or Lake 0     1 A 
Page or Rabbit 0     1 C 
Loud or Ant 0     1 A 
Forced Choice Recognition Raw Score   
Forced Choice Recognition Percent Correct 
(≤8 years = ____ / 13) 
(9+ years = ____ / 16) 
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Appendix H 
BASC-2 Alpha Coefficient Reliabilities for Clinical Scales 
In Community-Recruited Clinical and Control Groups 
 Child  
Self-Report 
(n = 32) 
Adolescent 
Self-Report 
(n = 14) 
Parent 
Report 
Child 
(n = 32) 
Parent Report 
Adolescent 
(n = 14) 
Composite Scales     
School Problems .64 .57 __ __ 
Inattention/Hyperactivity .35 .45 __ __ 
Personal Adjustment .68 .71 __ __ 
Internalizing Problems .90 .76 .93 .93 
Behavioral Symptoms 
Index 
__ __ .91 .88 
Adaptive Skills __ __ .92 .91 
Externalizing Problems __ __ .92 .94 
Clinical Scales     
Attitude to School .82 .10 __ __ 
Attitude to Teachers .32 .65 __ __ 
Sensation Seeking __ .16 __ __ 
Atypicality .76 .69 .86 .60 
Locus of Control .42 .07 __ __ 
Social Stress .80 .75 __ __ 
Anxiety .78 .56 .90 .92 
Depression .61 .78 .85 .72 
Sense of Inadequacy .59 .14 __ __ 
Somatization __ .45 .82 .87 
Attention Problems .07 .18 .01 .50 
Hyperactivity .37 .76 .92 .87 
Aggression __ __ .80 .86 
Conduct Problems __ __ .86 .88 
Withdrawal __ __ .58 .20 
Adaptive Scales     
Relations with Parents .74 .78 __ __ 
Interpersonal Relations .45 .08 __ __ 
Self-Esteem .22 .29 __ __ 
Self-Reliance .59 .57 __ __ 
Adaptability __ __ .64 .63 
Social Skills __ __ .89 .90 
Leadership __ __ .87 .86 
Activities of Daily Living __ __ .15 .39 
Functional Communication __ __ .59 .84 
Validity Scales     
F Index .48 .19 .59 .73 
L Index .46 .06 __ __ 
V Index .05 .00 __ __ 
Note: BASC-2 = Behavior Assessment System for Children – Second Edition. 
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Appendix I 
BRIEF Parent Report Cronbach’s Alpha Reliability Coefficients for Control and Clinical 
Participants (n = 46) 
 
Subscales 
 
Cronbach’s Alpha 
Inhibit .92 
Shift .86 
Emotional Control .86 
Initiate .79 
Working Memory .93 
Plan/Organize .88 
Org. of Material .78 
Monitor .86 
Index Scales  
BRI .93 
MI .97 
GEC .98 
Validity Scales  
Negativity .82 
Inconsistency .89 
Note: BRIEF = Behavior Rating Index of Executive Function; BRI = Behavioral Regulation 
Index; MI = Metacognition Index; GEC = Global Executive Composite. 
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Appendix J 
Control Group VSVT Classification Statistics 
 Cumulative %  
of sample at cut-
score 
PVT Cut-
Score 
Sn Sp LR+ LR- PPP NPP Control Simulation 
VSVT          
     Easy Correct ≤ 7 0.00 1.00 0.00 1.00 0.00 .54 0.00% 0.00% 
 ≤ 8 0.00 1.00 0.00 1.00 0.00 .54 0.00% 0.00% 
 ≤ 9  .05 1.00 0.00 .95 1.00 .55 0.00% 5.26% 
 ≤ 10 .11 1.00 0.00 .89 1.00 .56 0.00% 10.53% 
 ≤ 11 .11 1.00 0.00 .89 1.00 .56 0.00% 10.53% 
 ≤ 12 .16 1.00 0.00 .84 1.00 .58 0.00% 15.79% 
 ≤ 13 .16 1.00 0.00 .84 1.00 .58 0.00% 15.79% 
 ≤ 14 .21 1.00 0.00 .79 1.00 .59 0.00% 21.05% 
 ≤ 15 .26 1.00 0.00 .74 1.00 .61 0.00% 26.32% 
 ≤ 16 .26 1.00 0.00 .74 1.00 .61 0.00% 26.32% 
 ≤ 17 .37 1.00 0.00 .63 1.00 .65 0.00% 36.84% 
 ≤ 18 .37 1.00 0.00 .63 1.00 .65 0.00% 36.84% 
 ≤ 19 .37 1.00 0.00 .63 1.00 .65 0.00% 36.84% 
 ≤ 20 .42 .95 9.26 .61 .89 .66 4.55% 42.11% 
 ≤ 21 .47 .95 10.42 .55 .90 .68 4.55% 47.37% 
 ≤ 22 .47 .86 3.47 .61 .75 .66 18.18% 47.37% 
 ≤ 23 .68 .77 3.01 .41 .72 .74 22.72% 68.42% 
VSVT          
     Difficult 
Correct 
≤ 7 0.00 1.00 0.00 1.00 0.00 .54 0.00% 0.00% 
 ≤ 8 .05 1.00 0.00 .95 1.00 .55 0.00% 5.26% 
 ≤ 9  .05 1.00 0.00 .95 1.00 .55 0.00% 5.26% 
 ≤ 10 .12 1.00 0.00 .89 1.00 .56 0.00% 10.53% 
 ≤ 11 .21 1.00 0.00 .79 1.00 .59 0.00% 21.05% 
 ≤ 12 .32 1.00 0.00 .68 1.00 .63 0.00% 31.58% 
 ≤ 13 .32 1.00 0.00 .68 1.00 .63 0.00% 31.58% 
 ≤ 14 .42 .95 9.26 .61 .89 .66 4.54% 42.11% 
 ≤ 15 .47 .95 10.42 .55 .90 .68 4.54% 47.37% 
 ≤ 16 .47 .95 10.42 .55 .90 .68 4.54% 47.37% 
 ≤ 17 .47 .95 10.42 .55 .90 .68 4.54% 47.37% 
 ≤ 18 .53 .95 11.58 .50 .91 .70 4.54% 52.63% 
 ≤ 19 .63 .77 2.78 .48 .71 .71 22.72% 63.16% 
 ≤ 20 .68 .68 2.15 .46 .65 .71 31.81% 68.42% 
 ≤ 21 .68 .64 1.88 .50 .62 .70 36.36% 68.42% 
 ≤ 22 .79 .50 1.58 .42 .58 .73 50.00% 78.95% 
 ≤ 23 .84 .27 1.16 .58 .50 .67 72.73% 84.21% 
Appendix G continued on the next page 
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Appendix J (continued) 
Control Group VSVT Classification Statistics 
        Cumulative %  
of sample at cut-
score 
PVT Cut-
Score 
Sn Sp LR+ LR- PPP NPP Control Simulation 
VSVT          
     Total Correct ≤ 22 .05 1.00 0 .95 1.00 .55 0.00% 5.26% 
 ≤ 23 .16 1.00 0 .84 1.00 .58 0.00% 15.79% 
 ≤ 24 .16 1.00 0 .84 1.00 .58 0.00% 15.79% 
 ≤ 25 .26 1.00 0 .74 1.00 .61 0.00% 26.32% 
 ≤ 26 .26 1.00 0 .74 1.00 .61 0.00% 26.32% 
 ≤ 27 .26 1.00 0 .74 1.00 .61 0.00% 26.32% 
 ≤ 28 .26 1.00 0 .74 1.00 .61 0.00% 26.32% 
 ≤ 29 .32 1.00 0 .68 1.00 .63 0.00% 31.58% 
 ≤ 30 .32 1.00 0 .68 1.00 .63 0.00% 31.58% 
 ≤ 31 .42 1.00 0 .58 1.00 .67 0.00% 42.11% 
 ≤ 32 .42 1.00 0 .58 1.00 .67 0.00% 42.11% 
 ≤ 33 .47 1.00 0 .53 1.00 .69 0.00% 47.37% 
 ≤ 34 .47 .95 10.42 .55 .90 .68 4.55% 47.37% 
 ≤ 35 .47 .95 10.42 .55 .90 .68 4.55% 47.37% 
 ≤ 36 .47 .95 10.42 .55 .90 .68 4.55% 47.37% 
 ≤ 37 .47 .95 10.42 .55 .90 .68 4.55% 47.37% 
 ≤ 38 .47 .95 10.42 .55 .90 .68 4.55% 47.37% 
 ≤ 39 .47 .95 10.42 .55 .90 .68 4.55% 47.37% 
 ≤ 40 .47 .95 10.42 .55 .90 .68 4.55% 47.37% 
 ≤ 41  .53 .86 3.86 .55 .77 .68 13.64% 52.63% 
 ≤ 42 .58 .82 3.18 .51 .73 .69 18.18% 57.89% 
 ≤ 43 .68 .73 2.51 .43 .68 .73 27.27% 68.42% 
 ≤ 44 .68 .68 2.15 .46 .65 .71 31.82% 68.42% 
 ≤ 45 .74 .64 2.03 .41 .64 .74 36.36% 73.68% 
 ≤ 46 .79 .45 1.45 .46 .56 .71 54.55% 78.95% 
 ≤ 47 .84 .27 1.16 .58 .50 .67 72.73% 84.21% 
Note: Sn = sensitivity, Sp = specificity, LR+ = positive likelihood ratio; LR- = negative likelihood ratio; 
PPP = positive predictive power; NPP = negative predictive power; VSVT = Victoria Symptom Validity 
Test 
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Appendix K 
Combined Clinical Groups VSVT Classification Statistics 
 Cumulative %  
of sample at cut-
score 
PVT Cut-
Score 
Sn Sp LR+ LR- PPP NPP Clinical Simulation 
VSVT          
     Easy Correct ≤ 7 0.00 1.00 0.00 1.00 0.00 .54 0.00% 0.00% 
 ≤ 8 0.00 1.00 0.00 1.00 0.00 .54 0.00% 0.00% 
 ≤ 9  .05 .99 3.89 .96 .33 .89 1.35% 5.26% 
 ≤ 10 .11 .99 7.79 .91 .50 .90 1.35% 10.53% 
 ≤ 11 .11 .99 7.79 .91 .50 .90 1.35% 10.53% 
 ≤ 12 .16 .97 5.84 .87 .43 .90 2.70% 15.79% 
 ≤ 13 .16 .97 4.67 .87 .38 .90 3.38% 15.79% 
 ≤ 14 .21 .97 6.23 .82 .44 .91 3.38% 21.05% 
 ≤ 15 .26 .95 5.56 .77 .42 .91 4.73% 26.32% 
 ≤ 16 .26 .95 4.87 .78 .38 .91 5.41% 26.32% 
 ≤ 17 .37 .93 5.45 .68 .41 .92 6.76% 36.84% 
 ≤ 18 .37 .93 4.96 .68 .39 .92 7.43% 36.84% 
 ≤ 19 .37 .90 3.64 .70 .32 .92 10.14% 36.84% 
 ≤ 20 .42 .88 3.46 .66 .31 .92 12.16% 42.11% 
 ≤ 21 .47 .83 2.80 .63 .26 .92 16.89% 47.37% 
 ≤ 22 .47 .72 1.71 .73 .18 .91 27.70% 47.37% 
 ≤ 23 .68 .55 1.53 .57 .16 .93 44.59% 68.42% 
VSVT          
     Difficult Correct ≤ 7 0.00 1.00 0.00 1.00 0.00 .54 0.00% 0.00% 
 ≤ 8 .05 .99 3.89 .96 .33 .89 1.35% 5.26% 
 ≤ 9  .05 .98 2.60 .97 .25 .89 2.03% 5.26% 
 ≤ 10 .11 .97 3.89 .92 .33 .89 2.70% 10.53% 
 ≤ 11 .21 .96 5.19 .82 .40 .90 4.05% 21.05% 
 ≤ 12 .32 .91 3.60 .75 .32 .91 8.78% 31.58% 
 ≤ 13 .32 .91 3.33 .76 .30 .91 9.46% 31.58% 
 ≤ 14 .42 .85 2.83 .68 .27 .92 14.86% 42.11% 
 ≤ 15 .47 .81 2.50 .65 .24 .92 18.92% 47.37% 
 ≤ 16 .47 .77 2.06 .68 .21 .92 22.97% 47.37% 
 ≤ 17 .47 .76 1.95 .70 .20 .92 24.32% 47.37% 
 ≤ 18 .53 .72 1.85 .66 .19 .92 28.38% 52.63% 
 ≤ 19 .63 .66 1.83 .56 .19 .93 34.46% 63.16% 
 ≤ 20 .68 .55 1.51 .58 .16 .93 45.27% 68.42% 
 ≤ 21 .68 .48 1.32 .66 .14 .92 52.03% 68.42% 
 ≤ 22 .79 .33 1.18 .64 .13 .92 66.89% 78.95% 
 ≤ 23 .84 .18 1.02 .90 .12 .90 82.43% 84.21% 
Appendix H continued on next page 
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Appendix K (continued) 
Combined Clinical Groups VSVT Classification Statistics 
        Cumulative %  
of sample at cut-
score 
PVT Cut-
Score 
Sn Sp LR+ LR- PPP NPP Clinical Simulation 
VSVT          
     Total Correct ≤ 21 0.00 .99 0.00 1.01 0.00 .89 0.68% 0.00% 
      ≤ 22 .05 .99 3.89 .96 .33 .89 1.35% 5.26% 
 ≤ 23 .16 .98 7.79 .86 .50 .90 2.03% 15.79% 
 ≤ 24 .16 .96 3.89 .88 .33 .90 4.05% 15.79% 
 ≤ 25 .26 .96 6.49 .77 .45 .91 4.05% 26.32% 
 ≤ 26 .26 .96 6.49 .77 .45 .91 4.05% 26.32% 
 ≤ 27 .26 .95 4.87 .78 .38 .91 5.41% 26.32% 
 ≤ 28 .26 .94 4.33 .78 .36 .91 6.08% 26.32% 
 ≤ 29 .32 .94 5.19 .73 .40 .91 6.08% 31.58% 
 ≤ 30 .32 .93 4.67 .73 .38 .91 6.76% 31.58% 
 ≤ 31 .42 .90 4.15 .64 .35 .92 10.14% 42.11% 
 ≤ 32 .42 .89 3.89 .65 .33 .92 10.81% 42.11% 
 ≤ 33 .47 .89 4.12 .59 .35 .93 11.49% 47.37% 
 ≤ 34 .47 .88 3.89 .60 .33 .93 12.16% 47.37% 
 ≤ 35 .47 .86 3.51 .61 .31 .93 13.51% 47.37% 
 ≤ 36 .47 .85 3.19 .62 .29 .93 14.86% 47.37% 
 ≤ 37 .47 .84 2.92 .63 .27 .93 16.22% 47.37% 
 ≤ 38 .47 .79 2.26 .67 .22 .92 20.95% 47.37% 
 ≤ 39 .47 .76 1.95 .70 .20 .92 24.32% 47.37% 
 ≤ 40 .47 .73 1.75 .72 .18 .92 27.03% 47.37% 
 ≤ 41  .53 .71 1.81 .67 .19 .92 29.05% 52.63% 
 ≤ 42 .58 .64 1.61 .66 .17 .92 35.82% 57.89% 
 ≤ 43 .68 .59 1.66 .54 .18 .94 41.22% 68.42% 
 ≤ 44 .68 .49 1.35 .64 .15 .92 50.68% 68.42% 
 ≤ 45 .74 .43 1.28 .62 .14 .93 57.43% 73.68% 
 ≤ 46 .79 .30 1.12 .71 .13 .92 70.27% 78.95% 
 ≤ 47 .84 .16 1.01 .97 .11 .89 83.78% 84.21% 
Note: Sn = sensitivity, Sp = specificity, LR+ = positive likelihood ratio; LR- = negative likelihood ratio; 
PPP = positive predictive power; NPP = negative predictive power; VSVT = Victoria Symptom Validity 
Test. 
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Appendix L 
Control Group Embedded Digit Span Classification Statistics 
        Cumulative %  
of sample at cut-
score 
PVT Cut-
Score 
Sn Sp LR+ LR- PPP NPP Control Simulation 
Digit Span          
     DS ACSS ≤ 1 .35 1.00 0.00 .65 1.00 .63 0.00% 35.00% 
 ≤ 2 .40 1.00 0.00 .60 1.00 .65 0.00% 40.00% 
 ≤ 3 .45 1.00 0.00 .55 1.00 .67 0.00% 45.00% 
 ≤ 4 .50 1.00 0.00 .50 1.00 .69 0.00% 50.00% 
 ≤ 5 .50 1.00 0.00 .50 1.00 .69 0.00% 50.00% 
 ≤ 6 .50 1.00 0.00 .50 1.00 .69 0.00% 50.00% 
 ≤ 7 .55 .95 12.10 .47 .92 .70 4.55% 55.00% 
 ≤ 8 .60 .82 3.30 .49 .75 .69 18.18% 60.00% 
 ≤ 9 .75 .77 3.30 .32 .75 .77 22.72% 75.00% 
 ≤ 10 .85 .55 1.87 .28 .63 .80 45.45% 85.00% 
 ≤ 11 .90 .45 1.65 .22 .60 .83 54.55% 90.00% 
 ≤ 12 .90 .27 1.24 .37 .53 .75 72.73% 90.00% 
 ≤ 13 .95 .09 1.05 .55 .49 .67 90.91% 95.00% 
          
     RDS ≤ 2 .15 1.00 0.00 .85 1.00 .56 0.00% 15.00% 
 ≤ 3 .15 1.00 0.00 .85 1.00 .56 0.00% 15.00% 
 ≤ 4 .40 1.00 0.00 .60 1.00 .65 0.00% 40.00% 
 ≤ 5 .45 1.00 0.00 .55 1.00 .67 0.00% 45.00% 
 ≤ 6 .50 .96 11.50 .52 .91 .69 4.35% 50.00% 
 ≤ 7 .65 .78 2.99 .45 .72 .72 21.74% 65.00% 
 ≤ 8 .80 .57 1.84 .35 .62 .76 65.22% 80.00% 
 ≤ 9 1.00 .35 1.53 0 .57 1.00 86.96% 100% 
          
     RDS-R ≤ 4 .15 1.00 0.00 .85 1.00 .56 0.00% 15.00% 
 ≤ 5 .20 1.00 0.00 .80 1.00 .58 0.00% 20.00% 
 ≤ 6 .30 1.00 0.00 .70 1.00 .61 0.00% 30.00% 
 ≤ 7 .40 1.00 0.00 .60 1.00 .65 0.00% 40.00% 
 ≤ 8 .50 1.00 0.00 .50 1.00 .69 0.00% 50.00% 
 ≤ 9 .50 1.00 0.00 .50 1.00 .69 0.00% 50.00% 
 ≤ 10 .50 .91 5.50 .55 .83 .67 9.09% 50.00% 
 ≤ 11 .60 .86 4.40 .46 .80 .70 13.64% 60.00% 
 ≤ 12 .80 .64 2.20 .31 .67 .78 36.36% 80.00% 
 ≤ 13 .85 .36 1.34 .41 .55 .73 63.64% 85.00% 
 ≤ 14 .95 .09 1.05 .55 .49 .67 90.91% 95.00% 
Note: Sn = sensitivity, Sp = specificity, LR+ = positive likelihood ratio; LR- = negative likelihood ratio; 
PPP = positive predictive power; NPP = negative predictive power; DS ACSS = Digit Span Age 
Corrected Scaled Score; RDS = Reliable Digit Span; RDS-R = Reliable Digit Span Revised 
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Appendix M 
Combined Clinical Groups Embedded Digit Span Classification Statistics 
        Cumulative %  
of sample at cut-
score 
PVT Cut-
Score 
Sn Sp LR+ LR- PPP NPP Clinical Simulation 
Digit Span          
     DS ACSS ≤ 1 .35 .99 50.75 .65 .88 .92 0.69% 35.00% 
 ≤ 2 .40 .99 29.00 .61 .80 .92 1.38% 40.00% 
 ≤ 3 .45 .97 13.05 .57 .64 .93 3.45% 45.00% 
 ≤ 4 .50 .92 6.59 .54 .48 .93 7.59% 50.00% 
 ≤ 5 .50 .85 3.30 .59 .31 .92 15.17% 50.00% 
 ≤ 6 .50 .74 1.91 .68 .21 .91 26.20% 50.00% 
 ≤ 7 .55 .59 1.33 .77 .15 .90 41.38% 55.00% 
 ≤ 8 .60 .48 1.14 .84 .14 .90 52.41% 60.00% 
 ≤ 9 .75 .36 1.17 .70 .14 .91 64.14% 75.00% 
 ≤ 10 .85 .23 1.10 .66 .13 .92 77.24% 85.00% 
 ≤ 11 .90 .16 1.07 .63 .13 .92 84.14% 90.00% 
 ≤ 12 .90 .09 .99 1.12 .12 .87 91.03% 90.00% 
 ≤ 13 .95 .04 .99 1.21 .12 .86 95.86% 95.00% 
 ≤ 14 .95 .03 .98 1.81 .12 .80 97.24% 95.00% 
 ≤ 15 1.00 .01 1.01 0 .12 1.00 98.62% 100% 
 ≤ 16 1.00 .01 1.01 0 .12 1.00 99.31%  
     RDS ≤ 2 .15 .99 21.30 .86 .75 .89 0.70% 15.00% 
 ≤ 3 .15 .99 21.30 .86 .75 .89 0.70% 15.00% 
 ≤ 4 .40 .99 28.60 .61 .80 .92 1.41% 40.00% 
 ≤ 5 .45 .92 5.81 .60 .45 .92 7.75% 45.00% 
 ≤ 6 .50 .80 2.54 .62 .26 .92 19.72% 50.00% 
 ≤ 7 .65 .56 1.47 .63 .17 .92 44.37% 65.00% 
 ≤ 8 .84 .32 1.23 .50 .14 .94 68.31% 80.00% 
 ≤ 9 1.00 .14 1.16 0.00 .14 1.00 85.92% 100% 
 ≤ 10 1.00 .05 1.05 0.00 .13 1.00 95.07% 100% 
 ≤ 11 1.00 .01 1.01 0.00 .13 1.00 96.48% 100% 
 ≤ 12 1.00 .02 1.02 0.00 .13 1.00 97.89% 100% 
 ≤ 13 1.00 .01 1.01 0.00 .13 1.00 98.59% 100% 
     RDS-R ≤ 2 0.00 .99 0.00 1.01 0.00 .86 0.81% 0.00% 
 ≤ 3 0.00 .99 0.00 1.01 0.00 .86 0.81% 0.00% 
 ≤ 4 .15 .99 18.45 .86 .75 .88 0.81% 15% 
 ≤ 5 .20 .98 8.20 .82 .57 .88 2.44% 20% 
 ≤ 6 .30 .96 7.38 .73 .55 .89 4.07% 30% 
 ≤ 7 .40 .95 8.20 .63 .57 .91 4.88% 40% 
 ≤ 8 .50 .92 6.15 .54 .50 .92 8.13% 50% 
 ≤ 9 .50 .85 3.42 .59 .36 .91 14.63% 50% 
 ≤ 10 .50 .72 1.76 .70 22 .90 28.46% 50% 
 ≤ 11 .60 .61 1.54 .66 .20 .90 39.02% 60% 
 ≤ 12 .80 .42 1.39 .47 .18 .93 57.72% 80% 
 ≤ 13 .85 .29 1.20 .51 .16 .92 70.73% 85% 
 ≤ 14 .95 .15 1.12 .32 .15 .95 84.55% 95% 
 ≤ 15 .65 .07 1.02 .77 .14 .89 93.50% 95% 
 ≤ 16 1.00 .03 1.03 0 .14 1.00 96.75% 100% 
 ≤ 17 1.00 .03 1.03 0 .14 1.00 96.75% 100% 
 ≤ 18 1.00 .02 1.03 0 .14 1.00 97.56% 100% 
 ≤ 19 1.00 .02 1.02 0 .14 1.00 98.37% 100% 
 ≤ 20 1.00 .01 1.01 0 .14 1.00 99.19% 100% 
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Appendix N 
Control Group WRAML-2 Embedded Measures Classification Statistics 
 Cumulative %  
of sample at cut-
score 
PVT Cut-
Score 
Sn Sp LR+ LR- PPP NPP Control Simulation 
          
WRAML-2           
     
Discriminability  
≤ 27.50 .05 1.00 0.00 .95 1.00 .54 0.00% 5.00% 
 ≤ 50.00 .10 1.00 0.00 .90 1.00 .55 0.00% 10.00% 
 ≤ 55.00 .20 1.00 0.00 .80 1.00 .58 0.00% 20.00% 
 ≤ 55.88 .25 1.00 0.00 .75 1.00 .59 0.00% 25.00% 
 ≤ 57.50 .30 1.00 0.00 .70 1.00 .61 0.00% 30.00% 
 ≤ 60.00 .40 1.00 0.00 .60 1.00 .65 0.00% 40.00% 
 ≤ 65.00 .45 1.00 0.00 .55 1.00 .67 0.00% 45.00% 
 ≤ 75.00 .55 1.00 0.00 .45 1.00 .71 0.00% 55.00% 
 ≤ 87.50 .60 .91 6.60 .44 .86 .71 9.09% 60.00% 
 ≤ 90.00 .65 .86 4.77 .41 .81 .73 13.64% 65.00% 
 ≤ 92.50 .65 .64 1.79 .55 .62 .67 36.36% 65.00% 
 ≤ 94.12 .70 .64 1.93 .47 .64 .70 36.36% 70.00% 
 ≤ 95.00 .70 .45 1.28 .66 .54 .63 54.55% 70.00% 
 ≤ 97.06 .70 .32 1.03 .94 .48 .54 68.18% 70.00% 
 ≤ 97.50 .75 .14 .87 1.83 .44 .38 86.36% 75.00% 
          
      d Prime ≤ -1.00 .05 1.00 0.00 .95 1.00 .54 0.00% 5.00% 
 ≤ -0.5 .10 1.00 0.00 .90 1.00 .55 0.00% 10.00% 
 ≤ 0.0 .15 1.00 0.00 .85 1.00 .56 0.00% 15.00% 
 ≤ 0.5 .30 1.00 0.00 .70 1.00 .61 0.00% 30.00% 
 ≤ 1.0 .45 1.00 0.00 .55 1.00 .67 0.00% 45.00% 
 ≤ 1.5 .55 1.00 0.00 .45 1.00 .71 0.00% 55.00% 
 ≤ 2.0 .55 1.00 0.00 .45 1.00 .71 0.00% 55.00% 
 ≤ 2.5 .60 .95 13.20 .42 .92 .72 4.5% 60.00% 
 ≤ 3.0 .60 .91 6.60 .44 .86 .71 4.5% 60.00% 
 ≤ 3.5 .65 .64 1.79 .55 .62 .67 13.6% 65.00% 
 ≤ 4.0 .70 .27 .96 1.10 .47 .50 72.7% 70.00% 
 ≤ 4.5 .75 .14 .87 1.83 .44 .38 86.4% 75.00% 
 ≤ 5.0 1.00 0.00 1.00 0.00 .48 0.00 100% 100% 
          
Forced Choice % 
Correct 
≤ 38 .10 1.00 0.00 .90 1.00 .55 0.00% 10.00% 
 ≤ 44 .20 1.00 0.00 .80 1.00 .58 0.00% 20.00% 
 ≤ 50 .25 1.00 0.00 .75 1.00 .59 0.00% 25.00% 
 ≤ 56 .40 1.00 0.00 .60 1.00 .65 0.00% 40.00% 
 ≤ 63 .45 1.00 0.00 .55 1.00 .67 0.00% 45.00% 
 ≤ 81 .50 1.00 0.00 .50 1.00 .69 0.00% 50.00% 
 ≤ 92 .50 .95 11.00 .52 .91 .68 4.55% 50.00% 
Note: Sn = sensitivity, Sp = specificity, LR+ = positive likelihood ratio; LR- = negative likelihood ratio; 
PPP = positive predictive power; NPP = negative predictive power; WRAML-2 = Wide Range 
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Appendix O 
Clinical Group WRAML-2 Embedded Measures Classification Statistics 
 Cumulative %  
of sample at cut-
score 
PVT Cut-
Score 
Sn Sp LR+ LR- PPP NPP Clinical Simulation 
          
WRAML-2           
     
Discriminability  
≤ 27.50 .05 1.00 0.00 .95 1.00 .81 1.50% 5.00% 
 ≤ 50.00 .10 .99 8.10 .91 .67 .82 1.50% 10.00% 
 ≤ 55.00 .20 .99 16.20 .81 .80 .83 1.50% 20.00% 
 ≤ 55.88 .25 .99 20.25 .76 .83 .84 1.50% 25.00% 
 ≤ 57.50 .30 .99 24.30 .71 .86 .85 1.50% 30.00% 
 ≤ 60.00 .40 .98 16.20 .62 .80 .87 3.00% 40.00% 
 ≤ 65.00 .45 .96 12.15 .57 .75 .88 4.50% 45.00% 
 ≤ 75.00 .55 .95 11.14 .47 .73 .90 6.0% 55.00% 
 ≤ 87.50 .60 .83 3.47 .48 .46 .89 20.9% 60.00% 
 ≤ 90.00 .60 .78 2.70 .51 .40 .89 26.9% 60.00% 
 ≤ 92.50 .65 .73 2.93 .48 .37 .89 32.8% 65.00% 
 ≤ 94.12 .65 .69 2.11 .51 .34 .89 37.3% 65.00% 
 ≤ 95.00 .65 .60 1.65 .58 .29 .88 47.8% 65.00% 
 ≤ 97.06 .70 .57 1.62 .53 .29 .88 52.2% 70.00% 
 ≤ 97.50 .75 .37 1.19 .68 .23 .86 76.1% 75.00% 
          
      d Prime ≤ -1.00 .50 1.00 0.00 .95 1.00 .78 0.00% 5.00% 
 ≤ -0.5 .10 1.00 0.00 .90 1.00 .79 0.00% 10.00% 
 ≤ 0.0 .15 1.00 0.00 .85 1.00 .80 0.00% 15.00% 
 ≤ 0.5 .30 .99 20.10 .71 .86 .83 1.50% 30.00% 
 ≤ 1.0 .45 .96 10.05 .58 .75 .85 4.50% 45.00% 
 ≤ 1.5 .55 .93 7.37 .49 .69 .87 7.50% 55.00% 
 ≤ 2.0 .55 .90 5.26 .50 .61 .87 10.40% 55.00% 
 ≤ 2.5 .60 .84 3.65 .48 .52 .88 16.40% 60.00% 
 ≤ 3.0 .60 .75 2.36 .54 .41 .86 25.40% 60.00% 
 ≤ 3.5 .65 .60 1.61 .59 .33 .85 40.30% 65.00% 
 ≤ 4.0 .70 .40 1.17 .74 .26 .82 59.70% 70.00% 
 ≤ 4.5 .75 .24 .99 1.05 .23 .76 76.10% 75.00% 
 ≤ 5.0 1.00 0.00 1.00 0.00 .23 0.00 100% 100% 
          
    Forced Choice 
% 
≤ 38 .10 1.00 0.00 .90 1.00 .56 0.00% 10.00% 
 ≤ 44 .20 1.00 0.00 .80 1.00 .59 0.00% 20.00% 
 ≤ 50 .25 1.00 0.00 .75 1.00 .61 0.00% 25.00% 
 ≤ 56 .40 1.00 0.00 .60 1.00 .66 0.00% 40.00% 
 ≤ 63 .45 1.00 0.00 .55 1.00 .68 0.00% 45.00% 
 ≤ 81 .50 1.00 0.00 .50 1.00 .70 0.00% 50.00% 
 ≤ 92 .50 1.00 0.00 .50 1.00 .70 0.00% 50.00% 
Note: Sn = sensitivity, Sp = specificity, LR+ = positive likelihood ratio; LR- = negative likelihood ratio; 
PPP = positive predictive power; NPP = negative predictive power; WRAML-2 = Wide Range 
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Appendix P 
Control Group Rey FIT Classification Statistics 
        Cumulative %  
of sample at cut-
score 
PVT Cut-
Score 
Sn Sp LR+ LR- PPP NPP Control Simulation 
Rey FIT           
     Recognition  ≤ 2 .05 1.00 0.00 .95 1.00 .54 0.00% 5.00% 
 ≤ 3 .20 1.00 0.00 .80 1.00 .58 0.00% 20.00% 
 ≤ 4 .20 1.00 0.00 .80 1.00 .58 0.00% 20.00% 
 ≤ 5 .25 1.00 0.00 .75 1.00 .59 0.00% 25.00% 
 ≤ 6 .35 1.00 0.00 .65 1.00 .63 0.00% 35.00% 
 ≤ 7 .35 1.00 0.00 .65 1.00 .63 0.00% 35.00% 
 ≤ 8 .35 1.00 0.00 .65 1.00 .63 0.00% 35.00% 
 ≤ 9 .35 .86 2.57 .75 .70 .59 13.64% 35.00% 
 ≤ 10 .45 .77 1.98 .71 .64 .61 22.73% 45.00% 
 ≤ 11 .50 .77 2.20 .65 .67 .63 22.73% 50.00% 
 ≤ 12 .55 .55 1.21 .83 .53 .57 45.45% 55.00% 
 ≤ 13 .65 .45 1.19 .77 .52 .59 54.55% 65.00% 
 ≤ 14 .75 .41 1.27 .61 .54 .64 59.09% 75.00% 
          
    False Positives ≥ 1 .45 .85 3.00 .65 .75 .61 13.64% 45.00% 
 ≥ 2 .30 .91 3.30 .77 .75 .59 13.64% 30.00% 
 ≥ 3 .20 .91 2.20 .88 .67 .56 9.09% 30.00% 
 ≥ 4 .20 1.00 0.00 .80 1.00 .58 0.00% 20.00% 
 ≥ 5 .15 1.00 0.00 .85 1.00 .56 0.00% 20.00% 
 ≥ 6 .15 1.00 0.00 .85 1.00 .56 0.00% 15.00% 
 ≥ 7 .10 1.00 0.00 .90 1.00 .55 0.00% 15.00% 
 ≥ 8 .10 1.00 0.00 .90 1.00 .55 0.00% 10.00% 
       ≥ 9 .05 1.00 0.00 .95 1.00 .54 0.00% 5.00% 
Note: Sn = sensitivity, Sp = specificity, LR+ = positive likelihood ratio; LR- = negative likelihood ratio; 
PPP = positive predictive power; NPP = negative predictive power; Rey FIT = Rey 15-Item Test 
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Appendix Q 
Community Clinical Group Rey FIT Classification Statistics 
        Cumulative %  
of sample at cut-
score 
PVT Cut-
Score 
Sn Sp LR+ LR- PPP NPP Clinical Simulation 
Rey FIT           
     Recognition  ≤ 2 .05 1.00 0.00 .95 1.00 .54 0.00% 5.00% 
 ≤ 3 .20 .91 2.30 .88 .67 .57 8.70% 20.00% 
 ≤ 4 .20 .87 1.53 .92 .57 .56 13.00% 20.00% 
 ≤ 5 .25 .87 1.92 .86 .63 .57 13.00% 25.00% 
 ≤ 6 .35 .87 2.68 .75 .70 .61 13.00% 35.00% 
 ≤ 7 .35 .87 2.68 .75 .70 .61 13.00% 35.00% 
 ≤ 8 .35 .83 2.01 .79 .64 .59 17.40% 35.00% 
 ≤ 9 .35 .78 1.61 .83 .58 .58 21.70% 35.00% 
 ≤ 10 .45 .74 1.73 .74 .60 .61 26.10% 45.00% 
 ≤ 11 .50 .74 1.92 .68 .63 .63 26.10% 50.00% 
 ≤ 12 .55 .70 1.81 .65 .61 .64 30.40% 55.00% 
 ≤ 13 .65 .70 2.14 .50 .65 .70 30.40% 65.00% 
 ≤ 14 .25 .57 .58 1.33 .33 .46 56.50% 75.00% 
          
     False 
Positives 
≥ 1 .45 .74 1.73 .74 .60 .61 26.09% 45.00% 
 ≥ 2 .30 .96 6.90 .73 .86 .61 4.35% 30.00% 
 ≥ 3 .20 .96 4.60 .84 .80 .58 4.35% 20.00% 
 ≥ 4 .20 1.00 0.00 .80 1.00 .59 0.00% 20.00% 
 ≥ 5 .20 1.00 0.00 .80 1.00 .59 0.00% 15.00% 
 ≥ 6 .15 1.00 0.00 .85 1.00 .58 0.00% 15.00% 
 ≥ 7 .15 1.00 0.00 .85 1.00 .58 0.00% 10.00% 
 ≥ 8 .10 1.00 0.00 .90 1.00 .56 0.00% 10.00% 
 ≥ 9 .05 1.00 0.00 .95 1.00 .55 0.00% 5.00% 
Note: Sn = sensitivity, Sp = specificity, LR+ = positive likelihood ratio; LR- = negative likelihood ratio; 
PPP = positive predictive power; NPP = negative predictive power; Rey FIT = Rey 15-Item Test 
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Appendix R 
Control Group Automatized Sequences Classification Statistics 
        Cumulative %  
of sample at cut-
score 
PVT Cut-
Score 
Sn Sp LR+ LR- PPP NPP Control Simulation 
Automatized Sequences          
   Alphabet Time ≥ 3 1.00 .05 1.05 0.00 .49 1.00 95.45%  
 ≥ 4 1.00 .14 1.16 0.00 .51 1.00 86.36% 100% 
 ≥ 5 .85 .32 1.25 .47 .53 .70 68.18% 85.00% 
 ≥ 6 .80 .45 1.47 .44 .57 .71 54.55% 80.00% 
 ≥ 7 .70 .73 2.57 .41 .70 .73 27.27% 80.00% 
 ≥ 8 .70 .82 3.85 .37 .78 .75 18.18% 70.00% 
 ≥ 9 .60 .86 4.40 .46 .80 .70 18.18% 70.00% 
 ≥ 10 .60 .86 4.40 .46 .80 .70 18.18% 70.00% 
 ≥ 11 .60 .86 4.40 .46 .80 .70 18.18% 70.00% 
 ≥ 12 .60 .86 4.40 .46 .80 .70 18.18% 70.00% 
 ≥ 13 .60 .86 4.40 .46 .80 .70 13.64% 60.00% 
 ≥ 14 .55 .91 6.05 .50 .85 .69 9.09% 55.00% 
 ≥ 15 .50 .95 11.00 .52 .91 .68 4.55% 50.00% 
 ≥ 16 .45 1.00 0.00 .55 1.00 .68 0.00% 45.00% 
 ≥ 17 .45 1.00 0.00 .55 1.00 .68 0.00% 45.00% 
 ≥ 18 .45 1.00 0.00 .55 1.00 .68 0.00% 45.00% 
 ≥ 19 .40 1.00 0.00 .60 1.00 .65 0.00% 40.00% 
 ≥ 20 .35 1.00 0.00 .65 1.00 .63 0.00% 35.00% 
 ≥ 21 .30 1.00 0.00 .70 1.00 .61 0.00% 30.00% 
 ≥ 22 .25 1.00 0.00 .75 1.00 .59 0.00% 25.00% 
 ≥ 27 .20 1.00 0.00 .80 1.00 .58 0.00% 20.00% 
 ≥ 31 .15 1.00 0.00 .85 1.00 .56 0.00% 15.00% 
 ≥ 42 .05 1.00 0.00 .95 1.00 .54 0.00% 5.00% 
          
     Counting Time ≥ 3 1.00 .05 1.05 0.00 .49 1.00 95.45% 100% 
 ≥ 4 1.00 .09 1.10 0.00 .50 1.00 90.91% 100% 
 ≥ 5 .85 .45 1.56 .33 .59 .77 54.55% 85.00% 
 ≥ 6 .80 .77 3.52 .26 .76 .81 22.73% 80.00% 
 ≥ 7 .65 .95 14.3 .37 .93 .75 4.55% 65.00% 
 ≥ 8 .55 1.00 0.00 .45 1.00 .71 0.00% 55.00% 
 ≥ 11 .45 1.00 0.00 .55 1.00 .67 0.00% 45.00% 
 ≥ 12 .40 1.00 0.00 .60 1.00 .65 0.00% 40.00% 
 ≥ 13 .35 1.00 0.00 .65 1.00 .63 0.00% 35.00% 
 ≥ 16 .30 1.00 0.00 .70 1.00 .61 0.00% 30.00% 
 ≥ 18 .20 1.00 0.00 .80 1.00 .58 0.00% 20.00% 
 ≥ 23 .15 1.00 0.00 .85 1.00 .56 0.00% 15.00% 
 ≥ 25 .10 1.00 0.00 .90 1.00 .55 0.00% 10.00% 
 ≥ 54 .05 1.00 0.00 .95 1.00 .54 0.00% 5.00% 
          
    Days of the 
Week 
≥ 2 .95 .05 1.00 1.10 .48 .50 95.45% 95.00% 
 ≥ 3 .85 .64 2.34 .24 .68 .82 36.36% 85.00% 
 ≥ 4 .65 .86 4.77 .41 .81 .73 13.64% 65.00% 
 ≥ 5 .50 1.00 0.00 .50 1.00 .69 0% 50.00% 
 ≥ 6 .45 1.00 0.00 .55 1.00 .67 0% 45.00% 
 ≥ 7 .30 1.00 0.00 .70 1.00 .61 0% 30.00% 
Appendix R continued on the next page 
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Appendix R (continued) 
Control Group Automatized Sequences Classification Statistics 
    Days of the 
Week 
≥ 8 .25 1.00 0.00 .75 1.00 .59 0.00% 25.00% 
 ≥ 9 .25 1.00 0.00 .75 1.00 .59 0.00% 25.00% 
 ≥ 10 .20 1.00 0.00 .80 1.00 .58 0.00% 20.00% 
 ≥ 11 .10 1.00 0.00 .90 1.00 .55 0.00% 10.00% 
 ≥ 17 .05 1.00 0.00 .95 1.00 .54 0.00% 5.00% 
   Months of Year ≥ 4 1.00 .09 1.10 0.00 .50 1.00 90.91% 100% 
 ≥ 5 .90 .59 2.20 .17 .67 .87 40.91% 90.00% 
 ≥ 6 .75 .68 2.36 .37 .68 .75 31.82% 75.00% 
 ≥ 7 .65 .73 2.39 .48 .68 .70 27.27% 75.00% 
 ≥ 8 .60 .73 2.20 .55 .67 .67 27.27% 65.00% 
 ≥ 9 .60 .77 2.64 .52 .71 .68 22.73% 65.00% 
 ≥ 10 .60 .82 3.30 .49 .75 .69 22.73% 60.00% 
 ≥ 11 .40 .82 2.20 .73 .67 .60 18.18% 60.00% 
 ≥ 12 .40 .86 2.93 .69 .73 .61 18.18% 40.00% 
 ≥ 16 .35 .86 2.57 .75 .70 .59 18.18% 35.00% 
 ≥ 17 .30 .86 2.2 .81 .67 .58 18.18% 30.00% 
 ≥ 18 .20 .86 1.47 .93 .57 .54 18.18% 20.00% 
 ≥ 22 .15 .86 1.10 .98 .50 .53 13.64% 15.00% 
 ≥ 23 .10 .91 1.1 .99 .50 .53 9.09% 10.00% 
 ≥ 26 .05 .91 .55 1.05 .33 .51 9.09% 10.00% 
 ≥ 28 .05 .95 1.10 1.00 .50 .53 4.55% 5.00% 
 ≥ 35 0.00 .95 0.00 1.05 0.00 .51 4.55% 0.00% 
     Total Time ≥ 12 1.00 .05 1.05 0.00 .49 1.00 95.45% 100% 
 ≥ 13 1.00 .09 1.10 0.00 .50 1.00 90.91% 100% 
      ≥ 14 1.00 .23 1.29 0.00 .54 1.00 77.27% 100% 
 ≥ 15 .90 .27 1.24 .37 .53 .75 72.73% 100% 
 ≥ 16 .90 .32 1.32 .31 .55 .78 68.18% 100% 
 ≥ 17 .90 .41 1.52 .24 .58 .82 59.09% 100% 
      ≥ 18 .90 .50 1.80 .02 .62 .85 50.00% 90.00% 
 ≥ 20 .85 .64 2.34 .24 .68 .82 36.36% 85.00% 
 ≥ 21 .85 .68 2.67 .22 .71 .83 31.82% 85.00% 
 ≥ 22 .75 .68 2.36 .37 .68 .75 31.82% 75.00% 
 ≥ 24 .75 .77 3.30 .32 .75 .77 22.73% 75.00% 
 ≥ 25 .65 .77 2.86 .45 .72 .71 22.73% 70.00% 
 ≥ 33 .60 .77 2.64 .52 .71 .68 22.73% 60.00% 
 ≥ 34 .60 .82 3.30 .49 .75 .69 18.18% 60.00% 
 ≥ 36 .55 .82 3.03 .55 .73 .67 18.18% 55.00% 
 ≥ 38 .50 .82 2.75 .61 .71 .64 18.18% 50.00% 
 ≥ 39 .50 .86 3.67 .58 .77 .66 13.64% 50.00% 
 ≥ 45 .50 .91 5.50 .55 .83 .67 9.09% 50.00% 
 ≥ 47 .45 .91 4.95 .61 .82 .65 9.09% 45.00% 
 ≥ 52 .40 .91 4.40 .66 .80 .63 9.09% 40.00% 
 ≥ 58 .35 .95 7.70 .68 .88 .62 4.55% 35.00% 
 ≥ 59 .30 1.00 0.00 .70 1.00 .61 0.00% 30.00% 
 ≥ 62 .25 1.00 0.00 .75 1.00 .59 0.00% 25.00% 
 ≥ 82 .20 1.00 0.00 .80 1.00 .58 0.00% 20.00% 
 ≥ 86 .15 1.00 0.00 .85 1.00 .56 0.00% 15.00% 
 ≥ 92 .10 1.00 0.00 .90 1.00 .55 0.00% 10.00% 
 ≥ 123 .05 1.00 0.00 .95 1.00 .54 0.00% 5.00% 
Note: Sn = sensitivity, Sp = specificity, LR+ = positive likelihood ratio; LR- = negative likelihood ratio; 
PPP = positive predictive power; NPP = negative predictive power 
  127 
 
Appendix S 
Community Clinical Group Automatized Sequences Classification Statistics 
        Cumulative %  
of sample at cut-
score 
PVT Cut-
Score 
Sn Sp LR+ LR- PPP NPP Clinical Simulation 
Automatized Sequences          
     Alphabet Time ≥ 2 1.00 0.00 1.00 0.00 .48 0.00 100%  
 ≥ 3 1.00 .04 1.04 0.00 .48 1.00 95.65%  
 ≥ 4 1.00 .13 1.15 0.00 .50 1.00 86.96% 100% 
 ≥ 5 .85 .30 1.22 .49 .52 .70 65.22% 85.00% 
 ≥ 6 .80 .57 1.84 .35 .62 .76 43.48% 80.00% 
 ≥ 7 .70 .65 2.01 .46 .64 .71 34.78% 70.00% 
 ≥ 8 .70 .74 2.68 .41 .70 .74 26.09% 70.00% 
 ≥ 9 .60 .74 2.30 .54 .67 .68 26.09% 60.00% 
 ≥ 10 .60 .78 2.76 .51 .71 .69 21.74% 60.00% 
 ≥ 11 .60 .83 3.45 .48 .75 .70 17.39% 60.00% 
 ≥ 12 .60 .87 4.60 .46 .80 .71 13.04% 60.00% 
 ≥ 13 .60 .87 4.60 .46 .80 .71 13.04% 60.00% 
 ≥ 14 .55 .87 4.21 .52 .79 .69 13.04% 55.00% 
 ≥ 15 .50 .87 3.83 .58 .77 .67 13.04% 50.00% 
 ≥ 16 .45 .87 3.45 .63 .75 .65 13.04% 45.00% 
 ≥ 18 .40 .87 3.07 .69 .73 .63 13.04% 40.00% 
 ≥ 19 .40 .91 4.60 .66 .80 .64 8.70% 40.00% 
 ≥ 20 .35 .91 4.03 .71 .78 .62 8.70% 35.00% 
 ≥ 21 .30 .91 3.45 .77 .75 .60 8.70% 30.00% 
 ≥ 22 .25 .96 5.75 .78 .83 .59 4.35% 25.00% 
 ≥ 27 .20 .96 4.60 .84 .80 .58 4.35% 20.00% 
 ≥ 31 .15 .96 3.45 .89 .75 .56 4.35% 15.00% 
 ≥ 40 .05 .96 1.15 .99 .50 .54 4.35% 5.00% 
 ≥ 42 .05 1.00 0.00 .95 1.00 .55 0.00% 5.00% 
          
     Counting Time ≥ 4 1.00 .09 1.10 0.00 .49 1.00 91.30% 100% 
 ≥ 5 .85 .30 1.22 .49 .52 .70 69.57% 85.00% 
 ≥ 6 .80 .65 2.30 .31 .67 .79 34.78% 80.00% 
 ≥ 7 .65 .83 3.74 .42 .76 .73 17.39% 65.00% 
 ≥ 8 .55 .91 6.33 .49 .85 .70 8.70% 55.00% 
 ≥ 11 .45 .91 5.18 .60 .82 .66 8.70% 45.00% 
 ≥ 12 .40 .91 4.6 .66 .80 .64 8.70% 40.00% 
 ≥ 13 .35 .91 4.03 .71 .78 .62 8.70% 35.00% 
 ≥ 14 .30 .96 6.90 .73 .86 .61 4.35% 30.00% 
 ≥ 16 .30 1.00 0.00 .70 1.00 .62 0.00% 30.00% 
 ≥ 18 .20 1.00 0.00 .80 1.00 .59 0.00% 20.00% 
 ≥ 23 .15 1.00 0.00 .85 1.00 .58 0.00% 15.00% 
 ≥ 25 .10 1.00 0.00 .90 1.00 .56 0.00% 10.00% 
 ≥ 54 .05 1.00 0.00 .95 1.00 .55 0.00% 5.00% 
          
 Days of the Week  ≥ 1 .95 0.00 .95 0.00 .45 0.00 100% 100% 
 ≥ 2 .95 .04 .99 1.15 .46 .50 95.65% 95.00% 
 ≥ 3 .85 .43 1.50 .35 .57 .77 56.52% 85.00% 
 ≥ 4 .65 .78 2.99 .45 .72 .72 21.74% 65.00% 
 ≥ 5 .50 .87 3.83 .58 .77 .67 13.04% 50.00% 
 ≥ 6 .45 .96 10.35 .58 .90 .67 4.35% 45.00% 
 ≥ 7 .30 .96 6.90 .73 .86 .61 4.35% 30.00% 
 ≥ 8 .25 .96 5.75 .78 .83 .59 4.35% 25.00% 
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Appendix S (continued) 
Community Clinical Group Automatized Sequences Classification Statistics 
        Cumulative %  
of sample at cut-
score 
PVT Cut-Score Sn Sp LR+ LR- PPP NPP Clinical Simulation 
 Days of the Week ≥ 9 .20 1.00 0.00 .80 1.00 .59 0.00% 25.00% 
 ≥ 10 .20 1.00 0.00 .80 1.00 .59 0.00% 20.00% 
 ≥ 11 .10 1.00 0.00 .90 1.00 .56 0.00% 10.00% 
 ≥ 17 .05 1.00 0.00 .95 1.00 .55 0.00% 5.00% 
  Months of Year ≥ 4 1.00 .04 1.05 0.00 .48 1.00 95.65% 100% 
 ≥ 5 .90 .26 1.22 .38 .51 .75 73.91% 90.00% 
 ≥ 6 .75 .30 1.08 .82 .48 .58 69.57% 75.00% 
 ≥ 7 .65 .48 1.25 .73 .52 .61 52.17% 65.00% 
 ≥ 8 .65 .48 1.25 .73 .52 .61 52.17% 65.00% 
 ≥ 9 .60 .52 1.25 .77 .52 .60 47.83% 60.00% 
 ≥ 10 .60 .52 1.25 .77 .52 .60 47.83% 60.00% 
 ≥ 12 .40 .52 .84 1.15 .42 .50 47.83% 40.00% 
 ≥ 16 .30 .78 1.38 .89 .55 .56 21.74% 35.00% 
 ≥ 17 .25 .83 1.43 .91 .56 .56 17.39% 30.00% 
 ≥ 18 .20 .87 1.53 .92 .57 .56 13.04% 20.00% 
 ≥ 21 .15 .87 1.15 .98 .50 .54 13.04% 15.00% 
 ≥ 22 .15 .91 1.73 .93 .60 .55 8.70% 15.00% 
 ≥ 23 .10 .91 1.15 .99 .50 .54 8.70% 10.00% 
 ≥ 25 .05 .91 .58 1.04 .33 .53 8.70% 5.00% 
 ≥ 28 .05 .96 1.15 .99 .50 .54 4.35% 5.00% 
 ≥ 44 .00 .96 0.00 1.05 0.00 .52 4.35% 0.00% 
     Total Time ≥ 14 1.00 .09 1.10 0.00 .49 1.00 91.30% 100% 
 ≥ 15 .90 .17 1.09 .58 .49 .67 82.61% 100% 
 ≥ 16 .90 .26 1.22 .38 .51 .75 73.91% 100% 
 ≥ 17 .90 .26 1.22 .38 .51 .75 73.91% 100% 
      ≥ 18 .90 .35 1.38 .29 .55 .80 65.22% 90.00% 
 ≥ 20 .85 .35 1.30 .43 .53 .73 65.22% 85.00% 
 ≥ 22 .75 .39 1.23 .64 .52 .64 60.87% 75.00% 
 ≥ 23 .75 .43 1.33 .58 .54 .67 56.52% 75.00% 
 ≥ 25 .70 .48 1.34 .63 .54 .65 52.17% 70.00% 
 ≥ 26 .60 .52 1.25 .77 .52 .60 47.83% 60.00% 
 ≥ 28 .60 .61 1.53 .66 .57 .64 39.13% 60.00% 
 ≥ 29 .60 .65 1.73 .61 .60 .65 34.78% 60.00% 
 ≥ 33 .60 .78 2.76 .51 .71 .69 21.74% 60.00% 
 ≥ 36 .55 .78 2.53 .58 .69 .67 21.74% 55.00% 
 ≥ 37 .55 .78 2.53 .58 .69 .67 21.74% 55.00% 
 ≥ 38 .50 .83 2.88 .61 .71 .66 17.39% 50.00% 
 ≥ 47 .50 .87 3.83 .58 .77 .67 13.04% 45.00% 
 ≥ 49 .40 .87 3.07 .69 .73 .63 13.04% 40.00% 
 ≥ 52 .40 .91 4.60 .66 .80 .64 8.70% 40.00% 
 ≥ 58 .35 .91 4.03 .71 .78 .62 8.70% 35.00% 
 ≥ 59 .30 .91 3.45 .77 .75 .60 8.70% 30.00% 
 ≥ 62 .25 .91 2.88 .82 .71 .58 8.70% 25.00% 
 ≥ 69 .20 .91 2.30 .88 .67 .57 8.70% 20.00% 
 ≥ 82 .20 .96 4.60 .84 .80 .58 4.35% 20.00% 
 ≥ 86 .15 .96 3.45 .89 .75 .56 4.35% 15.00% 
 ≥ 92 .10 1.00 0.00 .90 1.00 .56 0.00% 10.00% 
 ≥ 123 .05 1.00 0.00 .95 1.00 .55 0.00% 5.00% 
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Appendix T 
Control Group SVT Classification Statistics 
 Cumulative %  
of sample at cut-
score 
SVT Cut-Score Sn Sp LR+ LR- PPP NPP Control Simulation 
BASC-2 Child          
     V Index ≥ 1 .35 .91 3.85 .72 .78 .61 9.09% 100.00% 
 ≥ 2 .35 .95 7.70 .68 .88 .62 4.55% 35.00% 
 ≥ 3 .25 1.00 0.00 .75 1.00 .59 0.00% 25.00% 
 ≥ 4 .20 1.00 0.00 .80 1.00 .58 0.00% 20.00% 
 ≥ 5 .15 1.00 0.00 .85 1.00 .56 0.00% 15.00% 
 ≥ 9 .10 1.00 0.00 .90 1.00 .55 0.00% 10.00% 
          
BASC-2 
Parent 
         
     F Index ≥ 1 .70 .87 5.37 .35 .82 .77 13.04% 70.00% 
 ≥ 3 .40 1.00 0.00 .60 1.00 .66 0.00% 40.00% 
 ≥ 4 .35 1.00 0.00 .65 1.00 .64 0.00% 35.00% 
 ≥ 5 .20 1.00 0.00 .80 1.00 .59 0.00% 20.00% 
 ≥ 9 .10 1.00 0.00 .90 1.00 .56 0.00% 10.00% 
 ≥ 12 .05 1.00 0.00 .95 1.00 .55 0.00% 5.00% 
          
BRIEF - Parent          
     Negativity ≥ 1 .75 .91 8.63 .27 .88 .81 8.70% 75.00% 
 ≥ 2 .60 1.00 0.00 .40 1.00 .74 0.00% 60.00% 
 ≥ 3 .55 1.00 0.00 .45 1.00 .72 0.00% 55.00% 
 ≥ 4 .40 1.00 0.00 .60 1.00 .66 0.00% 40.00% 
 ≥ 5 .35 1.00 0.00 .65 1.00 .64 0.00% 35.00% 
 ≥ 6 .30 1.00 0.00 .70 1.00 .62 0.00% 30.00% 
 ≥ 7 .15 1.00 0.00 .85 1.00 .58 0.00% 15.00% 
 ≥ 9 .05 1.00 0.00 .95 1.00 .55 0.00% 5.00% 
Note: Sn = sensitivity, Sp = specificity, LR+ = positive likelihood ratio; LR- = negative likelihood ratio; 
PPP = positive predictive power; NPP = negative predictive power; BASC-2 = Behavior Assessment 
System for Children – Second Edition; BRIEF = Behavior Rating Inventory of Executive Function 
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Appendix U 
Community Clinical Group SVT Classification Statistics 
 Cumulative %  
of sample at cut-
score 
SVT Cut-Score Sn Sp LR+ LR- PPP NPP Clinical Simulation 
BASC-2 Child          
     V Index ≥ 1 .35 .87 2.68 .75 .70 .61 13.04% 100.00% 
 ≥ 2 .35 .91 4.03 .71 .78 .62 8.70% 35.00% 
 ≥ 3 .25 1.00 0.00 .75 1.00 .61 0.00% 25.00% 
 ≥ 4 .20 1.00 0.00 .80 1.00 .59 0.00% 20.00% 
 ≥ 5 .15 1.00 0.00 .85 1.00 .58 0.00% 15.00% 
 ≥ 9 .10 1.00 0.00 .90 1.00 .56 0.00% 10.00% 
          
BASC-2 
Parent 
         
     F Index ≥ 1 .70 .70 2.30 .43 .67 .73 30.43% 70.00% 
 ≥ 2 .40 .83 2.30 .73 .67 .61 17.39% 70.00% 
 ≥ 3 .40 .83 2.40 .72 .67 .63 13.04% 40.00% 
 ≥ 4 .35 .96 8.05 .68 .88 .63 4.35% 35.00% 
 ≥ 5 .20 .96 4.60 .84 .80 .58 4.35% 20.00% 
 ≥ 6 .10 .96 2.30 .94 .67 .55 4.35% 10.00% 
 ≥ 9 .10 1.00 0.00 .90 1.00 .56 0.00% 10.00% 
 ≥ 12 .05 1.00 0.00 .95 1.00 .55 0.00% 5.00% 
          
BRIEF - Parent          
     Negativity ≥ 1 .75 .39 1.23 .64 .52 .64 60.87% 75.00% 
 ≥ 2 .60 .52 1.25 .77 .52 .60 47.83% 60.00% 
 ≥ 3 .60 .74 2.30 .54 .67 .68 26.09% 55.00% 
 ≥ 4 .40 .83 2.30 .73 .67 .61 17.39% 40.00% 
 ≥ 5 .35 .96 8.05 .68 .88 .63 4.35% 35.00% 
 ≥ 6 .30 .96 6.90 .73 .86 .61 4.35% 30.00% 
 ≥ 7 .15 1.00 0.00 .85 1.00 .58 0.00% 15.00% 
 ≥ 9 .05 1.00 0.00 .95 1.00 .55 0.00% 5.00% 
Note: Sn = sensitivity, Sp = specificity, LR+ = positive likelihood ratio; LR- = negative likelihood ratio; 
PPP = positive predictive power; NPP = negative predictive power; BASC-2 = Behavior Assessment 
System for Children – Second Edition; BRIEF = Behavior Rating Inventory of Executive Function 
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Appendix V 
BASC-2 Parent and Child/Adolescent Correlation Coefficients for Overlapping Clinical Scales 
 Parent / Child Reports 
(n = 42) 
Parent/ Adolescent 
Reports 
(n = 24) 
Clinical Scales   
Atypicality .19 .56** 
Anxiety .25 .33 
Depression .14 .22 
Somatization __ .42* 
Attention Problems .41** .45* 
Hyperactivity .30 .39 
Note: BASC-2 = Behavior Assessment System for Children – Second Edition; * = p > .05; ** 
= p > .01 
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Appendix W 
Frequency of Failure for Participants with ADHD (n = 60) at Previously Established Cut-Off 
Scores  
  Cut-off ADHD 
VSVTa   
  Invalid   
     Easy Correct ≤ 7 0% (0) 
     Difficult Correct ≤ 7 0% (0) 
     Total Correct ≤ 17 0% (0) 
 Questionable    
     Easy Correct 8 - 15 7% (4) 
     Difficult Correct 8 - 15 27% (16) 
     Total Correct 18 - 29 8% (5) 
 Valid   
     Easy Correct ≥ 16 93% (54) 
     Difficult Correct ≥ 16 73% (44) 
     Total Correct ≥ 30 92% (55) 
Digit Span   
     ACSSb ≤ 5 19% (11) 
     RDSb ≤ 6 22% (13) 
     RDS-Rc ≤ 11 40% (21) 
ASTe   
     Alphabet1 ≥ 8 25% (3) 
     Counting1 ≥ 6 17% (2) 
     Days of Week1 ≥ 4 8% (1) 
     Months1 ≥ 10 42% (5) 
     Total1 ≥ 27 25% (3) 
Note: Sample size varies slightly across measures, thus frequency and percentage are reported. 
Cut-off scores were identified from the following publications; VSVTa = Slick et al., 1997 
VSVT manual with adult normative data; ACSSb and RDSb = Kirkwood et al., 2011 child and 
adolescent mTBI sample; RDS-Rc = Spencer et al. 2013 and Young et al., 2012 adult veterans; 
ASTe = Kirkwood et al., 2014 child and adolescent mTBI sample; 1 = time in seconds 
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Appendix X 
Frequency of PVT Failure Rate for Participants with ADHD (n = 60) at Newly Proposed Cut-
Off Scores 
PVT Cut-Score ADHD 
VSVT   
     Easy Correct ≤ 17 11% (7) 
     Dif. Correct ≤ 12 15% (9) 
     Total Correct ≤ 31 17% (10) 
Digit Span   
     DS ACSS ≤ 4 8% (5) 
     RDS ≤ 5 10% (6) 
     RDS-R ≤ 8 7% (4) 
AST   
     Alphabet ≥ 19 8% (1) 
     Count to 20 ≥ 8 8% (1) 
     Days of Week ≥ 6 8% (1) 
     Months of Year ≥ 22 8% (1) 
     Total Time ≥ 52 8% (1) 
Note: Cut-off scores presented were identified in Table 10 as optimal for the entire clinical 
sample. Frequency and percentage of failure rate is presented due to varied sample size across 
measures. 
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Appendix Y 
 
Figure 1. Number of PVTs and SVTs failed, organized by community- recruited group. 
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